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ABSTRACT

An abstract o f the dissertation o f Itai Chipinda for the Doctor o f Philosophy in
Environmental Sciences and Resources: Chemistry presented April 6,2007.

Title:

Selected Chemistry o f Biologically-Active Thiols: N-Acetylpenicillamine
and 2-Mercaptobenzothiazole in Nitrosothiol Formation and Role in
Allergic Contact Dermatitis Respectively.

Two biologically-active thiols, N-acetylpenicillamine (NAP) and 2mercaptobenzothiazole (MBT), were studied in this thesis. NAP is known to combine
with nitric oxide (NO) to produce S-nitroso-N-acetylpenicillamine (SNAP) and MBT
is a known allergen.
The formation, reaction dynamics, and detailed kinetics and mechanism o f the
reaction between nitrous acid (HNO 2), prepared in situ, and NAP to produce SNAP
were studied. The reaction is first order in nitrite, NAP and acid in pH conditions at or
slightly higher than the pKa o f HNO 2 . Both HPLC and quadrupole time-of-flight mass
spectrometry techniques confirmed the formation o f SNAP and the absence o f any
other products. Cu(I) ions were found to be effective SNAP-decomposition catalysts.
The formation o f SNAP occurs through two distinct pathways. One involves the direct
reaction o f NAP and HNO 2 to form SNAP and eliminate water, and the second
pathway involved the initial formation o f the nitrosyl cation, NO+, which then

nitrosates the thiol. The bimolecular rate constant for the reaction o f NAP and HNO 2
was derived as 2.69 M "1 s'1, while that o f direct nitrosation by the nitrosyl cation was
3.00 x 104 M ’ 1 s '1. A simple reaction network made up o f four reactions was found to
be sufficient in simulating the formation kinetics and acid-induced decomposition o f
SNAP.
The chemical mechanism leading to M BT’s allergenicity is unknown. It was
hypothesized that the thiol group is critical to M BT’s covalent binding/haptenation to
nucleophilic protein residues. Hypochlorous acid oxidized MBT to the disulfide, 2, 2 ’dithiobis(benzothiazole) (MBTS), within the glove matrix. Cysteine reduced MBTS to
MBT with subsequent formation o f the mixed disulfide 2-amino-3-(benzothiazol-2-yl
disulfanyl)-propionic acid. Simultaneous reduction o f MBTS and disulfide formation
with Cys34 on bovine serum albumin was observed, suggesting a potential route o f
protein haptenation through covalent bonding between cysteinyl residues on proteins
and the MBT/MBTS thiol moiety. Guinea pigs were sensitized to MBT using a
modified guinea pig maximization assay (GPMT) and cross-reactivity towards MBTS
and the free thiol-lacking or blocked compounds benzothiazole (BT), 2hydroxybenzothiazole (HBT) and 2-(methylthio)benzothiazole (MTBT) assessed.
MBT and MBTS, but not BT, HBT or MTBT elicited allergic contact dermatitis
(ACD) in MBT-sensitized animals.
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CHAPTER 1

NITRIC OXIDE DONORS: FORMATION, CHARACTERIZATION AND
STABILITY OF EXOGENOUS NITRIC OXIDE DONORS

1. INTRODUCTION
Nitric oxide (NO) was discovered by the British scientist Joseph Priestley more
than two centuries ago when he reacted nitric acid with metallic copper (R1.1). It is
among the numerous nitrogen oxides where nitrogen exhibits positive oxidation states
ranging from +1 to +5.

3Cu + SHN03 -> 2 NO + 3Cu(N03)2 +4H20

R 1 .1

The NO molecule is also produced as a free radical (*N=0) when molecular nitrogen
and oxygen combine in high temperature environments such as when lightning occurs.
In fact, NO is formed in the trophosphere by the action o f lightning . 1 Other sources o f
NO include automobile and aircraft engines ,2 electric arc processes and power plants.
It is also found in large amounts in cigarette smoke - concentrations o f 800 ppm NO
have been reported .3 NO is formed in the soil by nitrifying bacteria and removed by
denitrifying bacteria which form nitrous oxide from it .4 So, nitric oxide, along w ith
other oxides o f nitrogen, is constantly being released into the air from the soil as part
1

o f the cycle involving plants and bacteria, both o f which are capable o f producing NO.
This molecule has some commercial uses which include the detection o f surface
radicals on polymers, bleaching o f rayon, as a stabilizer for propylene and methyl
ether, and it is also used as an intermediate in the Ostwald process. The Environmental
Protection Agency (EPA) includes NO among the various oxides o f nitrogen (NOx)
which are responsible for environmental pollution and degradation. Examples o f
deleterious effects o f NO include ozone depletion, production o f acid rain and other
toxic chemicals, atmospheric particulates, eutrophication, global warming and
visibility impairment in urban areas .5

1.1 The Chemistry and Biology of Nitric Oxide
1.1.1 Physical Properties of Nitric Oxide
Nitric oxide occurs as one o f the simplest odd-electron diatomic molecules. Figure
1.1 depicts the molecular orbital diagram o f NO with the unpaired electron occupying
the antibonding 2pFl* molecular orbital on free NO (Figure 1.1(a)). In a crystalline
field such as when NO coordinatively bonds with metal ions or is adsorbed on
inorganic matrixes, the degeneracy o f the 2 p llb is perturbed and there is stabilization
o f the 2pab relative to the 2pFlb as shown in Figure 1.1 (b). The molecular orbital
arrangement (Figure 1.1) gives NO a bond order o f 2.5 which is intermediate between
a double and triple bond. NO is a colorless gas at room temperature with a nine-fold
solubility in hydrophobic solvents such as hexane relative to water. Table 1.1
summarises its physical properties. The endorthemicity o f NO formation coupled with

2

the large positive Gibbs energy o f formation (Table 1.1) implies that NO is
thermodynamically unstable. The reported values for the half-life o f NO under
physiological conditions range from

0 .1

to

6

s and these values are shortened to the

milliseconds order in whole blood owing to the rapid reaction o f NO with
oxyhemoglobins .6

2pa
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2p7ix
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2p7ix
2P° b

H
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Figure 1.1: Filling o f the molecular orbitals fo r fre e NO (a) a n d fo r the molecule in
a crystalline fie ld (b). N-O distance
triple bond.

=

1.1 A 0 (intermediate between double bond and

Table 1.1: Physical properties o f NO.

Property

Value

Colour

Colorless

Boiling point

-152 °C

Melting point

-164 °C

N -0 bond distance

1.1 A0

Dipolar moment

0.17 D

Gibbs energy of formation (AHf°)

90 kJ/mol (gas)
87.7 kJ/mol (liquid)

Molar Entropy (S°gas)

211 J/mol.K

Solubility at 25 °C

1.9 mM (water), 14 mM (methanol),
11 mM (toluene), 18 mM (hexane)

1.1.2 Biological Production of Nitric Oxide

Oxidative deamination o f one o f the two equivalent guanidino nitrogen atoms
on the amino acid L-arginine, which is present in high concentrations in blood (60-80
pM), is the widely accepted biosynthetic route that avails NO in the mammalian
physiological system . 7 Scheme 1.1 summarizes the mechanism responsible for NO
production. The process is catalyzed by three distinct nitric oxide synthase (NOS)
isoforms .8 NO is thus a result o f a complete series o f oxidative/reductive events
involving a number o f co-factors for which there are specific binding sites on the
4

enzyme.

/

H ,0

HN

O,

HN

NADPH NADP

H2N

0.5 mol 0.5 mol
NADPH NADP+

H,N

L-Arginine

H ,0

HN

H2N
L-Citrulline

N-Hydroxy-L-Arginine

NH

AMP

ATP

OH

OH

L-arginosuccinate

O

O
Aspartate

Fumarate

where R is HO

NH,

Scheme 1.1: Biological production o f N O fro m L-arginine and adenosyl
triphosphate (ATP) driven recycling o f L-citrulline back to L-arginine in the
presence aspartate. NO production is catalyzed by the three N OS isoforms in the
presence o f the co-factor NADPH.

N-hydroxy-arginine is the intermediate, when molecular oxygen oxidizes the nitrogen
on L-arginine, leading to L- citrulline and NO. In the presence o f adenosine
triphosphate (ATP) and aspartate, L-citrulline is recycled back to L-arginine and
fumarate through the intermediate L-arginosuccinate. The three isoforms have
5

been cloned and sequenced and Table 1.2 outlines the location, sources and activation
of the three isoforms. The naming o f these isoforms is derived from the tissues in
which they were first cloned and identified .9' 11 Neuronal NOS (nNOS/NOS I) and
endothelial NOS (eNOS/NOS III) are constitutively expressed (hence the term cNOS)
in neuronal and endothelial cells respectively while inducible NOS (iNOS/NOS II) is
expressed in cells involved in inflammation such as macrophages after stimulation
with cytokines, chemokines and/or endotoxins. These isoforms are present in other
cells as well . 12' 16 The similarities and differences inherent in the three isoforms are
highlighted in Figure 1.2. NOS III, unlike the other isoforms, possesses hydrophobic
anchors due to myristoylation and palmitoylation (covalent linkages o f the fatty acids,
myristic and palmitic acids to the enzyme) which it uses to dock to the plasma
membrane. NOS I contains a special region o f the protein called the PDZ domain
which provides selectivity toward sites in nerve synapses . 17 The enzyme consists o f an
oxygenase and a reductase domain (similar to the cytochrome P450 enzyme family)
each having their own catalytic activities. The oxygenase domain contains binding
sites for heme and tetrahydrobiopterin (BH 4 ) and is linked through a binding site for
calmodulin (CaM) to the reductase domain. This reductase domain contains binding
sites for flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN) and
nicotinamide adenine dinucleotide phosphate (NADPH). The primary amino acid
sequence is 51-57% homologous for the three isoforms. cNOS and iNOS do not differ
in their specific activity.

6

Table 1.2: Description o f the NOs isoforms.
Molecular
Weight
kDa

Isoform

nNOs
(NOS I)

Intracellular
Location

Astrocytes
Macrophages,
monocytes,
leukocytes,

Cytosolic

131

eNOs
(NOS III)

Neurons,
adrenal
medullary

Membrane
associated

161

iNOs
(NOS II)

Human Cellular
Sources

Endothelium,
platelets,
smooth muscle

Membrane
(inactive)
Cytosolic
(active)

133

Presence

Activation

Ca2+ increase
leading to
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Figure 1.2: Similarities and differences o f the N O S isoforms

The major difference is that cNOS activity is dependent on the transient
increase in intracellular Ca2+ which binds to a calmodulin (CaM) protein to
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activate the enzyme whereas iNOS is not Ca2+ dependent. The levels o f cNOS in
stimulated endothelial and neuronal cells have been shown to be at the sub
micromolar level relative to those (1-10 pM) in macrophages . 18 cNOS is transiently
activated and a low NO output isoform, while iNOS expression results in relatively
sustained production and high NO output.
Production o f NO was believed, until recently, to be a localized process
because the half life o f locally acting NO is only a few seconds. Recent studies have
disputed this notion. The use o f Fick’s second law o f diffusion and the diffusion co
efficient o f NO in liposomes (1.3 x 10' 5 cm 2 s' 1 at 20 °C) has enabled the estimation o f
the diffusion distances o f NO at given half-lives and these distances have been shown
to be 1-70 times more than the cell diameter . 19 The implications o f these calculations
are that endogenously produced NO may be able to exert its biological effects on
adjacent cells and thus the NOS-derived production o f NO does not have to be
localized within the cell. The rate o f production o f NO in anaesthetized and awake rats
was reported to be 0.33-0.85 and 0.36 - 0.72 pmol kg ' 1 h ' 1 respectively .20 The
estimated rate in humans is around 0.9 pmol kg ' 1 h ' 1.21 There is evidence to suggest
that in some special situations NO can be synthesized by other mechanisms even
though NOS is the main source .22
Chemiluminescence and analysis o f the oxidative metabolites o f NO (NO 2 +
NO3 = NOx) have been employed to show evidence o f the production o f NO by the
xanthine oxidase pathway and by the reaction o f H 2 O 2 and L-Arginine in a nonenzymatic way .23 The reduction o f nitrites in acid and reducing conditions, which
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occurs in ischaemic processes, has also been reported as a source o f NO .24

1.1.3 Nitric Oxide: “Friend or Foe?”
“A startlingly simple molecule (that) unites neuroscience, physiology,
immunology, and revises scientists’ understanding o f how cells communicate” was
how NO was hailed when Science voted it the molecule o f the year in 1992.25 This
was prompted by mounting evidence in which this paramagnetic molecule was shown
to be an important participant in several physiological and pathophysiological
processes. Prior to the last three decades NO had largely been ignored as a major
player in biological and biochemical mechanisms responsible for the important
physiologic occurrences ranging from immune responses to the manifestation o f a
number o f diseases. Numerous reviews have reported on work which highlights the
versatility o f the biology o f NO in the mammalian body .26-40 Solubility o f NO in both
hydrophobic and hydrophilic media enables it to permeate into hydrophobic regions of
membranes and interact with proteins and enzymes. Among its diverse and beneficial
functions, NO has been implicated in neurotransmission ,41 vascular smooth muscle
relaxation 42 immune regulation ,43 and inhibition o f platelet aggregation .44 The
evidence brought forward by the 1998 Nobel laureates Furchgott, Ignarro and Murad 45
which tied NO to the acetylcholine-induced endothelium derived relaxation factor
(EDRF) perhaps highlighted the most studied physiological role o f NO. N O ’s
proposed mechanism o f vasodilation is through activation o f the soluble form o f the
enzyme guanylate cyclase (sGC) by interaction o f NO with the prosthetic heme Fe(II)
9

ion and subsequent scission o f the Fe(II)-histidine bond. This high affinity Fe-NO
binding has been shown to activate sGC to catalyze the conversion o f guanyl
triphosphate (GTP) to cyclic guanyl monophosphate (cGMP) leading to
phosphorylation o f the enzyme, Protein Kinase G (PKG). An overview o f the cascade
of events is shown in Scheme 1.2.

GM P

Bloodi

iVesssi

V
<7

VasodiSati
V a s o d ila t flH

ATP: adenosinetriphosphate
PDE: phosphodiesterase

Scheme 1.2: The role o f NO in the activation o f soluble sGC. sG C catalyses the
form ation o f cyclic guanyl monophosphate fro m guanyl triphosphate. cGMP is
responsible fo r the activation o f the protein-phosphorylating enzyme, protein kinase
G (PKG). P D E ’s convert cGM P to GTP causing loss o f NO related vasodilating
effects.
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Scheme 1.3: Summary o f the chemistry o f NO. The direct effects o f NO, shown on
the left, are usually elicited at low NO concentrations, whereas the indirect effects o f
NO, shown on the right side, are elicited at high NO concentrations.

Numerous studies have also revealed diverse pathophysiological roles o f NO
including cytotoxicity in the innate immune system ,46 carcinogenicity ,47 cerebral
malaria ,48 edema formation , 49 endotoxic shock and apoptosis .50 The reaction o f
superoxide dismutase and hydrogen peroxide with NO produces the cytotoxic
peroxynitrite (ONOO') ion. The ONOO" is a potent oxidant which can nitrosate
proteins and nucleic acids, and can cause lipid peroxidation 51’53 (potentially its m ost
devastating action), in vivo. iNOS expression, by nature o f its increased

production o f NO, is central to the involvement o f NO in diseased states where excess
NO reacts with proteins, metalloproteins and oxidants. Scheme 1.3 highlights the
numerous reactions o f NO to biomolecules. The occurrence o f higher concentrations
o f NO leads to the production o f nitrosants such as N 2 O 3 and potent oxidants such as
HNO 3 . These chemicals may cause DNA damage, lipid oxidation, protein nitration. It
is thus apparent that NO participates in numerous complex chemical and biological
reactions in the mammalian body.

1.2 S-Nitrosothiols (RSNO’s)
1.2.1 Physiological S-Nitrosothiols
NO has been administered in the form o f organic nitrates (sublingually) for
patients with ischaemic heart disease and other sources have included molecules such
as sodium nitroprusside (intravenously (IV)), Angeli’s salt (in dogs), nitroglycerine,
amyl nitrite and diazeniumdiolates (NONOates) (orally ) . 54,55 These NO donors fell out
o f favor, though, when evidence emerged that some patients developed tolerance to
the NO releasing organic nitrates . 56 Cyanide toxicity was a possibility in the case o f
nitroprussides 57 and little was known o f the fate o f diazeniumdiolates that were
subsequently formed in the body. Inhaled NO gas (iNO) is able to provide important
therapeutic benefits to babies with persistent pulmonary hypertension o f the
newborn,

fO

although concerns about toxicity still remain.

These complications and the evidence for the formation o f endogeneous
thionitrites prompted the scientific world to propose S-nitrosothiols as possible
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therapeutic NO donors. S-Nitrosothiols have the general structure RSNO (where R is
mainly an organic group). Methods development in bioimaging o f NO coupled with
immunochemistry techniques and electron spin resonance spectroscopy has made it
possible to detect both free and bound NO in biological samples. Emerging and
compelling evidence now supports a fundamentally different thinking from the
traditional views o f nitric oxide biology which were based around four key principles:
(1) NO synthases have unique and independent physiological functions; (2) NO
diffuses freely in biological systems to carry out the tasks o f each isoform; (3) the
physiological actions o f NO are mediated primarily by cGMP; and (4) the cytotoxic
properties o f NO are the consequence o f noxious and nonspecific chemistry. In a new
paradigm shift, S-nitrosylation o f the thiol group o f cysteine has emerged as the
>
prototype redox-based post-translational thiol and protein modification responsible for
a lot o f NO related functions . 59 Among the various possible nitrosative/oxidative
modifications by SNO/NOx/NO, only S-nitrosylation o f proteins, peptides and amino
acids has unequivocally been shown to function not only as a reservoir o f NO
bioactivity, but also in redox homeostasis and in conveying or regulating physiological
cellular signals .60 RSNO’s are processed, transported, imported, exported and
degraded, and can operate both as second messengers and as a precisely regulated
mechanism for the control o f protein function. Even though the concentrations at
which RSNOs occur, in vivo, is debatable, it is now widely agreed that endogeneous
RSNOs exist both intracellularly and extracellularly. Endothelium-dependent
relaxation (of thoracic aorta) is correlated temporally with covalent modification by
13

NO o f many thiol-containing proteins throughout the vessel wall . 61 It has also been
observed that GSNO, rather than NO, provides most endogenous NO bioactivity in the
lung 62 and in addition, GSNO is a more potent, in vitro, human airway smooth muscle
relaxant, than theophylline .63
Perhaps the most compelling evidence for the specific NOS derived nitrosation
and existence o f endogenous RSNO’s was the ‘biotin switch’ assay which
demonstrated, in vivo, S-nitrosylation o f several neuronal proteins in mouse brain,
including some known to co-localize with nNOS. The detection and subsequent
identification by both mass fingerprinting and immunoblotting with individual,
protein-specific antibodies o f twenty-one biotinylated prominent RSNO-proteins 64
showed that 12 o f the 21 S-nitrosylated proteins found exist as endogenously Snitrosylated species in brain lysates. Consistent with the multi-faceted regulatory
function o f NO, RSNO-proteins included metabolic (enzyme), structural/cytoskeletal,
signaling and ion-channel proteins. Strikingly, S-nitrosylation was abrogated in the
nervous system o f nNOS knockout mice 65 and no RSNO-proteins were isolated from
their brain lysates. This conclusively confirmed the existence o f in vivo Snitrosylation, the numerous RSNO related funtions and the specificity o f the Snitrosylation. Human serum albumin, the most abundant protein thiol in plasma, is
endogenously S-nitrosylated 66 and fusions o f albumin, at concentrations that do not
change osmotic pressure, have been shown to increase blood pressure,

fil consistent

with sequestration o f endogenous NO as an RSNO-protein. The factors that determine
RSNO levels, in vivo, such as the release o f RSNO-metabolizing enzymes and other
14

transition-metal-containing proteins from injured cells during preparatory techniques
or disease, might contribute to observed variances in RSNO levels. The reasons that
these levels change in diseased states as shown in Table 1.3 are not well understood
despite numerous investigations.

Table 1.3: Occurrence o f RSNOs with diseases and proposed production pathways.

Disease

Location of RSNO

Mechanism

Arthritis

RSNOs in joints

Local NO production

Bronchopulmonary
dysplasia

Lung RSNO-proteins

Induction o f iNOS

Pre-term birth

RSNO-proteins in lung

Pulmonary hypertension

RSNO-Hb (RBC)

Low O 2 saturation

Hypoxemic neonates

Tracheal RSNOs

Synthetic defect

Diabetes

RSNO-Hb (RBC)

Defective release

Cystic fibrosis

GSNO in airway lining fluid

Decreased NO/GSH substrates

Asthma

GSNO in airway lining fluid

Accelerated metabolism

Inflammatory lung disease

RSNOs in exhaled-breath
condensate

Multiple sclerosis

Anti-RSNO-Cys antibodies
RSNOs in cerebrospinal fluid

Unkown
Induction o f iNOS

Pre-eclampsia

RSNO-albumin in plasma

Impaired RSNO release

Sepsis

RSNOs in RBCs, plasma,
other tissues?

Induction o f iNOS

Tuberculosis

Plasma RSNOs

Macrophage production

Hypercholesterolemia

Plasma RSNOs

Increased synthesis in plasma

Pneumonia

Airway RSNOs

Induction o f iNOS
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1.2.2 Formation of RSNOs
<S-Nitrosothiols are thioesters o f nitrite with the generic structure R -S-N = 0 and
are direct analogues o f the nitrite esters o f alcohols, the O-nitroso compounds. The
nature o f the relatively labile S-NO bond has propelled S-nitrosothiols to become a
fast emerging class o f exogenous NO donors. The fate o f the thiol/thiolate moiety
from exogenously formed nitrosothiols, once the S-N bond cleaves to afford NO has
been been o f little concern as the thiol/thiolates, in general, do not significantly alter
the make-up o f the thiol/thiolate intracellular and extracellular environment. In cases
where exogenous thiols have been nitrosated with the objective o f making them NO
donors in the body, careful attention has been given to the thiol moiety to avoid
unwanted side reactions once the NO has been delivered. Efforts have always been
made by utilizing thiol groups that are structurally similar or have reactivities that are
similar to endogenous thiols. Figure 1.3 lists some o f the known synthetic and
naturally occurring S-nitrosothiols .68 The need to work on assessing the beneficial
effect o f having nitrosatable proteomes/peptides and using this information as the
basis for synthesizing pharmaceuticals that have good pharmacokinetic properties and
tissue specificities has resulted in a number o f interesting synthesis studies. The
grafting o f an organic nitrate structure onto existing drugs through chemical spacers,
such as aliphatic, aromatic, or a heterocyclic chains has led to the synthesis o f several
new chemical entities such as nitric oxide-releasing aspirin and nitroso-derivatives of
flurbiprofen69. In the latter, the profile o f the parent drug, not only changed with
respect to pharmacologic properties, but also with respect to better safety profiles.
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Figure 1.3 : Examples o f endogenous and exogenous nitrosothiols

The myth that RSNO’s are formed from a simple reversible association NO
and RSH is erroneous and an oversimplification o f the nature o f the S-NO bond
formation. Table 1.4 summarises the main nitrosant production pathways and the
locations o f the nitrosation reactions. The nitrosation reactions can be
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categorically placed into two main groups based on the nitrosant; NO+ and NO
nitrosations. The synthesis o f RSNO which consists o f the reaction between thiols and
nitrous acid (which furnishes NO+) as shown in reaction R1.2 is more prevalent under
acidic conditions and is most likely to occur in low pH environments such as
asthmatic airways, ischaemic tissue and in the stomach.

HN02 + RSH -* RSNO + H 20

R1.2

Nitrogen trioxide (N 2 O 3 ) is another potent thiol nitrosant that is produced from
resident nitrite, acquired through dietary uptake and NOS activity. This also serves as
an alternative source o f S-nitrosylation in low pH conditions 22 and this reaction
mechanism could have evolved to protect against microbial pathogens encountered in
the gut, and to recycle NO bioactivity. In an aqueous environment, reaction o f NO
with dioxygen proceeds via dinitrogen trioxide (N 2 O 3 ). This species is thus implicated
in the protein S-nitrosylation under aerobic conditions. Partitioning within biological
membranes and hydrophobic compartments is predicted to accelerate N 2 O 3 formation
and subsequent S-nitrosylation. If RSNO-proteins are formed in mitochondria under
similar conditions, then NO 2 ’ might provide a channel for S-nitrosylation when NOS
activity is limited. Cysteine thiols (Cys-SH) can undergo a range o f NO-dependent
electrophilic and oxidative modifications as well as NO-independent oxidation by
reactive oxygen species (ROS). NOS generate superoxide (O 2 ) in addition to NO
(although NO >

02

’), which leads to the formation o f nitrosating species as shown in

Table 1.4.
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Table 1.4: Mechanisms o f S-Nitrosylation.
NO+ Reactions

RS(H) + X-NO—► RS-NO + X" + (H4)

Targets

Reactions resulting in formation o f nitrosant, X-NO
Acidification

N 0 2" + H+

N 0 /0 2

NO + 0 2 —►

N 0 /0 2'(when [NO] »
Metal-catalyzed

[O f]

Airway
Ischaemic tissue
gut

HO-NO

ONO-NO (N20 3)

membrane proteins

0 2N 0 - N 0 (N20 4)

serum albumin

NO + O f

ONO-NO (N20 3)

NOs substrate

NO + Mn+ - -

Mn+-NO

Cysp93 o f Hb
plasma glutathione

N O f + 2Mn+-*- Mn+-NO + M(n' 1)+
Transnitrosy lation

CysP93 o f Hb

RS-NO
(RS)2Fe-(NO)2

N O- reactions

RS7RS + NO'

RS-NO

Radical-radical

R S -+ N O -* - RS-NO

Radical-intermediate

RS‘ + NO

(RS-NO )' + Y

glutathione
serum albumin
RS-NO + Y'

It is also possible that NOS-derived NO serves as a substrate in enzymecatalyzed S-nitrosylation reactions. From this perspective, the progression from Snitrosylation to sulfenic acid (SOH)/disulfide (SS), to sulfinic (S 0 2') and irreversible
sulfonic (SO 3 ') acids represents a graded transition from signaling functions through
adaptation to nitrosative and oxidative stress and, finally, to toxicity. Figure 1.4 shows
the general correlation o f the RSNO effects with an increase in the amount of
oxygenated nitrogen species and RSNOs. Sustained and/or extreme redox-related
stress is associated with irreversible protein modification and pathophysiological
sequelae. Therefore, reversible modifications including the formation o f protein
sulphenic acid or disulphide linkages (intramolecular, or mixed disulphides
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including glutathionylation) are, for the most part, associated with the transfer o f NO
and homeostatic maintenance o f the cellular redox state, whereas irreversible
modifications, including the formation o f some sulfinic acids and o f sulfonic acids, are
associated with irreversible alterations in cell fate.

SO,H
s o 2h

ss

SOH

NO/NOx/
SNO

SNO
Signalling

Adaptation
(redox state)

Pathophysiology

Figure 1.4: Correlation o f the occurrence o f NO/ISOx/S NO oxidized protein thiols
with physiological and pathophysiological processes.

S-nitrosylation by NOS
In vivo imaging o f cells using the fluorogenic NO+ scavenger, 4, 5diaminofluorescein, revealed that NOS localization and activation are spatially
coincident and co-temporal with nitrosation reactions .70 Few o f the protein and thiol
targets are known, because the molecular details for NOS-mediated nitrosylation o f
endogenous thiols are poorly defined. Despite this, all known NOS isoforms and
physiological stimuli that activate NOSs lead to nitrosative chemistry and thus to Snitrosylation. When Zhang and Hogg stopped NO synthesis with a NOS inhibitor, the
intracellular RSNO levels declined by 50% after 3 h implicating NOS in the direct
20

nitrosylation o f thiols . 71 Immunohistochemical detection o f nitrosocysteine has shown
regulation o f protein S-nitrosylation by eNOS, nNOS and iNOS in several tissues 72
thus strongly linking NOS signaling with endogenous S-nitrosylation. The question o f
whether RSNOs are products o f NO (radical) generated by NOS, or whether NOS
produces alternative nitrosants, has yet to be resolved. In partially purified enzyme
preparations, RSNOs are thought to account for most NO bioactivity (i.e. NO itself is
a minor product or undetectable ) . 73

S-nitrosylation catalyzed by heme
The fact that hypoxic vasodilation is not completely blocked by NOS inhibitors
implies that red blood cells (RBCs) mediate hypoxic vasodilation by acting as a
vehicle for

02

-regulated delivery o f NO signals, in the form o f RSNOs. Human

hemoglobin (Hb), in particular, has been shown to bind and convert NO to a bioactive
nitrosothiol (at Cysp93), coincident with blood oxygenation . 74 An NO+ equivalent is
transferred from the p-heme binding site (where it resides as FeNO) to the reactive
thiol o f Hb during this allosterically driven reaction, in which the binding o f O2
induces a change in the conformation o f Hb from the deoxygenated (T) state to the
oxygenated (R) state. This signaling pathway provides a means o f producing a rapid
and graded vascular response to changes in tissue O2 concentrations, thereby matching
regional blood flow with local metabolic demand.
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Transnitros(yl)ation
Transnitrosylation is arguably the only chemical reaction involving NO that
has been shown to occur in vivo. The existence o f RSNO-proteins and Snitrosoglutathione (GSNO) in a dynamic equilibrium suggests that transnitrosylation
via GSNO is an integral mechanism for RSNO-protein formation. Indicative o f the
equilibrium was the finding that mouse hepatocytes lacking GSNO reductase
(GSNOR), an enzyme that specifically metabolizes GSNO , 75 had higher levels o f
protein S-nitrosothiols after induction o f iNOS. Inhibition o f eNOS was associated
with a compensatory rise in plasma low-mass RSNOs and a fall in nitrosylated
<7/

albumin,

implicating transnitrosylation in the production o f low-mass RSNOs.

Furthermore, the anti-platelet activity o f albumin-SNO is potentiated by low-mass
thiols, suggesting that low-mass RSNOs formed via transnitrosylation represent a
significant pathway for the delivery o f bioactive NO from plasma reservoirs to
platelets .77 The location o f basic and/ or acid residues in close proximity to the target
thiol in some proteins, provides a m otif for specific transnitrosylation . 78 Non-heme
iron-nitrosyls, including dinitrosyl-iron complexes (DNICs) o f the form X 2 Fe(NO )2
(where X can be, but is not limited to, protein or low-mass thiols) are also capable o f
S-nitrosylation via NO+ transfer. DNICs are present constitutively in cells and
tissues , 79 as products o f NO (radical) chemistry with pools o f non-heme iron (e.g.
iron-sulfur proteins and ferritin), and they might exist in equilibrium with RSNOs as
reservoirs o f NO bioactivity. S-nitrosylation o f targets in the plasma or vessel wall
may be effected by DNICs exported from endothelial cells . 80 Further evidence o f S-
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nitrosylation is provided by the observation that S-nitrosylation o f bovine serum
albumin (BSA) by NO occurs much more readily than does nitrosation o f glutathione
or cysteine,

o|

but BSA nevertheless catalyzes the formation o f exogenous CysNO and

GSNO .82

Copper catalysis o f S-nitrosylation
Copper-mediated catalysis o f S-nitrosylation might be a relevant mechanism
for generating bioactive RSNOs in the plasma. Studies have shown that a co-ordinate
bond between copper and the Cys34 residue o f BSA enables copper to catalyze Snitrosylation o f this residue by N O . 83 The two proposed mechanisms are that copper
either oxidizes NO- to NO+ or generates a thiyl-radical intermediate that subsequently
reacts with NO- directly (Table 1.4). Rationalization o f the predominance o f albuminSNO over other RSNOs at physiological plasma NO concentrations (perhaps 1-10
nM), is derived from the dominance o f metal catalysis o f the auto-oxidation and
transnitrosylation reactions. It has been proposed that NO binds to the mononuclear
Cu(II) site on ceruloplasmin (CP, the major copper-containing protein o f plasma ) 84
which is also the site o f iron oxidation. NO+ is transfered to glutathione (to form
GSNO) and Cu(I) formed during this process. Increased CP levels have been
measured along with increases in nitrosothiols in cases o f hypercholesterolemia, even
though the disease is characterized by impaired NOS activity . 85 CP and other
copper/metal ion-containing oxidases could exploit similar mechanisms and have a
major role in the synthesis o f bioactive nitrosothiol under physiological conditions.
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1.2.3 Stability and Decomposition of RSNO’s
The mechanism by which nitrosothiols are degraded, enzymatically or nonenzymatically, are o f key importance to the understanding o f S-nitrosylation in health
and disease. Homolytic bond dissociation energies (BDEs) o f the S-N bond in RSNOs
can vary from ~22 to 32 kcal . 86 The variable nature o f the RS-N O linkage, which is
influenced by the nature o f the R-group, has the propensity to accept an unpaired
electron from elsewhere in the protein or peptide or from alternative e" donors, and by
proximate ionizing and aromatic species resulting in a wide variation o f homolytic and
heterolytic BDEs. This variability is also reflective o f the mechanism o f NO addition:
NO+ transfer, versus NO* - S* addition, versus the formation o f an RSNO*' radical
anion intermediate (NO* + S'). The nature o f the RSNO linkage is reflected in the S-N
bond length where the SNO group in proteins and peptides might have a varying
double-bond character as shown by the canonical structures below.

C -S-N=0
I

►

C-S+= N -0 '
II

The two resonance structures given imply that the stability o f any class o f RSNO
hinges on the R group and it stands to reason that a tertiary C-S surrounded by
electron donating R groups will stabilize canonical structure II making tertiary RSNOs
more stable than their secondary and primary counterparts. The order o f stability is
reversed when the R groups on the sulfur have a negative inductive effect. With
protein-SNOs the nature o f the RSNO linkage can vary substantially and may be
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influenced by the presence o f stabilizing and destabilizing groups, sources o f protons
and electrons, and by other aspects o f protein structure. Deviations from physiological
pH, ionic strength and redox status that alter protein structure or electronic state can
profoundly alter SNO stability.
Trace metal ions such as copper and iron have been reported to catalyze release
87 8Q

o f NO from nitrosothiols '

and the presence o f considerable levels o f the metal ions

in the physiologic environment either as the protein bound ions or metal ion centers on
metalloenzymes has made the proposed mechanisms outlined in Scheme 1.4
interesting possibilities .90 It has also been proposed that the reduction o f Cu(II) to
Cu(I) (Pathway a, Scheme 1.4) by residual levels o f thiolate ions (from trace
hydrolysis o f the S-nitrosothiol) 91 or other reducing agents such as ascorbic acid (at
low concentrations < 100 pM ) 92 initiates the Cu catalyzed degradation o f RSNO’s.
Cu(II) is oxidized back to Cu(I) by a one electron process affording the cleavage o f
the S-N bond to yield a thiolate and NO. It has also been suggested that formation o f a
Cu(II)-RSNO complex (pathway b, Scheme 1.4) is a necessary condition for the
copper catalyzed decomposition where an inner-sphere electron transfer process is
effective .93 M utant copper, zinc-superoxide dismutases (Cu,Zn-SOD; also known as
SOD1), which have been linked with the neurodegeneration observed in familial
amyotrophic lateral sclerosis (fALS), have labile copper ions that accelerate the
decomposition o f GSNO in the presence o f added reductant (to reduce Cu(II) to
Cu(I) ) . 94 Hence, it is possible that crucial RSNOs might be depleted in fALS and other
related diseases. Amyloid precursor protein of Alzheimer’s disease and the prion
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protein o f Creutzfeld-Jacob disease also bind copper and reduce it to Cu(I) . 95 Hence,
copper chemistry could have interesting implications for RSNO homeostasis. There is
need for more work on the interaction o f nitrosothiols with metal ions to clearly
outline the potential disease mechanisms.

RSNO
extrinsic reducer
or RS' from RSNC
hydrolysis

RS + NO
Cu
RSNO
1/2RSSR
Cu

+RS

NO

Scheme 1.4: Copper catalyzed decomposition o f S-nitrosothiols effected by Cu(l)
ions. Pathways a96 and b93 have been proposed.

1.2.4 Kinetics of RSNO Formation
The scientific literature contains contrasting statements on whether low
molecular weight thiols or protein bound cysteine residues are nitrosylated more
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readily. The accumulation o f N O , O 2 and N 2 O 3 in hydrophobic regions o f proteins was
used by Keshive et al as a basis for the observed faster rate o f S-nitrosylation on
Cys34 o f bovine serum albumin relative to free cysteine and tryptophan .97
Contrastingly, Kharitonov and co-workers reported a second-order rate constant for
the reaction o f N 2 O 3 with GSH which was about 50 times greater than that with
no

BSA.

The discrepancy in the reported values can however be explained by careful

analysis o f the amount o f nitrosant (NO) that was used by Kharitonov and co-workers.
The reaction conditions (excess [NO*]) supported rapid conversion o f NO* to nitrite
during the mixing procedure thus hampering the protein from facilitating Snitrosylation o f the cysteine residue. It is generally agreed that N 2 O 3 is the principal
nitrosant under physiological aerobic conditions where N 2 O3 = k[N 0 ] 2 [0

2 ] 99

and NO+

becomes the dominant nitrosant as the pH goes down. The principal issue highlighted
by the findings o f Jaffrey and colleagues 100 is the differential susceptibility o f proteins
to S-nitrosylation both in vitro and in vivo. In some well-studied cases the 3, 4, 9
protein conformation and/or the presence o f specific allosteric effectors (pC>2 , pH and
metal ions, including Ca

and Mg ) are important determinants o f S-nitrosylation

rates. Moreover, it has consistently been found that in proteins in which functional
modulation by NO has been characterized (haemoglobin , 101 ryanodine receptor , 102
methionine adenosyltransferase , 103 caspase104), targeting o f S-nitrosylation exhibits
remarkable specificity whose pH dependence can never be underestimated. Exposure
to NO under physiological conditions results in the modification o f only a single,
necessary and sufficient cysteine thiol. What is also apparent from these studies is that
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clinical explanation o f the mechanistic basis o f the selectivity o f S-nitrosylation
among and within proteins provides strong support for the proposition that, as for
other posttranslational protein modifications, NO related protein modifications are
governed by controlled pH o f consensus motifs. For example, the reactive cysteine
that forms the site o f NO binding to the (3-subunit o f haemoglobin is located between
an acidic and a basic amino acid (His-Cys93-Asp). The cysteine sulphur would thus be
apposed to acidic or to basic side chains depending on the oxygen-regulated
configuration o f the haemoglobin tetramer. As a consequence, acid-base catalysis
alternately promotes nitrosylation and denitrosylation o f haemoglobin ((3-Cys93) in a
conformation-dependent fashion. This analysis which supports the proposal o f an
acid-base m otif for protein S-nitrosylation has proved to be predictive in wellcharacterized cases in which critical cysteines have been identified . 105,106 Examination
o f the primary sequences o f the RSNO-proteins identified by Jaffrey and colleagues 107
reveals the presence in most cases o f one or more cysteines flanked by acidic and/or
basic residues. Another classic example o f a localized pH dependent nitrosylation is
the GSNO-mediated S-nitrosylation o f hepatic methionine adenosyltransferase (MAT)
shown in Scheme 1.5 where the Cysl21 residue, closely apposed to the basic
guanidine groups o f Arg357 and Arg363 and to the y-carboxylate o f Asp355, is
1 AO

selectively targeted.

Control experiments where the residues were substituted with

residues containing uncharged side chains showed inhibition o f nitrosylation leading
to the rationalization that the basic groups are responsible for lowering the Cysl21
pKa (increasing nucleophilicity) with the acidic group increasing the GSNO pKa
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(lowering nucleophilicity) thus promoting NO+ transfer from GSNO to Cysl21.
Despite the ease with which the biologically relevant thiols can be nitrosated as
shown in these and other studies, there seems to be a general lack o f kinetics data and
a mechanistic understanding o f how the S-nitrosothiols are formed . 109 There is need to
probe the kinetics o f the nitrosation 110,111 in vitro with the aim o f linking these
reactions with what actually transpires in the mammalian body. Detailed
understanding of how the RSNO’s are formed cannot be achieved without identifying
and characterizing the products o f the nitrosation reaction.
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Scheme 1.5: Concerted acid-base catalysis o f GSNO-mediated nitrosylation o f the
C ysl21 residue o f methionine adenosyltransferase (MAT).
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Does NO specifically and preferably target the sulfur center on a thiol? What
are the possibilities and effects o f the formation o f N-nitrosothiols and Cnitrosothiols? W hat effect does the formation o f the S-N bond have on the other
functional groups on the thiol or protein o f interest? These and a host o f other relevant
questions can only be addressed with the incorporation o f specific and sensitive
detection methods and instrumentation - an area that has not received much attention
in RSNO research work. In-depth understanding o f the kinetics and mechanisms o f
thiol nitrosation as well as information pertaining to the stabilities o f various
nitrosothiols will aid in the design o f RSNOs with better pharmacokinetic properties.
The present studies provide mechanistic details o f the formation o f a novel Snitrosothiol. The role o f metal ions in the formation o f the S-N bond was investigated
as endogeneous trace metals may influence nitrosothiol formation. The kinetics o f the
nitrosation reactions with respect to different pH environments and complete
characterization o f the nitrosation products were coupled with computer modeling o f
the nitrosation reactions.
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CHAPTER 2

ALLERGIC CONTACT DERMATITIS (ACD): LATEX AND RUBBER
ACCELERANTS

2. INTRODUCTION
Allergies from work-related exposures to chemical agents such as latex/rubber
additives are among the most frequently encountered and are a leading cause o f
occupational illness. Irritant dermatitis, allergic contact dermatitis (ACD) and
urticarial reactions have been associated with chemical accelerators present in latex
and nitrile/synthetic rubber gloves, clothing such as underwear and shoes and other
medical/personal care devices. In a study o f hospital employees who used gloves,
24.4% reported glove-induced symptoms. 112 Over 10% o f these subjects were patch
test positive to rubber-related chemicals. If this is reflective o f the entire health care
industry o f approximately

8

million workers, then one can assume that about 2 0 0 , 0 0 0

health care workers are sensitized to chemical accelerators from latex. Thiuram
(23.3%) and mercaptobenzothiazole (MBT, 20.9%)-induced ACD was reported to be
prevalent in student athletes . 113 Conde-Salazar et al 114 reported that 25.9% o f Spanish
construction workers/patients with cutaneous lesions or a clinical history consistent
with occupational dermatitis were patch-test positive to latex chemicals and 23.7% of
31

them specifically to thiurams. An informed understanding o f the how these chemical
additives induce allergy may provide for the ability within the industry to alter the
chemical’s form/allergenicity or to substitute them with less allergenic chemicals.
Even though many reports identifying chemical allergens and considerable effort has
been focused on investigating contact allergy at a molecular and cellular level, these
efforts have always fallen short o f in terms o f disease prevention chiefly because o f
frequent and rapid introduction o f new chemical entities (NCE), many o f which are
potential allergens.

2.1 Latex and Rubber Allergies - Accelerants
The adoption o f universal precautions to protect against bloodbome pathogens
led to an increased demand for natural rubber latex used in surgical and examination
gloves. The products in which latex (natural rubber) is used include adhesives, foam,
carpet backing and in a number o f "dipped" products. Dipped products include gloves,
catheters, condoms and balloons. Natural rubber, o f which over 90% comes from the
latex, or milky sap, o f the rubber tree - Hevea brasiliensis115 is also found in toys,
erasers, sports equipment, clothing, elastic bands, and many medical and dental
devices. The sensitization o f workers to latex and latex related products was first
reported in 1979116, triggering a lot o f research in this field. Examples o f high risk
populations for sensitization to rubber products or additives include rubber-industry
workers, health care workers (from wearing rubber gloves), individuals with
congenital urinary anomalies (from use o f catheters and other latex devices),
32

individuals who have undergone multiple medical/surgical procedures and individuals
with a history o f non-medication related anaphylactic reactions during anaesthesia.
Latex allergy has been known to be caused by either or both o f two classes o f agents
(in latex or rubber) depending on the rubber product. Latex proteins on powdered
gloves and similar products can easily aerosolize and be inhaled leading to Type I
•

allergies and asthma;

1 17

•

•

whereas, low molecular weight compounds which are used in

the rubber or latex manufacturing process predominantly are associated with irritant
and allergic (Type IV) contact dermatitis . 118 Rubber/latex additives are usually
organosulfur chemical compounds used to speed up the vulcanization process, which
is essentially the binding or clustering of glove material through disulfide bridges. The
formation o f glove material into a ‘matrix/lattice’ structure allows the material to
stretch and recoil . 119 There are three main classes o f chemical accelerators in gloves
and medical devices, namely, thiurams, dithiocarbamates and mercaptobenzothiazoles
with less common compounds like p-phenylamine (used in the manufacture o f black
rubber products ) . 120 Apart from allowing the cross-linking and imparting the elasticity,
accelerators also act as anti-oxidants to provide integrity to the latex during use; and
stabilize the latex for long term storage against environmental factors such as heat,
ultraviolet light, ozone and humidity . 121 Figure 2.1 lists examples o f chemicals that are
used as rubber/latex vulcanization accelerators and antioxidants. Accelerators such as
the benzothiazoles and dithiocarbamates are ‘high volume chemicals (HVP)’ which
are also used as corrosion inhibitors in auto radiator fluids, flotation agents for the
collection o f sulfide ores, lubricants and in pesticide manufacture. For example 233

mercaptobenzothiazole (MBT) has an annual production o f about 40,000 tons in
Europe and over 450,000 tons in the USA . 122
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Figure 2.1: Structural examples o f compounds which are used as vulcanization
accelerators and antioxidants.
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2.2 Prevalence of Contact Dermatitis
The prevalence o f rubber accelerant-induced irritant and allergic contact
dermatitis in the general population is not fully known. Data compiled by the US
Bureau o f Labor Statistics for the period 1973-1984 estimated that o f all
occupationally-related conditions, occupational skin disease accounted for 40% .123
The Occupational Disease Statistics Unit in San Francisco (1982) reported the
occurrence o f contact dermatitis (both ACD and irritant contact dermatitis (ICD)) to
constitute 90% o f all occupational skin disease cases . 124 Compensation statistics from
a study in South Carolina gave 48% as the estimate o f occupational disease workers'
compensation due to occupational contact dermatitis . 125 The annual costs for
occupational contact dermatitis cases (due to lost work days, medical care and
disability payments) were reported to be in the range $222 million-$l billion . 126 This
cost is high, even though compensation is only given when the employee can prove
that their dermatitis has resulted from contact with an allergen in the work place,
according to strict criteria . 127 Contact dermatitis is hence a significant economic
problem to industry. Leggat and co-workers have reported that almost one third o f the
sampled dentists in Australia had experienced symptoms o f hand dermatoses as a
result o f glove use.

1O
R

In Japan, studies on glove-using personnel from different

hospitals showed a hand dermatose prevalence ranging between 43.2% and 59.3%
•
100
•
with thiurams being the major class o f sensitizers. In a North American study 59%
o f workers who reported contact disorders were in wet occupations with estimated
incidence rates being high among bakers, hairdressers, dental surgery assistants and
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kitchen workers/cooks. Reported causative agents were primarily chromate, nickel,
rubber additives and epoxy resins . 130
Efforts in the natural rubber latex glove industry, strongly supported by
recommendations from the European Committee for Standardization (CEN, TC 205,
n i

WG3) and the European Commission,

led to the reduction o f the content and use of

thiurams by substituting them as accelerants with compounds such as
dithiocarbamates and benzothiazoles. At that time ACD prevalence to thiurams was
much greater than with other chemical rubber additives. Allergenic potency can not
be inferred from comparing prevalences since exposure time and dose are major
determinants in prevalence rates. Recorded data in Denmark from 1995 to 2004, for
example, showed a statistically significant decline in the frequency o f sensitization to
‘thiuram m ix’ even though cross-reactivity to other accelerators still persisted for
individuals already sensitized to thiurams . 132 There has also been a decline, though
not statistically significant, in frequencies o f sensitization to sulfur accelerators from
the benzothiazoles in North America. The reason for the decline in prevalence o f ACD
from specific chemicals may be due to multiple factors which might include avoidance
o f high accelerant level gloves in the health sector environment and chemical
substitution and reduction in product allergen content. Figure 2.2 which is based on
studies carried out on North American health care workers attempts to put the
•

•

•

•

•

prevalence MBT and mercapto mix (MM) induced sensitization m perspective.

1

Rubber additives are still the most frequent contact allergens reported in
occupational contact dermatitis . 134 The current standards do not contain
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recommendations for quantitative measurements o f residual chemicals in finished
rubber products and high (part per thousand by weight) levels have been recently
reported in commercially available latex and nitrile exam gloves . 135 Even though
rubber chemical allergenic effects have been well documented in occupations where
latex products are commonly used (mainly the health care industry where it is
estimated that 8-12 % o f the health care workers in North America are sensitized to
latex products), the accelerators have also been implicated in a number o f ailments
including embryolethality , 136 cancer and neurotoxicity . 137,138
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Figure 2.2: Prevalence o f M B T and mercapto mix induced hand dermatoses.
Adapted from Reference.139 • M B T IB Mercapto M ix (MM)
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2.3 Mechanisms and Allergic Contact Dermatitis
Latex products contain both naturally occuring latex proteins and chemical
additives such as accelerators and antioxidants. Several o f these proteins have been
identified as respiratory allergens. Inhalation o f these proteins (usually bound to glove
powder) has produced allergic sensitization with subsequent asthmatic and
anaphylactic reactions (Type I allergic reactions). Less commonly, the proteins can
also produce an immediate allergic skin reaction. Latex chemicals are more commonly
associated with irritant and allergic contact dermatitis (Type IV, Delayed Type
Hypersensitivity Reaction). Two characteristic events lead to the manifestation o f the
allergy irrespective o f the type o f allergy. These events are: (i) sub-clinical
sensitization/induction phase whereby the immune system is exposed to the
immunogen for the first time and develops both effector and memory cells that are
specific for the particular immunogen, (ii) elicitation phase, during which re-exposure
to the same antigen or a similarly reacting antigen triggers a clinical response to the
immunogen with release o f mediators such as cytokines chemokines and inflammatory
mediators.

2.3.1 Type I: Anaphylactic Reactions
Latex proteins are responsible for Type I Hypersensitivity (Gell-Coombs
classification), including anaphylactic reactions.140"142 This is the form o f latex allergy
which is immunoglobulin E (IgE) mediated.143 Sensitization occurs by exposure to
latex proteins resulting in production o f IgE antibodies that are specific for the inhaled
38
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‘foreign’ proteins. The production o f IgE antibodies is T-cell dependent and the
produced IgE antibodies will bind to receptors on mast cells, basophils and, to a lesser
extent, on other cells such as eosinophils and macrophages. When a sensitized
individual encounters the offending antigen the protein is readily recognized by the
specific IgE on mast cells.
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Figure 2.3: Pathogenesis o f Type I allergy.

This activates the mast cells leading to the release o f primary chemical
mediators such as histamine, serotonin, heparin and proteases, subsequently causing
increased vascular permeability, smooth muscle contraction, granulocyte chaemotaxis,
connective tissue degradation and extravasation. Mast cell activation also leads
39
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to the production o f secondary mediators which are synthesised de novo and comprise
o f arachidonic acid metabolites (prostaglandins, thromboxanes and leukotrienes).
Figure 2.3 outlines the processes that occur in Type I allergy. Type I immune
responses are immediate and symptoms usually take a few minutes (15-30 min; early
phase) to a few hours (2-12 hrs; late phase) to manifest. The reaction may involve skin
(urticaria and eczema), eyes (conjunctivitis), nasopharynx (rhinorrhea, rhinitis),
bronchopulmonary tissues (asthma) and gastrointestinal tract (gastroenteritis) among
other ailments.144

2.3.2 Type IV: Delayed Type Hypersensitivity Reactions
Originally termed the ‘tuberculin reaction’, from the observation by Koch in
1890 (of people infected with Mycobacterium tuberculosis) o f the delayed positive
reaction to intradermal injections o f a concentrated lysate o f a mycobacterial culture,
this allergic response has evolved to be known as Type IV hypersensitivity or delayedtype hypersensitivity (DTH). Low molecular weight chemicals, such as those found in
rubber products are known to cause DTH in the skin upon direct contact. Since the
mid 1930’s it has been generally accepted that a low molecular weight xenobiotic
(< 500 Da) does not occupy a sufficient volume, once it has penetrated the skin, to
produce immunological sensitization. The xenobiotic has to bind to a protein/peptide
to form a macromolecular immunogen in the form o f a hapten-carrier complex. This
generally accepted ‘hapten hypothesis’ behind Type IV hypersensitivity was first
proposed by Landsteiner and Jacobs in 1936145 and revisited by Dupuis and Benezra in
40
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1980.146 The skin possesses antigen-presenting cells (APC) know as Langerhans' cells
(LC). LC’s are immature dendritic cells that are derived from the bone-marrow and
are present in the epidermis, constituting a population o f 3% o f all epidermal cells.
Antigen recognition and internalization signals the LC’s to mature into dendritic cells
(DC), while migrating from the epidermis via the dermis into the efferent lymphatic
system. LC migration has been shown to be crucial to the generation o f sensitization
and is dependent upon the expression o f cytokines such as tumor necrosis factor-a
(TNF-a), interleukin ip (IL-lp), and other cytokines/chemokines.147,148 Upon arrival
o f the mature LC-derived DC in the paracortical (T-cell dependent) areas o f the
regional lymph node, the antigen (hapten-peptide complex) is presented on the surface
o f a major histocompatibility complex (MHC) class II protein to a CD4+ nai've T cell
(lymphocyte). On presentation o f the antigen to CD4+ naive T cells in the lymph
node, a population o f antigen-specific memory T cells proliferates (and also effector
cells). This T-cell proliferation is the result o f the sensitization phase and the
individual becomes primed with a population o f circulating T cells that can recognize
specifically the same (or cross-reactive) hapten upon subsequent challenge. Figure 2.4
summarises the processes that occur from the time the xenobiotic penetrates the
stratum comeum to the proliferation o f antigen specific T-cells. Subsequent exposure
to the same hapten in a sensitized individual leads to the same haptenation process as
in the induction phase. However, during elicitation, antigen presentation to memory T
cells occurs both in the skin (memory T cells migrate from the blood circulation into
the dermis) and in the lymph nodes (Figure 2.5). Memory T cells in the skin signal the
41
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Figure 2.4: (Adapted from Smith Pease et al)149 Sensitization phase o f Type I V
Hypersensitivity. A hapten binds to skin proteins, after being absorbed into the
epidermis, to form an immunogen. The modified proteins (hapten-carrier complex)
are recognized and internalized by Langerhans ’ cells (LC) (a) which migrate into
the dermis (b) and eventually to the draining lymph node (c) while maturing into
dendritic cells. The hapten-carrier complex is processed into short sequence
peptides (with the hapten still bound) which are displayed on the surface o f the
major histocompatibility complex I I (M H CII) o f the cell (d). The T-cell receptors
(TCR) o f naive CD4+ T-cells in the paracortex o f the lymph node (e) recognize the
hapten-peptide complex resulting in the generation and proliferation o f a
population o f memory T cells.
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Figure 2.5: (Adaptedfrom Smith Pease et al.)ls0 Mechanism o f elicitation in
delayed-Type I V hypersensitivity, (a); The immunogen is recognised and
internalised by an L C or an A P C and processed into peptides, (b); This peptide is
then recognised by a memory T cell that is present in the dermis, (c); The
recognition o f the antigen stimulates the migration o f the T cell into the epidermis
and also stimulates the release o f cytokines and chemokines. (d); The action o f
interferon-y release fro m the activated T cell stimulates keratinocytes to secrete
cytokines (e), which in turn stimulates monocyte, macrophage and T cell (both
CD4+and CD8+) infiltration into the epidermis ( f and g).

release o f the cytokine interferon-y (INF-y) upon antigen recognition. This cytokine
has multiple stimulatory influences, including inducing the expression o f intercellular
adhesion molecules (such as ICAM-1), MHC class II molecules and proinflammatory
cytokines such as interleukin (IL)-lp, IL-6 and granulocyte macrophage colony
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stimulating factor (GM-CSF) from keratinocytes.144 Local recruitment o f monocytes
and lymphocytes from the blood and lymphatic circulations to the site o f contact
follows the local release o f these proinflammatory cytokines. Infiltration o f cells into
the epidermis causes the clinical symptoms o f erythema and oedema, which peaks
between 48-72 hours following antigen exposure. Exact mechanisms o f antigen
specificity in both sensitization and elicitation remain unknown.

2.3.3 ACD vs ICD
Irritant contact dermatitis (ICD) is a direct toxic reaction observed when the
skin reacts, usually within minutes, to initial contact with a reactive exogenous
chemical. ACD is an inflammatory process caused by an allergenic substance and is
mediated through immunologic mechanisms, whereas ICD is an inflammatory
reaction which is a result o f direct tissue damage. Severity o f ACD and ICD depends
on the nature o f the primed T-cells and inflammatory mediators (for ACD), the nature
o f the tissue and keratinocytes that are damaged (for ICD) and the location and
condition o f the skin at the point o f contact (gloved hands, earrings, wrist watches,
elastic from underwear, condoms). The generation o f ACD may be dependent upon
the exposure frequency and concentration o f specific types o f chemicals that are
absorbed by the skin. Chemicals that can cause ACD can also be irritants (dosedependent). However, not all chemical irritants are allergens. It has been postulated
that differential cytokine expressions may discriminate between irritant and allergic
reactions.151 Although the mechanisms o f irritancy appear to be distinct from those o f
44
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hypersensitivity reactions in the initial stages o f xenobiotic contact there are some
similarities between ACD and ICD pathological sequelae. For example, the skin
becomes infiltrated with monocytes, lymphocytes and macrophages following
exposure to an irritant, similar to that seen in the elicitation stage o f ACD following
secondary contact with allergen making it difficult to distinguish between ACD and
ICD. Clinically, ACD and ICD symptoms include redness, itching, crusting, swelling,
blistering, oozing, dryness, scaliness and thickening o f the skin; although, the dose
required to elicit an ACD in sensitized individuals is usually much less than that to
produce skin irritation. ICD symptoms usually subside after a few hours, whereas
ACD symptoms may persist for days. Hence, there is the potential for some overlap to
occur between allergenic and irritant contact dermatitis mechanisms and clinical
diagnosis.

2.3.4 Cutaneous Metabolism - “Prohapten Hypothesis”
Some molecules that do not have the capacity to covalently bind to protein can
act as skin sensitizers. The hypothesis, which rationalizes the observed lack o f
reactivity o f these compounds, is that chemical allergens are either chemically or
metabolically activated into protein-reactive compounds and hence the term
‘prohaptens’. Examples o f chemical activation are the air oxidation o f linalool

1o

,

turpentine 153,154 and p-phenylenediamine (PDP) which converts them into strong
sensitizers. Cutaneous xenobiotic metabolism seems to be the more common route
through which chemicals are activated. Dupuis and Benezra155 hypothesized that such
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molecules (called 'prohaptens') are actively metabolized to protein-reactive haptens by
cutaneous enzymes. The existence o f cutaneous xenobiotic-metabolising enzymes has
only been demonstrated within the last 10-15 years. The skin, particularly the
epidermis, is now known to be a living tissue containing many o f the metabolic
enzymes that were previously thought to be isolated to the liver.156 The enzyme
activity in the skin (examples range from 0.1% to 28% for Phase I reactions and from
0.6% to 50% for phase II reactions), though significant (considering the surface area
o f the skin), is lower than that in the liver. Studies over the past decade have
demonstrated that skin cells, especially epidermal keratinocytes, express a variety o f
Phase I and II xenobiotic metabolizing enzymes, such as cytochrome P450’s
(CYP450), cyclooxygenase (COX), flavin-containing monooxygenases (FMOs),
peroxidases, transferases, dehydrogenases, reductases and esterases.157' 160
The CYP450’s are generally considered to be the most ubiquitous and broadranging metabolizing enzymes in the skin (as in the liver) and to date, several isoforms
from CYP families 1-3 have been identified in skin, both directly, at the mRNA and
protein levels or indirectly from enzyme- selective substrate activity assays.161,162 Most
o f the phase I metabolic enzymes given in Table 2.1 have been identified in the skin
and they metabolize the xenobiotics by presumably introducing or unmasking
hydrophilic functional groups on the compound. Even though the transformation (to a
hydrophilic compound) will, in most cases, result in the detoxification and subsequent
elimination via glucuronidation and other Phase II metabolic activities, the availability
o f a reactive group/intermediate will, in some cases, promote adduct formation
46
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between the chemical and reactive protein residues. Cinnamic alcohol allergy has been
observed to be mediated via a metabolic pathway163,164 and the same pathway has been
observed for urushiol (found in poison ivy),165 eugenol166 and PDP.167

Table 2.1: Enzymes available in the skin.

E nzym e

Sulfotransferase

Glutathione S-transferase

A ctivation M echanism

Sulfation at -NH2, - S 0 2N H 2, -OH

Glutathione conjugation at epoxides and halides

Amidases

Amide hydrolysis

Esterases

Ester hydrolysis to yield acid and alcohol

Flavin containing m onooxygenases

Oxidation o f tertiary and secondary amines,
imines and arylamines

Cytochrome P450 (e.g isoforms like
CYP 3A/7, CY P1A2, CYP2E1)

Phase II enzymes and
UD P-glucuronosyltransferase

Hydroxylation, epoxidation, N-, 0 - , S- dealkylation,
N - and S- oxidation, oxidative deamination, ring
cleavage o f heterocyclic ring systems.
Conjugation reactions, glucuronidation at -OH,
-COOH, -NH2 and -SH

2.2.5 Other Mechanisms - Pharmacological Interactions
Recent evidence where immune responses have been observed with chemicals
that are neither protein reactive nor prone to bioactivation and the generation o f drug
specific T cell clones (TCC) has prompted the revision o f the ‘hapten and prohapten
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hypothesis’ to include additional plausible mechanisms. Peculiar clinical findings such
as T cell-mediated skin reactions which occur within a few hours after exposure and
without previous exposure to the chemical are hypersensitivity reactions outside the
realms o f a normal immune response.

1AS

The kinetics o f such reactions are much too

fast to be explained by the induction o f a classical, primary immune response. Several
observations argue against protein haptenation and processing for select chemical
hypersensitivities; (a) using TCC, many different, chemically-inert drugs were found
to be able to stimulate T cells via the T cell receptor (TCR) in an MHC-independent
w a y , in particular, lamotrigine,169 carbamazepine,170 sulfamethoxazole (SMX),171
lidocaine172 and p-phenylenediamine.173 (b) antigen-specific TCC reacted even if the
APC were fixed by glutaraldehyde, excluding involvement o f antigen processing or
intracellular metabolism.174,175 © pulsing o f APC (incubation o f APC with the drug
followed by washing steps, which remove the drug), did not result in T cell
stimulation for lidocaine, lamotrigine, carbamazepine, ciproxin and SMX

17 f \

•

showing

the absence o f covalent binding o f drugs to APCs whereas the reactive metabolite,
SMX-nitroso (SMX-NO), could not be washed away, acting as a typical hapten, (d) in
some cases, the kinetics o f T cell activation is simply too fast for the involvement o f
antigen processing. It is impossible to reconcile the fact that, in the presence o f APC,
lidocaine and SMX activate T cells quasi-immediately (as revealed by a rapid and
sustained increase in intracellular Ca2+), defying the time required for intermediate
metabolism and processing steps.177 Collectively, this evidence and the fact that many
drug-specific TCC were found to be MHC-unrestricted178 supports the concept that T
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cells in allergic individuals recognize the noncovalently bound drugs, rather than drughaptenated peptides presented on the MHC. Some drugs are, therefore, thought to
attach directly onto the MHC-peptide complex without going through antigen
processing where TCR’s will recognize them by way o f a compatible (sandwich)
comformation.179 This concept, which has its basis on the pharmacological interaction
o f the xenobiotic with immune receptors has been termed the pharmacological
interaction (p-i) concept180 and is outlined in Figure 2.6.181 While the MHC-peptide
complex would not contribute to the binding energy, it would still be necessary for full
T cell activation. Certain drugs will bind specifically and reversibly to some o f the
highly variable antigen specific receptors in a direct way, instead o f covalently
modifying the MHC-peptide complex, which are the two feasible “partners” to
accommodate allergy-inducing drugs. Such a drug- TCR interaction would be
metabolism and antigen processing independent and, in fact, mimic drug interactions
with other, non-immunological receptors.
It is therefore apparent that the allergenic potency o f a chemical may
not be limited to its chemical/protein reactivity. Other aspects such as the structural
conformation o f a chemical are just as important, since they are responsible for the
pharmacological interaction o f a chemical with an immune receptor leading to T-cell
activation and an observed immune response. It must also be noted that the
drug/chemical must be at pharmacologically active concentrations at the site o f APC T-Cell interaction for p-i receptor mediated hypersensitivity to occur.
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Figure 2.6: (Adaptedfrom Pichler)182 The binding o f SM X to the MHC-peptide
complexes is o f low affinity and has no functional consequence (a). I f a T-cell with
a fittin g TCR on its way to screen the M H C molecules passes by, a stabilization o f
the binding by this ‘sandwich *may occur and a TCR transmits a signal to the cell
(b).

Metal ions such as Ni(II), unlike classical haptens, have also been
hypothesized to activate T cells by cross-linking their receptors to MHC molecules,
independent of the nature of the associated peptide.183 Weltzien and coworkers
identified and characterized an MHC-promiscuous, Ni-specific TCR where Ni
50
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was shown to interact simultaneously with the MHC and TCR by making contacts
with a conserved His81 in the MHC (HLA-DR) chain as well as Tyr29 and Tyr94 in
complementarity-determining region (CDR1) o f the TCR.184 Thus, Ni can form a
bridge between both receptors, much like a superantigen, even though requiring
idiotypic residues in the TCR. In fact, Ni binding may represent a “compromise”
between how a typical hapten and a small antigen incapable o f covalent binding may
interact with the MHC and the TCR as shown in Figure 2.7.

T cell

N i(II)

A PC

Figure 2.7: Stimulation o f T-cells via a hapten-like mechanism. N i may interact
either like a non-covalent hapten, or as depicted here, form ing equally strong, noncovalent interactions with both M H C and TCR. The “N i m ode” is a possible
intermediate between the hapten and p -i modes o f interaction which trigger immune
responses.

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

2.3 Protein Haptenation Mechanisms
Although other, less prevalent mechanisms o f chemical mediated allergy may
exist as described above, the general hallmark o f the hapten hypothesis is protein
binding. Protein haptenation leading to the production o f immunogenic hapten-protein
adducts is a necessary step in the induction phase o f most ACDs. Antigen processing,
whether its intra or extracellular185,186 is mainly responsible for the proteolysis o f
haptenated proteins into short sequence peptides (usually 9 to 25 amino acids) which
can be loaded onto the MHC II molecules for cell surface presentation to T-cell
receptors. Adduct formation between proteins and hapten/prohapten functional groups
has been shown to be mostly nucleophile-electrophile type reactions with the protein
residues acting as the electron rich functional groups. Xenobiotics with an
electrophilic center on either the parent compound, or as a result o f metabolic
activation, have been shown to be strong sensitizers relative to compounds lacking the
electrophilic centers.187 This is due to the ability o f these compounds to form covalent
bonds and co-ordination bonds involving bond energies ranging from 200 to 420
kJ/mol, as opposed the weak interactions, such as hydrophobic, hydrogen bonds and
ionic bonds where bond energies rarely exceed 50 kJ/mol.187 Where protein-hapten
complexes are postulated, the formation o f co-ordinate bonds has been touted as the
mechanism behind metal ion induced allergies. Metal ions are known to produce
geometrically highly defined coordination complexes with four or six electron donors
such as nitrogen or oxygen in amino acid side chains o f appropriate proteins or
peptides188 as exemplified in a study189 where it was demonstrated that H SA -N i
complexes, indeed, bear the potential to stimulate Ni reactive T cells in the
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presence o f appropriate antigen presenting cells (APC). Other physicochemical
properties such as octanol/water partition capability, molecular volume and substituent
effects are important in the feasibility o f a reaction between the hapten and protein
residues. Important protein characteristics such as folding, changes in pH depending
on the region in which the protein residue is located and competition from
neighbouring nucleophiles also need to be considered when studying allergenic
mechanisms. Electrophilic centers on allergens which are reactive to proteins include
carbonyls, sulfones and sulfoxides, aromatic rings with substituents which have a
strong negative inductive effect (such as the nitro group and halogens) and a ,(3unsaturated carbon atoms on aldehydes.
Figure 2.8 gives examples o f commonly encountered nucleophilic protein
residues and examples o f the mechanistic pathways through which haptenation may
occur. Where the allergen has a (3-unsaturated carbon the nucleophilic attack has been
known to occur via the 1,4 Michael addition mechanism.190 Another possible
mechanism is that o f disulfide formation between sulfhydryl moieties on protein
residues and free thiols on the allergen. Mixed disulfide bridges, which are strong
covalent bonds, have been known to introduce covalent modifications to native
proteins.191,192 There is general lack o f evidence on the occurrence o f mixed disulfides
between proteins and xenobiotics which can result in triggering o f the immune system.
Efforts need to be directed at studying the S-S linkage as a possible mechanism for
haptenation since disulfide formations occur under physiological conditions. Protein
haptenation has been studied193' 198 in an effort to detect, characterize and quantify the
53
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protein-hapten complex and these studies combined with the advent o f

Y
rs

NH
OH

(CH2)4
nh2

serme

histidine

lysine

OH

SH

cysteine

aspartate
OH

Sn2

CYP

H.o,

B

Nil

Nu

Pr

Pr

R\

(Y o — H

H20

)

- 1*

R'-

C
H—N:

h—

r r ---- H

Pi

■

X

R"
Pr

Pr

Figure 2.8: (A) Examples o f nucleophilic protein residues, (B) Reaction o f an
epoxide with a nucleophilic protein residue and (C) Imine (Schiff base) form ation
with prim ary amines. Enamines are form ed with secondary amines.

methodologies like immunochemistry, protein mass spectrometry and nuclear
magnetic resonance spectroscopy have made in-roads into the specificity o f the
characterization o f the protein-hapten adduct. The complete profiling o f the
proteinaceous constituents o f the skin is not available and this has limited
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haptenation studies to model proteins and peptides while making the logical
assumption that a protein-reactive electrophilic xenobiotic has the ability to modify
many available protein nucleophiles. To this effect human serum albumin (HSA) has
been commonly employed as a model protein where a number o f chemicals have been
demonstrated to covalently modify the Cys 34199, Lys 190200, Lys 199201, His 9, His
146, His 338202 and the DS3 peptide (which has a sequence analogous to the Nterminal part o f the human globin).203 What is apparent in these studies is the fact that
hapten binding to specific immunologically relevant proteins is yet to be established.
The cascade o f reactions and processes that take place during an immune
response are a result o f the recognition o f the protein-hapten adduct. The haptenation
process is, therefore, a very important step in the sensitization and eventual occurrence
o f chemical allergy. An insight into the specific nature o f the protein-hapten binding
that is immunologically relevant to sensitization will have an immense contribution to
the complete understanding o f the pathogenesis o f low molecular weight chemicalinduced allergies.

2.4 MBT: Mixed Disulfides or Otherwise
Considering the high volume production o f MBT (Section 2.1) and its
widespread use in glove manufacturing it is not surprising that a lot o f contact
allergies have been attributed to MBT exposure. Detected levels o f MBT in gloves
have been shown to vary with the type of glove.204,205 The variance is reflected in
reported cases such as the skin patch studies that were carried out by Emmett and co55
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workers.

Animals studies, especially the local lymph node assays (LLNA)

conducted with MBT and its disulfide have not been able to provide a sensitization
threshold. Botham and co-workers were able to classify MBT as a moderate sensitizer
in the Buehler test method.207 A modified LLNA was only able to identify MBT as a
sensitizer when 10 % sodium dodecyl sulfate (SDS) was used to disrupt the
epicutaneous layer o f the skin.208 MBT related production o f the sensitization
biomarkers IFN-gamma and IL-4 cytokine was also observed after pretreatment with
the SDS. 209 The findings reported by van Och210 and Ikarashi211 classified MBT as a
moderate sensitizer with conflicting sensitization potency data.
Given the haptenation mechanisms outlined in Section 2.3 it is not surprising
that MBT related allergy studies have not gone beyond clinical ACD case feports. The
fact that the benzene ring and the mercapto groups, which constitute MBT, are not
electrophilic (which is an essential pre-requisite for nucleophilic protein residue
reactivity; Section 2.3), may explain the lack o f reports probing the mechanistic
pathway o f MBT-protein haptenation. Considering the numerous reports on MBT
related dermatitis cases,

919 918
' it is essential that investigations be carried out to

ascertain the role o f both the benzene ring and the thiol in protein haptenation.
From an occupational platform it is important to investigate the fate o f M BT in
the latex/rubber matrix when the rubber is exposed to oxidants, as is often the case
where oxidants such as bleach, iodine and peroxides are used in a hospital setting. The
ultimate chemical form o f the hapten is important in haptenation studies. Oxidized
functional groups will have different reactivity towards protein residues. The
56
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candidacy o f MBT for metabolism warrants investigation given the availability o f
bioactivating enzymes in the epidermis.219 It has been shown that Rhodococcus
bacteria can hydroxylate the benzene ring on MBT.220 Similar metabolic activity is yet
to be unveiled with hepatic or epidermal enzymes.
The role o f mixed disulfides as linkages in adduct formation between haptens
and proteins has not been investigated in skin sensitization studies. Epidermal proteins
such as serum albumin, metallothionein and thioredoxin (Trx) have accessible
cysteinyl residues which are prone to mixed disulfide formation. The effect o f MBT
on redox regulating enzymes such as glutathione reductase (GR) and thioredoxin
reductase (TR) will need to be investigated if the hypothesis that MBT exerts its
allergenicity via the thiol moiety is adopted. GR and TR are vital enzymes responsible
for maintaining the antioxidant properties o f glutathione (GSH) and Trx.

"791

The

mammalian TR’s are a family o f selenium-containing pyridine nucleotide-disulphide
oxidoreductases with mechanistic and sequence identity, including a conserved -CysVal-Asn-Val-Gly-Cys- redox catalytic site, to GR’s. The availability o f accessible
cysteinyl residues on the active sites o f both GR and TR make the reductases attractive
proteins for MBT-enzyme interaction studies. In addition the broad substrate
specificity o f mammalian TR’s due to a second redox active site (a C-terminal -CysSeCys- (where SeCys is selenocysteine)) not found in GR or Escherichia coli TR
attracts possible TR-MBT studies. The existence o f TR within the keratinocytes222 and
the importance o f Trx to many aspects o f cell function such as protecting against
oxidant injury, cell growth and transformation, and the recycling o f ascorbate from its
57
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oxidized form

999

make it likely that MBT which penetrates the stratum cornea will

interact directly with the protein.
The delineation o f the MBT-protein haptenation mechanism(s) will avail
invaluable data with important parameters and descriptors that may be used to screen
thiol-based chemicals for sensitization potency. In-vivo

99 4

allergy screening methods

often do not require knowledge o f haptenation mechanisms, but considerable research
in in-vitro

is A f

’

and in-silico

00*7

methods o f screening to eliminate the need for live

animals in the screening assays may be more robust with the inclusion o f mechanistic
parameters for prediction o f chemical allergenic potency.
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CHAPTER 3

INSTRUMENTATION, MATERIALS AND METHODS

An extensive review o f the best possible instrumentation and methods was
done as an important pre-requisite to obtaining reasonable and good data in all
experiments. The choice o f methods and analytical instrumentation was dependent on
the research objectives and working hypothesis. A combination o f chemical tests and
analytical methods was adopted for the characterization o f reactions and identification
o f reaction intermediates and products.

3.1 INSTRUMENTATION

3.1.1 Spectrophotometry: Reactions which occurred in minutes or longer were
judged to be slow and were conveniently studied on either a Perkin Elmer Lambda 25
(Shelton, CT) or Beckman DU800 (Fullerton, CA) UV/Vis spectrophotometer, both
featuring a double-beam, all reflecting system within range 200 nm to 700 nm. A
holographic grating was used in the monochromator with two radiation sources, a
deuterium lamp (D2, UV) and a halogen or tungsten lamp (visible). The Perkin Elmer
spectrophotometer was interfaced to a Pentium III computer and utilized the UV
WinLab Software (Shelton, CT) for data collection and analysis while the Beckman
spectrophotometer was interfaced to an IBM PC computer and used the DU Series 800
Software (Fullerton, CA). Path length o f the cuvette was 1 cm. A VWR
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Scientific 1140A (Niles, IL) circulating water bath was coupled to the Beckman
DU800. The Beckman had the option o f using either a single cell holder or a multi-cell
holder (maximum o f 6) depending on the experiment. Water and acetonitrile were
used as the solvents.

3.1.2 Stopped-Flow Spectrophotometry; The coupling o f a high pressure mixer to a
UV-Vis detector was utilized to study reactions with high reaction rates. Reactions
which were rapid (with time scales as short as 2-5 seconds) were followed using the
stopped-flow technique which can monitor reactions with time scales as short as
milliseconds. A Hi-Tech Scientific SF-61DX2 (Bradford-on-Avon, UK) double
mixing stopped-flow spectrophotometer was used for acquisition o f absorbance data.
Reactions in which three or more reactants required separate mixing prior to
introduction into the observation chamber were analyzed using the double mixing
feature o f the DX2.228 Three radiation sources were used and these were a 12V, 50W
quartz tungsten halogen lamp, a 75 W Xenon arc lamp and a 100W short arc Mercury
lamp. A Czemy-Tumer type monochromator mounted on a rail was used with two
photomultipliers; a PM-60e (an end-on !4 inch Hamamatsu Model R1463) and a PM60s (a side-on 1-1/8 inch Hamamatsu Model R928). The transmission o f light from the
monochromator to the photomultiplier was through a 600-micron pure silica optic
fiber. A fused UV silica optical cell measuring 10 mm x 1.5 mm x 1.5 mm with a path
length o f 10 mm or 1.5 mm (depending on the position o f the optic fiber) was used.
The interfacing o f the instrument to a Pentium III computer via a 413 kHz 16 bit A/D
converter enabled the conversion o f data collected using the KinetAsyst T3
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software (Bradford-on-A von, UK) to digital form.

3.1.3 Fluorescence Spectrophotometry: Chromophores which had fluorescing
properties were used to follow relatively fast experiments on the Perkin-Elmer LS 50B
Luminescence spectrometer (Beaconsfield, UK) which had a pulsed (8 ps duration)
Xenon discharge lamp as the excitation light source and a wavelength accuracy o f ±
1.0 nm. The spectrophotometer utilized Monk-Gillieson type monochromators which
covered the ranges 200-800 nm (excitation) and 200-900 nm (emission). The sample
holder accommodated 10 mm quartz cuvettes enclosed in a thermostatting circulating
model 1140A water bath manufactured by VWR Scientific (Niles, IL). Detection and
amplification o f emitted photons was achieved by using gated photomultiplier tubes.
Data acquisition and processing was performed using the FI, Winlab software
(Beaconsfield, UK).

3.1.4 High Performance Liquid Chromatography (HPLC): HPLC analysis was
performed on a Shimadzu Prominence HPLC system controlled by a web browser
through a static IP address using the CBM-20A Prominence BUS Communication
Module (Columbia, MD). The system consisted o f an LC-20AT Prominence LC
(Kyoto, Japan) containing four LC-600 pumps, a DGU-20A5 Prominence degasser
(Kyoto, Japan) and an SIL-10AD VP auto-injector (Columbia, MD). Detection was
performed using an SPD-M10A Diode Array Detector (Columbia, MD) and an RF10A XL fluorescence detector (Columbia, MD). HPLC grade solvents were filtered
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on 0.5 pm FHUP (organic) and 0.45 pm HATF (aqueous) Millipore isopore membrane
filters (Bedford, MA) before they could be passed through the degasser. Injection
volumes ranged from 10 pi to 100 pi and separations were carried out on a 5 pm
particle size, 250 x 4.6 mm Supelco Discovery (Bellefonte, PA) C l 8 column (reverse
phase, 100 A pore size) at flow rates ranging from 0.5 ml/min to 1 ml/min. For protein
modification reactions, separations were done using a 5 pm particle size, 250 x 4.6
mm Phenomenex Jupiter (Torrance, CA) C l 8 protein column (reverse phase, 300 A
pore size). Solvents used were acetonitrile, methanol and water. 1 % trifluoroacetic
acid (TFA), 1 % formic acid (FA) and other buffered solvents were incorporated
whenever the need arose and either isocratic or gradient elutions were utilized. Data
was acquired and analyzed using the EZ-Start 7.3 Chromatography Software for
Windows (Columbia, MD).

3.1.5 Mass Spectrometry (MS): Electrospray ionization (ESI) and matrix-assisted
laser desorption ionization (MALDI) MS techniques are able to detect minor mass
changes in large biomolecules making them suitable for protein haptenation studies.
Tandem mass spectrometry enables the acquisition and structural elucidation o f
organic compounds, peptide or oligonucleotide sequencing, and targeting o f
previously characterised compounds in complex mixtures with a high specificity by
defining both the molecular weight and a diagnostic fragment o f the molecule
simultaneously. Both ESI and MALDI MS were employed in this project.
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3.1.5.1 Electrospray Ionization'. The ESI process depicted in Figure 3.1 can be
summarized by three processes which encompassed droplet formation, droplet
shrinkage and gaseous ion formation.

A high potential was applied at the

capillary tip (spray tip), while the analyte solution was passed through from a capillary
at a constant flow rate. The positive potential at the capillary tip shown in Figure 3.1
resulted in formation o f a stream o f droplets carrying positive ions at the tip, while the
negative ions o f the analyte solution migrated away from the tip. The electrostatic
forces caused charge separation at the liquid surface and deformation o f the emerging
drop (Taylor cone)

'y'X'y

which finally disintegrated to yield thousands o f micrometer

sized daughter droplets as depicted in Figure 3.1. The rapid shrinking o f the droplets
by evaporation o f solvent increased charge density on their surface and when the
droplet was sufficiently small such that the charge density of the droplet and the
attraction o f the positive ions to the counter electrode overcame the surface tension
holding the droplet together (Rayleigh Stability limit)233, coulombic explosion
(fission) occurred where smaller daughter ions were formed. The droplets carried an
excess o f ions o f one charge state enabling them to drift towards the counter electrode
located 1-3 cm distant from the capillary. The mass spectrometer which was used in
these studies was a Micromass QTOF-II (Waters Corporation, Milford, MA)
quadrupole time-of-flight mass spectrometer (qTOF MS). Analyte ions were generated
by positive-mode electrospray ionization (ESI). Samples were dissolved in 50/50
acetonitrile/water and pumped through a narrow, stainless steel capillary ( 7 5 - 150 pm
i.d.) at a flow rate o f between 1 pL/min and 1 mL/min.
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Figure 3.1: Diminishing o f the size o f the charged droplets wth solvent evaporation.

A voltage o f 3 or 4 kV was applied to the tip o f the capillary, which was
situated within the ionisation source o f the mass spectrometer. The strong electric
field, aided by a co-axially introduced nebulizing gas (nitrogen) flowing around the
outside o f the capillary, dispersed the solution emerging from the tip into an aerosol of
highly charged droplets. The source block was maintained at 80 °C with the
desolvation gas (nitrogen) maintained at 150 °C and a flow rate o f 400 L/h. The warm
flowing nitrogen assisted in solvent evaporation and helped to direct the spray towards
the mass spectrometer. The charged sample ions, free from solvent, passed through a
sampling cone orifice into an intermediate vacuum region and from there
64
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through a small aperture into the analyser o f the mass spectrometer which was held
under high vacuum. The lens voltages were optimised individually for each sample.
The settings varied with each set o f experiments. Tandem mass spectrometry (MSMS)
data was generated by collision-induced dissociation (CID) with argon. Visualization
and analysis o f data was done using the Micromass MassLynx 4.0 software suite for
Windows 2000 (Waters Corporation, Milford, MA).

3.1.5.2 Matrix Assisted Laser Desorption Ionization (MALDI): The MALDI
technique which was first introduced in 1988 by Hillenkamp and Karas

'I'X A

was used to

analyse biomolecules. Samples were diluted with UV absorbing matrix solution (50/50
ACN/2% TFA) and deposited as 1 pi aliquots o f each sample on a gold sample chip
(Ciphergen Biosystems, Inc., Fremont, CA) and allowed to air-dry. The MALDI
instrument was a linear TOF mass spectrometer (PBS lie, Ciphergen Biosystems,
Inc.). All spectra were acquired using a laser power at or slightly above the threshold
for ion production (laser step 140-160). A total o f 130 individual spectra (single laser
shots) were averaged into a composite spectrum for each sample spot. When the laser
beam irradiated the analyte-matrix mixture on the chip, as shown in Figure 3.2,
indirect vaporization o f the analyte resulted when the strongly absorbing matrix
vaporized and carried the analyte with it. Ionization resulted from the proton donation
o f the matrix to the analyte (positive mode). Individual spectra were calibrated,
baseline corrected, and normalized to total ion current (TIC), followed by
identification o f peak “clusters” representing peaks common to groups o f spectra. Data
analysis was performed using Biomarker Wizard software (Ciphergen
65
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Biosystems, Inc., Fremont, CA).
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Figure 3.2: Generation o f ions by Matrix Assisted Laser Desorption Ionization
(MALDI).

3.1.5.3 Charge Deconvolution - Maximum Entropy fo r E SI Mass Spectrometry:
Ionization o f biomolecules often leads to poorly resolved data due to multiply charged
ions and the fact that the mass o f a protein is usually quoted as the weighted mean o f
all the isotopic species in the molecule. For example a 10-kDa protein broadens by a
factor o f 1.27 if the resolution normally employed on quadrupole instruments is
adopted .235 The broadening increases significantly as the mass increases. ESI spectra
showing series o f multiply charged ions may be charge-deconvoluted by invoking
appropriate algorithms which are based on the knowledge that ESI does not
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"jump" over charge states. The lower m/z neighbor must have a charge state that is
greater by exactly 1 (for example: low mass neighbor o f a 3+ ion must be a 4+ ion and
so on). In the absence o f salts which lead to several quasimolecular ions such as
[M+Na]+ and [M+K]+, analytes forming [M+nH]n+ can be easily deconvoluted
resulting in excellent resolution.

The Micromass Maximum Entropy (MaxEnt, Waters Corporation, Milford,
MA) algorithm was utilized in these studies. The algorithm derives from the operating
principle which maximizes the probability o f getting the parent mass o given an
apparent mass spectrum y(m/z) while assuming Gaussian (normal) statistics for the
noise distribution. The MaxEnt algorithm uses equation 3.1 to calculate the most
probable parent mass o, given an apparent mass spectrum y(m/z) , where y is the
number o f counts at apparent mass m/z. The algorithm assumes Gaussian distribution
for the noise. Equation 3.1 derives from Bayes’ Rule236, as well as an informed a

priori probability for the parent mass spectrum P(o) which is computed from
multinomial probability law shown in equation 3.2

P {o\y ) =

P(y\o)P(o )

3.1

P(y )

3.2

where Z is the user's initial estimate o f the parent mass spectrum (usually, one choses a
flat prior, Z = 1, for the initial estimate o f the parent mass distribution). The
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MaxEnt software combined this algorithm with both the characteristics o f the
spectrometer and the noise to maximize P(o\y) and obtain good resolution which was
essential in characterizing minor mass shifts in protein haptenation experiments.

3.2. MATERIALS
All the commercially sourced compounds used in this work were used without further
purification. The compounds to be used were chosen based on the following criteria
after solubility in water and suitable organic solvents had been established: (a) their
structural similarity to endogenous thiols, (b) their known concentration levels in latex
gloves 237 and condoms238, (c) their wide applications in rubber manufacturing (d) a
substituted variant o f a previously-studied but still not well understood compound, (e)
possible drug use and /or effects, (f) confirmed toxicity effects, (g) commercial
availability from vendors, (h) storage and stability and (i) kinetic lability.

3.2.1 S-Nitrosation Experiments: iV-Acetyl-D-penicillamine (99%) (NAP), dimethyl
sulfoxide (DMSO) (99.9% with 1% v/v TMS), iVJV-dimethylaniline, EDTA,
deuterated hydrochloric acid (99.8%) and 1-octanesulfonic acid sodium salt were
purchased from Sigma- Aldrich (Milwaukee, WI). Sodium nitrite, sodium chloride,
sodium perchlorate and hydrochloric acid were from Fisher Scientific. Stock N AP and
nitrite solutions were prepared just before use. Reagent solutions were prepared with
distilled deionized water (Nanopure) from a Bamstead Sybron Corporation (Boston,
MA) water purification unit.
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Synthesis o f SNAP. To a stirred ice cold solution o f NAP (0.478 g, 25 mmol) in 8.0
mL of water containing 2.5 mL o f 1.0 M HC1 was added (0.173 g, 25 mmol) N aN 0 2 .
After 40 min at 5 °C the solution was treated with 5 mL acetone and stirred for a
further 10 min. The green precipitate was filtered off with vacuum filtration and
washed 5 times with ice cold water and 3 times with 10 mL aliquots o f acetone and
diethyl ether. The precipitate was left to dry out before a mass spectrometer analysis
could be done. The synthesized SNAP was utilized to derive a standard UV spectrum
from which a standard absorptivity coefficient could be calculated.

3.2.2 Latex Accelerant Studies'. Latex gloves were purchased from Best
Manufacturing Co. (Menlo, GA). Hypochlorous acid (HOC1; 7% w/w) and hydrogen
peroxide (H 2 O 2 ; 30 % w/w) which were used as oxidants were purchased from SigmaAldrich. Reducing agents cysteine and glutathione (GSH), mercaptoethanol,
dithiothreitol (DTT) were from Sigma-Aldrich. 5,5'-Dithio-bis(2-nitrobenzoic acid)
(DTNB), 2-mercaptobenzothiazole (MBT, 99%), benzothiazole (BT), 2methylthio(benzothiazole) (MTBT), 2-hydroxybenzothiazole (HBT), 2,2’dithiobis(benzothiazole) (MBTS, 99 % ), acetone (A), acetonitrile, formic acid (FA),
trifluoroacetic acid (TFA), olive oil (OO), dimethylsulfoxide (DMSO), hexyl
cinnamaldehyde (HCA), oxidized glutathione (GSSG), soluble starch, sodium
thiosulfate, sodium hydroxide, sodium perchlorate, phosphate buffered saline (PBS),
bovine serum albumin (BSA, fraction V), guinea pig serum albumin (GPSA, fraction
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V), N-ethylmaleimide, glutathione reductase (GR) from yeast and thioredoxin
reductase (TR) from rat liver, thioredoxin reductase assay kit, NADPH, glucose- 6 phosphate dehydrogenase (G 6 PD), phosphoric acid (H 3 PO 4 ), ammonium carbonate,
chlorzoxazone (CZ), 5-chloro-2-mercaptobenzothiazole (CMBT), trypsin,
chymotrypsin, dichloromethane and cremophor were all sourced from Sigma-Aldrich.
The barbiturates brevital and pentobarbital were purchased from Monarch
Phamaceuticals. TiterMax adjuvant was from CytRx Corporation (Norcross, GA).
Biorad Protein Assay dye was from Bio-Rad laboratories (Hercules, CA).
Dexamethasone and isoniazid-induced Sprague-Dawley rat liver S9 microsomes were
purchased from Invitro Technologies (Baltimore, MD). Human blood platelets were
■ jig

also used as a source o f GR and the Bradford assay

was used to determine the

protein concentration against a standard curve made from BSA and measured at 595
nm. Dialysis tubing (MWCO 3.5,12 and 30 kDa) was purchased from Spectrum
Laboratories (Rancho Dominguez, CA). Tritiated thymidine (3 H-TdR) was purchased
from Amersham Biosciences (Piscataway, NJ). Aquassure liquid scintillation cocktail
was from Perkin Elmer (Norton, OH). Standard hypochlorous solutions were prepared
by diluting liquid hypochlorous acid under a strong fume hood and standardizing it by
adding excess iodide which was then titrated against sodium thiosulfate with starch
indicator .240 This standardization was utilized to evaluate an absorptivity coefficient of
350 M ^cm ' 1 for aqueous HOC1 at 292 nm. This standardization was carried out before
each series o f kinetic experiments. Hydrogen peroxide was diluted from the liquid
hydrogen peroxide from the vendor. All solutions were prepared using nanopure water
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from a Millipore system (MilliQ; Bedford, MA).

3.2.3 Animal Studies (Murine Local Lymph Node Assay (LLNA) and the GuineaPig Maximization Test (GPMT)
Female mice (Balb/c) and female albino guinea pigs o f the Harley strain were
purchased from Charles River Laboratories (Wilmington, MA). All animals were
housed in the NIOSH Morgantown WV animal facilities accredited by the Association
for Assessment and Accreditation o f Laboratory Animal Care International
(AAALAC ) . 241 Room temperature was maintained between 65 and 78°F and the
relative humidity between 40 and 60%. Temperature and humidity were recorded and
logged daily by the animal care staff. A standard light/dark cycle was maintained on
12-hour intervals beginning about 6:00 AM (light) and ending about 6:00 PM (dark).
Cages were cleaned and sanitized weekly by the animal care staff. All protocols were
reviewed and approved by the NIOSH Animal Care and Use Committee (NIOSH
ACUC) before any animal studies could commence.

3.2.3.1 Animals: Female Balb/c mice which were at least 10 weeks old were used in
the LLNA. Adult albino Hartley guinea-pigs (600 - lOOOg) were used in the GPMT.
All mice were purchased from accredited animal vendors. Upon arrival, the animals
were allowed to acclimate for a minimum o f 7 days. They were housed under
controlled environmental conditions in HEPA-filtered ventilated polycarbonate cages
on autoclaved hardwood Beta-chip bedding provided food (autoclaved Prolab 3500
71

rodent chow) and autoclaved tap water ad libitum. Sentinel animals were free o f viral
pathogens, parasites, mycoplasmas, and Helicobacter.

3.3. EX PER IM EN TA L TECH N IQ U ES
3.3.1 Nitrosation o f NAP: All experiments were carried out at 25 ± 0.5 °C and at a
constant ionic strength o f 0.25 M (NaCl or NaC 1 0 4 ). Although some experiments were
run in sodium perchlorate, all experimental runs performed for the derivation o f
kinetics constants were run in NaCl. NaCl was preferred over NaC 1 0 4 because HC1
was the acid used in the formation o f nitrous acid. Control experiments, utilizing either
o f these inert salts, showed no difference in overall reaction dynamics. Inductively
coupled plasma mass spectrometry (ICPMS) was utilized to quantify the
concentrations o f metal ions in the water used to prepare reagent solutions. ICPMS
analysis showed negligible concentrations o f copper, iron, and silver (less than

0 .1

ppb) and approximately 1.5 ppb o f cadmium as the metal ion in highest
concentrations. Control experiments were performed in distilled deionized water
treated with the chelators EDTA or deferroxamine to establish the possible catalytic
effects o f adventitious metal ions. The reaction dynamics were mostly unaffected by
the use o f chelators. The reaction system studied was essentially the HNO 2 -NAP
reaction. The progress o f this reaction was monitored spectrophotometrically by
following the absorbance o f S-nitroso-A-acetyl-D-penicillamine (SNAP) at its
experimentally determined absorption peak o f 339 nm where an absorptivity
coefficient o f 890.5 M ''cm '' was evaluated using the synthesized SNAP (Section
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3.2.1). Product identification and verification was achieved by UV/VIS
spectrophotometry, HPLC, and QTOF-MS.
Kinetics measurements for fast reactions were performed with the stoppedflow spectrophotometer. Slower reactions and absorbance readings were performed on
the Perkin Elmer UV/VIS spectrophotometer. Stoichiometric determinations were
performed by varying NO 2 " and keeping both NAP and acid constant and testing for
the presence o f any remaining NO 2 " as the nitrous acid (HNO 2 ). The presence o f N O 2 ’
was quantitatively analyzed (gravimetrically) as the orange chloride salt o f />-nitrosoiVJV-dimethylaniline that was formed when the solution was reacted with N, Ndimethylaniline (NNDA ) . 242 Reaction was guaranteed to proceed to completion by
maintaining both acid and nitrite in excess over NAP. Due to the well-known
decomposition o f nitrosothiols , 243 product reaction solutions were not allowed to stand
for more than an hour before the addition o f NNDA. The salt formed, however, was
allowed to settle for 24 h before being filtered, dried, and weighed.

HPLC. All samples were loaded onto the Discovery C l 8 column. They were run
isocratically at 5% acetonitrile/TLO and all eluents were detected at a UV absorbance
o f 339 nm (for selective scans) with the maximum spectral scan mode employed to
detect all eluents. A flow rate o f 1 mL/min was maintained. All solutions for HPLC
analysis were made with Milli-Q Millipore purified water and filtered with the 0.45

/urn pore-sized PVDP Whatman Polypropylene filter devices (Whatman Inc, Florham
Park, NJ) before injection (10 pi\) onto the column using the auto injector. To curb the
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interaction o f the protonated amines on the analytes with the silanol groups on the
stationary phase (which was causing tailing o f the peaks) the sodium salt o f 1 octanesulfonic acid (0.005 M) was incorporated into the aqueous mobile phase. This
was sufficient to neutralize the protonated amines and produce good resolution while
eliminating peak tailing.

Mass Spectrometry. Analytes were dissolved in 50/50 acetonitrile/water, and analyte
ions were generated by positive-mode ESI using the specifications outlined in Section
3.1.5.1.

3.3.2 Computer Simulations - Kintecus: The reaction scheme was modeled using the
Kintecus software generated by James Ianni .244 Kintecus is a compiler used to model
the reactions o f chemical, biological, nuclear and atmospheric processes using three
input spreadsheet files: a reaction spreadsheet, a species description spreadsheet and a
parameter description spreadsheet. In addition, one can fit/optimize almost any
numerical value (rate constants, initial concentrations, starting temperature, etc.)
against an experimental dataset. Normalized sensitivity coefficients are used in
accurate mechanism reduction, determining which reactions are the main sources and
sinks (network analysis) and also shows which reactions require accurate rate
constants and which ones can have essentially guessed rate constants.

3.3.3 Oxidations o f Latex Accelerants: Stoichiometric analysis o f the HOCI/H 2 O 2 MBT was performed in excess HOC1 by varying the initial oxidant
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concentration. The total remaining oxidizing power o f the oxidant (e.g HOC1 + CI2 )
was determined by an iodometric titration. Acidified potassium iodide was added, in
excess, to the reaction solutions and the liberated iodine was titrated with sodium
thiosulfate using a starch indicator .240 Confirmation o f the stoichiometry was done
spectrophotometrically by observing the absorbance o f MBT at 324 nm
26,345 ±91 M ' 1cm '1) and HOC1 at 292 nm

(8292 nm

(£ 3 2 4

nm =

= 350 M ' W 1).

To oxidize MBT within the glove matrix each glove was weighed and cut into,
approximately, 1 cm strips. The pieces (1 g total wt.) were incubated in 10 mL o f 0.01
M CIO' on a shaker (250 rpm) at room temperature for 1 hr, and an aliquot was taken
for HPLC analysis. The oxidant exposed glove material was subsequently extracted
with ACN for 1 hour, and an aliquot taken for HPLC analysis. Five gloves were used
in each set o f experiments. As a control, another set o f gloves was cut into pieces and
incubated with distilled deionized water for

1

hr and subsequently extracted with

ACN. The control water and ACN samples were analyzed by HPLC-PDA.

3.3.4 Non-Enzymatic Reduction o f Oxidation Products: A stock solution o f 5 mM
MBTS and fresh solutions o f cysteine (5 mM) and DTNB (5 mM) were prepared in
50/50 ACN/H 2 O. The concentrations o f cysteine and DTNB were kept constant while
that o f MBTS was varied. Spectral scans were obtained and absorbances at 412 nm
and 320 nm were monitored to indicate formation o f 5-thio-2-nitrobenzoic acid (TNB)
from DTNB and M BT from MBTS, respectively. Preliminary experiments
demonstrated that MBT did not react with cysteine or DTNB, and MBTS did
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not react with DTNB under these conditions, confirming that changes in absorbance
were due to the MBTS-cysteine and DTNB-cysteine reactions. MBTS (0.248 mM)
was reacted with 0.496 mM cysteine for 1 hr at 37 °C. The products o f this reaction
were monitored by HPLC-PDA using an isocratic 40/60 ACN/H 2 O elution and
absorbances at 324 nm and 270 nm were routinely monitored and in some cases the
maximum spectral scan mode was employed.

Mass Spectrometry: A white, fluffy precipitate which formed in the reaction solution
was recovered by evaporation and dissolved in 50/50 ACN/0.1 % FA for mass spectral
analysis. Analytes were analyzed using positive-mode electrospray ionization (+ESI)
at a capillary voltage o f 2.8 kV and a flow rate o f 5 pL/min. The source block was
maintained at 80

0

C and the nitrogen desolvation gas was maintained at 150

0

C and a

flow rate o f 400 L/h. MS/MS data was generated via CID in argon at a collision
energy o f 15 eV.

3.3.5 Calibration o f Thiol Determination with Cysteine; Quantification o f BSA

Thiols: The method reported by Schultz 245 was modified: DTNB and cysteine 5 mM
stock solutions were prepared in a 50 mM (N H ^C O a buffer. Cysteine standards from
50 to 250 pM were each reacted with 1 mM DTNB at room temperature in a total
volume o f 2 mL. Absorbance readings taken at 412 nm (s^nm =14,150 M ' 1cm '1) after
15 min were plotted against the final cysteine concentration. The calibration curve was
used to determine BSA sulfhydryl concentration ([SH]/[BSA]) following
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reaction o f 0.4 mL o f 40 mg/mL BSA with 0.2 mL o f 5 mM DTNB for 2 hrs with
subsequent absorbance readings at 412 nm. The calibration curve was also used to
determine loss o f [SH]/[BSA] when BSA was incubated with MBTS.

3.3.6 Preparation o f Reduced BSA: The reconversion o f the Cys34 residue on BSA to
the free sulfhydryl form was performed by incubating equal volumes o f 40 mg/mL
BSA with 4 mM DTT in (NfL^CC^ buffer at room temperature for 3 h, followed by
dialysis (MWCO 3500) in 2L o f 50 mM (NfL^COa for 48 hrs with three buffer
changes during that period to ensure complete removal o f DTT. Post-dialysis BSA
concentrations were determined spectrophotometrically (S278nm = 43,000 M 'lcm '1).246

3.3.7 Reaction o f M BTS with BSA: A stock solution consisting o f 40 mg/mL BSA
was prepared in 50 mM (N H ^C O s (pH 8.2). Stock BSA solution (0.04 mL) and 1.96
mL, 0.248 mM MBTS were incubated for 1 hr on a shaker at 37 °C. A BSA control
was also incubated. HPLC and MS samples were obtained after dialysis (MWCO
3500) in 2L 50 mM (NFL^COs for 48 hrs with three buffer changes. Loss o f DTNB
reactivity (as described above) was used to determine loss o f thiol reactivity as a result
o f MBT binding. As controls, BSA thiol concentrations were determined for (i) fresh
BSA in buffer that was not incubated or dialyzed, (ii) DTT reduced BSA (in the
absence o f MBTS) that had been incubated under the same conditions (as the MBTS
treated BSA) and dialyzed, (iii) BSA which had been reduced by dithiothreitol (DTT)
and dialyzed. A comparison o f the kinetics o f the reaction o f DTNB with (i) reduced
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BSA, (ii) reduced and dialysed BSA, (iii) reduced BSA incubated with MBTS with
subsequent dialysis was performed. The thiol specific blocking reagent Nethylmaleimide (NEM) was used to ascertain Cys34 as the MBTS-targeted thiolcontaining residue on BSA. DTT reduced BSA (0.01 mg/ml; 180 pM ) was reacted with
1. 8 mM NEM for 30 min in a pH 7.4 (N H ^C O a buffer at room temperature with
subsequent dialysis. Aliquots were taken for [SH]/[BSA] determination (with DTNB)
and mass spectrometry. BSA pretreated with NEM and incubated with MBTS was
also subjected to mass spectrometry.

3.3.8 Trypsin/Chymotrypsin Digestion o f BSA: Untreated and modified BSA samples
were diluted to 50 pM and thermally denatured at 95 °C for 30 minutes. Thermal
denaturation was quenched by incubation in an ice bath for 30 minutes. Enzymatic
digests were carried out at a protein/enzyme ratio o f 40:1 (w/w) at 37 °C overnight in
50 mM (NH 4 ) 2 C 0 3 buffer. The digests were analyzed on the ESI-MS.

MS Analysis'. Analytes were diluted 25:1 with 50/50 ACN/1% FA and
analyzed by positive-mode ESI at a capillary voltage o f 3.3 kV, a cone voltage o f 45 V
and a flow rate o f 5 pL/min. The source block was maintained at 80

0

C and the

nitrogen desolvation gas was maintained at 150 ° C and a flow rate o f 400 L/h. The
resultant mass spectra were charge-deconvoluted using maximum entropy calculations
performed in MassLynx (M axEntl). The output range was 50-80 kDa at a resolution
o f 1.0 Da/channel.
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3.3.9 Accelerant Metabolism Studies: A combination o f (i) structural similarities
between a test compound and a known substrate (ii) the ability o f a particular CYP450
isoform to metabolize several different substrates is often exploited in designing
CYP450-new chemical entity (NCE) interaction experiments. This principle is
widespread in pharmaceutical drug development .247 The analogy between M BT and
CZ and the fact that (i) rhodococcus bacteria-mediated hydroxylation o f MBT 248 and
(ii) CYP450 isoform (3A4 and 2E1) hydroxylation o f CZ 249 were observed influenced
the incorporation o f induced liver microsomes where the activity o f the 3A4 and 2E1
isoforms had been boosted. The S9 rat liver microsomes were induced with
dexamethasone and isoniazid resulting in enhanced expression o f the 3A4 and 2E1
isoforms respectively. The method used to test the metabolic fate o f MBT and MBTS
was adopted from the work o f Peter and co-workers250 with modifications. Briefly, the
NADPH regenerating system (NRS) was prepared by combining 0.1 g o f sodium
bicarbonate (NaHCOa) with 8.5 mg NADPH, 39 mg glucose- 6 -phosphate and 30
units/ml glucose- 6 -phosphate dehydrogenase in a total volume o f 5 ml de-ionized
water. This solution was used immediately after preparation. A 0.35 mM stock
solution o f MBT was prepared in de-ionized water. 100 pi o f the 20 mg/ml
isoniazid/dexamethasone-induced S9 liver microsomes was placed in a test tube in an
ice bath followed by 640 pi o f 100 mM Tris buffer. 10 pi o f MBT was then added into
the test tube. The test tube containing liver microsomes and MBT and a second test
tube containing the NRS were placed in a 37 °C water bath with constant shaking for 5
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minutes. 250 pi o f the NRS were then added to the test tube containing the 750 jj.1
mixture o f MBT and the S9 fraction, and incubated for 1 hour at 37 °C. The
metabolism was stopped by addition o f 50 pL o f 43 % H3PO4. Incubations were then
extracted twice with

1

ml o f CH 2 CI2 by vortexing. The organic and aqueous layers

were separated by centrifugation at 3000 g for 10 min. After drying the combined
organic layers to dryness under N 2 at ambient temperature residues were redissolved
in 100 pL o f a 4:6 ACN:H 2 0 mixture by sonication and 20 pL aliquots were injected
into the HPLC column. The control experiment employed heat inactivated S9
microsomes.

3.3.10 Accelerant-Enzyme Studies : Enzyme Inhibition: The principle behind the
accelerant-enzyme interaction studies was hypothesized to be the same as that from
the the in vivo TR and GR catalyzed reactions with thioredoxin (Trx) and GSH as the
substrates, respectively. These reactions can be easily followed by observing the
change in fluorescence o f the co-factor NADPH as it is oxidized to NADP+.

T r x - S - S + NADPH + H +

Trx - ( S H \ + NADP+

GSSG + NADPH + H +-& -+ 2 GSH + NADP+

R3.3
R3.4

Where quenching o f the fluorescing NADPH presented problems such as in the round
about reduction o f proteins (reduced Trx goes on to reduce another protein disulfide)
and in the presence o f other fluorescing substrates alternative methods had to be
80

adopted. A faster and even cheaper alternative was the adoption o f DTNB as the
substrate (with TR; R3.5) and as a readily reduced disulfide (with GSH; R3.6a) with
the trade o ff being a reduction in the sensitivity o f the assay when absorbance is used.

DTNB + NADPH + H +—

2TNB + NADP+

R3.5

GSSG + NADPH + H +—

2GSH + NADP+

R3.6

DTNB + 3GSH -> TNB + GS-T NB + GSSG

R3.6a

3.3.10.1 TR Assay: Mammalian enzyme-mediated reduction o f MBTS was tested by
following the scheme for DTNB reduction 251 where DTNB was substituted with
MBTS as the substrate. Using the TR assay kit from Sigma, a stock solution (1 mM)
o f the test compound MBTS was prepared in DMSO. DTNB and NADPH were
prepared in DMSO as 10 mM and 48 mM solutions respectively, after which they
were stored at 4 °C. The working buffer was prepared by adding 50 pi o f the NADPH
solution to 2 ml o f the Assay Buffer 5x and bringing the final volume to 10 ml with
water. The working buffer was kept at room temperature. Absorbance was also
measured at 270 nm and 320 nm. Control experiments included incubations o f MBTS
with NADPH in the working buffer system and a positive control where DTNB was
added as the substrate. MBTS/DTNB was in excess over the TR to enable enzyme
saturation and maximum activity. The reaction scheme for a 0.5 ml reaction volume is
summarized in Table 3.1. Each reaction was started by adding MBTS with subsequent
mixing by inversion. The total amount o f protein in each assay was 0.2 mg/ml.
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Ultrapure water was used for all reagent preparations and dilutions and each assay was
run in triplicate.

Table 3.1: TR mediated reduction o f MBTS
Sample

Enzyme

Assay Buffer Working Buffer DTNB

MBTS

Blank

0

35 pi

450 pi

0

15 pi

Positive Control

5 pi

30 pi

450 pi

15 pi

0

Test Reaction

5 pi

30 pi

450 pi

0

15 pi

Inhibition studies were carried out by observing the same reaction protocol as
above with the difference being the inclusion o f both MBTS and DTNB as substrates.
A mixture o f MBTS and DTNB was used to start the reaction with subsequent
absorbance measurements at 412 nm. Table 3.2 outlines the reaction scheme that was
used in which a TR inhibitor solution (from the TR assay kit) was used as a control
experiment to show complete inhibition o f TR activity. A positive control utilized
DTNB as the sole substrate. The efficacy o f the thiol moiety on MBT/MBTS was
tested against MBT analogues BT, HBT and MTBT where each compound was
substituted in place o f the MBTS. The stock solutions o f the test chemicals were 1
mM.
The activity (Unit/mL) o f TR was derived from the rate o f production o f TNB
at 412 nm and calculated using equation 3.4;

82

Unit
AA
dil
=
x ---------ml
min EnzVol

3.4

where A A is change in absorbance, dil is the dilution factor o f the enzyme and EnzVol
is the volume (in ml) o f the enzyme that was used.

Table 3.2: Outline o f the inhibition studies on TR
Sample

Enzyme

Assay Buffer

Working
buffer

TR Inhibitor
Solution

DTNB

MBT/MBTS
BT/HBT/MTBT

Blank

0

20 pi

450 pi

0

15 pi

15 pi

Positive Control

5 pi

30 pi

450 pi

0

15 pi

0

Inhibited Sample

5 pi

20 pi

450 pi

10 pi

15 pi

0

Test Chemical

5 pi

15 pi

450 pi

0

15 pi

15 pi

3.3.10.2 GR Assay: Inhibitory behaviour o f M ET and its analogues on GR utilised
stock solutions o f the MBT, BT, HBT and MTBT (0.35 mM), NADPH (1 mM),
GSSG (0.1 mM) and GR from yeast (GR) (25 U/ml) prepared in 0.1 M phosphate
buffer at a pH o f 7.5 and stored at 4 °C before they could be used. Instrument
parameters were used as depicted in Table 3.3. The loss in fluorescence o f NADPH
was used to determine reaction rates o f the reduction o f GSSG. After obtaining a base
line when the reaction was carried out without any substrate, Michaelis-Menten
kinetics were performed using fixed concentrations o f test chemical (I), GR and
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NADPH with variation o f the the substrate (GSSG). Four variations o f the GSSG were
done for each run. To ascertain the nature o f the binding (reversible versus
irreversible) between M BT and GR, MBT was incubated with GR for 2 hrs and the
mixture dialyzed overnight against 0.1 M PBS using a cellulose membrane (MWCO =
12 kDa). The activity o f the dialyzed GR-MBT mixture on GSSG was then
investigated. A control sample o f GR was also dialyzed where the MBT was excluded
in the case non-specific dilutions occurring.

Table 3.3: Luminescence instrument set up.
Excitation
Wavelength (nm)
340

Emission
Wavelength (nm)
450

Excitation
slit width (nm)

2.5

Emission
slit width (nm)
5.5

3.3.10.3 GR from Human Blood Platelets: Human blood platelets were sampled as a
source o f GR for inhibition studies. Whole blood was collected in EDTA tubes and
centrifuged for 10 min at 4 °C at 600 g. Plasma was collected and centrifuged for 30
min at 2100 rpm after which the platelets were washed with PBS and reconstituted to
lm l PBS. Freezing was done at -80 °C to lyse the cells for 24 hrs. The lysed platelets
were centrifuged at 2 1 0 0 rpm for 30 min to remove membranes and supernatant fluid
collected as the source o f GR. Protein concentration was determined using the
Bradford assay .252 Activity o f GR in the supernatant fluid was determined and

^

inhibition studies were carried out as outlined above.

3.3.11 Topkat and Derek fo r Windows253'256: Toxicity prediction by computerassisted technology or TOPKAT 6.2 is a computer modeling software produced by
Accelrys (San Diego, CA) which makes use o f a number o f descriptors derived from
the molecular structure and reactivities o f known functional groups to predict the
sensitizing potency o f small molecular weight compounds. The use o f topological substructural descriptors qualifies TOPKAT as a versatile tool in toxicity prediction. The
software employs robust and cross-validated Quantitative Structure Toxicity
Relationship (QSTR) models for assessing potency. The deductive estimation o f risk
from existing knowledge (DEREK for Windows; Lhasa Limited, Leeds, UK) uses
knowledge bases covering several areas o f toxicology, including skin sensitization.
The information recorded about various aspects o f skin sensitization is used by Derek
whose main objective is to capture a link between the chemical structure and
bioactivity. This software provides the user with a target structural m otif believed to
cause skin sensitization along with a degree o f confidence in the obtained results.
MBT, MBTS and the MBT analogues were subjected to TOPKAT before they could
be tested on the animals.

3.3.12 Local Lymph Node Assay: The modified LLNA adopted for these studies was
according to the Interagency Coordinating Committee on the Validation o f Alternative
Methods (ICCVAM ) 257 standard method where mice were quarantined for at least one
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week following arrival and then grouped into homogenous groups o f five mice per
group (based on their weight) and tattooed. Figure 3.3 is a schematic o f the steps that
were followed in the overall administration o f the LLNA. The mice were dozed with
25 pL aliquots o f the test chemical, the positive control and the vehicle applied to the
back o f both ears for three consecutive days and allowed to rest on days 4 and 5. 0.2
ml of 20 pCi 3 H-TdR in 0.01 M PBS was injected intravenously by tail on day

6

and

after 5 hrs the mice were sacrificed via CO 2 inhalation. Left and right cranial lymph
nodes were excised, stored in 4 ml PBS and dissociated using frosted microscopic
slides.
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Figure 3.3: Overview o f the LLNA,
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After carefully removing the nodes from the capsule which settled at the
bottom o f the tube

6

ml o f PBS was added and centrifugation was done at 200 g for 10

min. The cells were washed a second time in PBS and then suspended in 3 ml o f 5 %
TCA after which they were allowed to sit for 18 to 60 hrs at 4 °C. The cells were
centrifuged again at 2 0 0 g for

10

min and the pellets resuspended and vortexed in

1

ml

o f 5 % TCA before transferring them into scintillation vials. An additional 1 ml o f 5 %
TCA which was used to rinse the tubes was also transferred into the scintillation vials.
Before scintillation counting could be started 10 ml o f the pseudocumene-based
Aquassure liquid scintillation cocktail was added to the vials. To measure the
background beta (P) count, a vial containing

10

ml o f scintillation cocktail and

2

ml of

TCA was included. The P count in samples was determined with subtraction o f the
background. Raw data consisted o f disintergrations per minute (DPM). The SI for a
concentration o f a test chemical was calculated using the ratio 3.5;

S i = DPMJ L .
DPMVII

3.5

where DPM tc was the activity due to the test chemical and DPM vh was the activity
due to the vehicle control which was the appropriate solvent. When a chemical
induced a 3-fold or greater SI for a particular concentration it is regarded as a skin
sensitizer.
When a dose-dependent response was observed for a test chemical, the linear
interpolation approaches was utilized to estimate the effective concentration (termed
EC3) o f the test chemical. Interpolation between two points on the SI axis, one
immediately above and one immediately below the SI value o f 3, was used to
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derive the EC3 value as shown in equation 3.6;

EC3=c+

3.6

where data points lying immediately above and below SI =3 had the coordinates (a,b)
and (c,d), respectively. The vehicle-treated control (SI = 1) was excluded from the
calculation. Proliferation data for the test groups was analyzed by one-way analysis of
variance (ANOVA).

3.3.13 Guinea Pig Maximization Test: One o f the recommended methods for
predictive allergenicity testing is the guinea pig maximization test (GPMT)258 which
incorporates Freund’s Complete Adjuvant (FCA) for induction. Figure 3.4 depicts the
general outline o f the GPMT procedure. The GPMT comprises o f an intradermal
induction with FCA on day 0; topical induction on day 7; a subsequent challenge on
day 21; and rechallenge on day 35 by closed-patch tests to the flanks o f the animal.

C

V
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#
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C
•
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Figure 3.4: Schematic presentation o f the GPMT procedure: The GPMT includes
FCA as an adjuvant in the intradermal injections on day 0.
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The GPMT procedure adopted for this project was essentially according to the
original description 259 and the standardized ASTM GPMT assay260 with modifications
to standardize the test and to objectify evaluation o f the patch test reactions. In
addition, FCA was replaced with Titer Max to eliminate the potential for FCA induced
pain and discomfort. The assay was used to test the cross reactivity o f MBT sensitized
animals to the MBT analogues MBTS, BT, HBT and MTBT. In each sensitization
study, 6 test animals received the test chemical on both patches and 4 control animals
were given exactly the same treatment as described for the test animals, but with the
induction substance (MBT) excluded. All the 10 animals (6 MBT sensitized and 4
non-sensitized) were challenged with the test chemicals. Female albino guinea pigs of
the Hartley strain weighing approximately 1000 g were used and the steps followed
were:

Induction. Day 0: Animals were anaesthetized with brevital (sodium methohexital; 30
mg/kg) before the shoulder region o f each guinea pig could be clipped free o f hair
exposing a 4 by 6 cm area on which three injection sites on each side o f the spine were
identified with at least 1.5 cm between sites. Three intradermal injections were given
in a row, on each side o f the shoulder. These were (i) 0.1 ml o f Titer Max (TM) in
water 40% w/v. (ii) 0.1 ml o f the test substance in a DMSO/Cremophor (1:9)
emulsion, (iii) 0.1 ml o f the preparation consisting o f a mixture o f the test substance
and TM in DMSO/Cremophor, where the concentration for TM was the same as in (i)
and the concentration for the test substance was the same as in (ii).
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Day 7: Topical booster sensitization was performed by applying test chemical to a 2 x
4 cm patch o f in the emulsifier to a 2 x 4 cm patch o f Whatmann filter paper until it
was saturated. The filter paper was then applied to the injection site o f guinea pigs and
occluded with 3.75 cm occlusive surgical tape. An elastic bandage was wrapped
around the torso to secure tape and left in place for 48 h.

Challenge procedure. Day 21: Hair was clipped from the animal flanks as described
above. A 25 % concentration o f the test compound (used for sensitizing) in the
emulsion was applied on a 2 x 2 cm piece o f filter paper, patched onto the animal as
decribed above and left in place for 24 h.

Evaluation. Day 22: The minimum criterion for an allergic (positive) reaction was a
confluent erythema and the observations were scored following the standardized
scoring scheme explained in Table 3.4. All tests were evaluated blindly 1 hr, 24 hrs
and 48 hrs after patch tests had been removed.

Cross-reactions: After the first challenge (MBT and MBTS) animals were allowed to
recover for two weeks before another challenge was perfonned with BT, HBT and
MTBT on the stomach area o f the animals. The same procedure and vehicle as in the
first challenge were used.
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Table 3.4: Scoring criteria fo r allergic reactions
D escription

R eactio n
Erythem a

Edem a

S core

erythem a and eschar
no erythem a

0

very slight erythem a (barely perceptible)

1

w ell-defined erythem a (pale red in color)

2

m oderate to severe erythem a (red and area w ell defined)

3

severe erythem a (beet redness to slight eschar form ation)

4

edem a form ation
no edem a

0

very slight edem a (barely perceptible)

1

slight edem a (edges o f area w ell-defined by definite raising)

2

m oderate edem a (edges raised approxim ately 1 m m )

3

severe edem a (raised more than 1 mm and extendingbeyond
area o f exposure)

4

Statistical calculation: The number o f positive test animals was compared to the
number o f positive animals tested with vehicle only. Statistical significance was
calculated with a one-sided Fisher’s exact test. When significant values (p = 0.05)
were obtained both in comparison with the controls tested with allergen and the
animals tested with vehicle alone, the compound in question was judged to be a
sensitizer. The sensitizers were also compared with one another in order to discover
significant differences between them and then a 2-sided Fisher’s exact test was used.
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CHAPTER 4

KINETICS AND MECHANISM OF THE FORMATION AND STABILITY OF
S-NITROSO-N-ACETYLPENICILLAMINE

4. INTRODUCTION
The S-nitrosation o f N-acetylpenicillamine (NAP) to give S-nitroso-Nacetylpenicillamine (SNAP) was studied in this project. NAP, which is a metabolite of
penicillamine, has metal chelating properties which were exploited in its use as a
clinical drug in metal poisoning.261,262 NAP which has the same metabolic behaviour
as D-penicillamine,

is administered orally and to date there is no evidence on the

adverse effects attributed to NAP administration making it a suitable NO delivery
molecule in exogenous based NO donor drugs. Even though the decomposition o f
SNAP with consequent release o f NO has been studied by numerous researchers264'267
the formation o f SNAP and the kinetics has not been studied. Characterization o f the
nitrosation o f NAP was carried out. The dependence o f S-nitrosation kinetics on a
number o f factors such as metal ions, pH and oxygen availability was also
investigated.
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4.1 RESULTS
4.1.1 Nitrosation o f NAP and Product Confirmation'. The stoichiometry o f the
reaction involved the reaction o f 1 mol of NAP with 1 mol o f nitrous acid to produce 1
mol o f SNAP accompanied by the elimination o f a water molecule and with the
reaction occurring solely at the thiol center:

"NINH

HS

'

N-acetyl-D-penicillam ine + H N O 2 —*

HO'

\

Q

N = 0

S-nitroso-N-acetyl-D-penicillamine

+ H2 O

R4.1

The stoichiometry was derived by the use o f several complementary
techniques. The SNAP synthesized in our laboratory was carefully weighed and its
UV spectra obtained and compared with that from a commercially available sample.
This spectrum is shown in Figure 4.1 A with a peak at 338.5 nm and an absorptivity
coefficient o f 890.5 M '1cm '1. For all our experimental data acquisitions, however, a
2max o f 339 nm with an absorptivity coefficient o f 890 M '1 cm '1 was used. Reactions
run for the deduction o f the stoichiometry were set up with [H+]o, [N02_]o »

[NAP]o

such that NAP was the limiting reagent. The reaction was allowed to proceed to
completion while rapidly scanning the reaction solution between 250 nm and 450 nm.
The maximum absorbance obtained at 339 nm was noted and the concentration o f
SNAP was deduced from this maximum absorption. Typical reaction times were
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in the range o f 5 - 15 min. Further incubation o f the reaction solutions showed a
decrease in the peak at 339 nm as the nitrosothiol slowly released the nitric oxide and
formed a disulfide (here SNAP is written as RSNO):268

2RSNO -> RSSR + 2NO

R4.2
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CD
JQ
1
o

£
<

0.6
0.4

0.2

0.0
300

400

500

600

Wavelength(nm)

Figure 4.1A: UV/Vis Spectrum o f 1.35 m M standard S-nitroso-Nacetylpenicillamine at neutral pH. Only one peak is available in the near-UV at 339
nm with an absorptivity coefficient o f 890 M 1 c m 1.

In the physiological environment, the half-life for reaction R4.2 is
approximately 10 h, and did not interfere with the kinetics o f reaction R4.1. Typical
spectra o f reactants and products are shown superimposed in Figure 4. IB. The
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product solution resulting from excess acid and nitrite is shown as spectrum a. It
differs from that shown in Figure 4.1 A because o f contribution from HNO 2 whose
spectrum is shown in Figure 4 .IB as spectrum b. Nitrite (spectrum c) also absorbs at
339 nm. The true absorption derived solely from SNAP was obtained after subtracting
contributions from nitrite and HNO 2 . In high enough acid conditions the expected
spectrum and absorptivity coefficient could be obtained by assuming that all excess
nitrite is in the form o f nitrous acid.
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(a ) 1 mM N A P, (b) 10 mM N 0 2', (c) 10 mM N 0 2' + 8 0 mM H*. (d) 1 m M N A P + 10 mM N 0 2' + 8 0 m M H*

Figure 4.1B: UV/Vis spectral scans o f reactants NAP (a), nitrite (b), nitrous acid
(c) and product SNAP (d). The structure seen in the spectrum o f SNAP is from
contribution from HNO 2 which, at these conditions, was in excess. The overall
absorbance observed a t 339 nm is higher than the expected 0.890 because o f
contributions from nitrite and nitrous acid.
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Figure 4.2A: (a) Product confirmation o f the nitrosation reaction. (a(i)) 8.334 mM
NAP + 4.167 m M H N 02 + 25 mM i t (a(ii)) 1.135 m M SNAP standard + 25 m M i t
(a(iii)) Co-injection o f 1.135 m M SNAP standard + 8.334 m M NAP + 4.167 m M
H N 02 + 25 mM i t . (b) Overlay o f the spectra in a. The appearance o f the single
peak at 5 min fo r (c) confirms the product to be SNAP.
Figure 4.2A shows the HPLC spectral data that were used to confirm that
SNAP is the sole product obtained from the reaction of nitrous acid and NAP.
96

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

Spectrum (i) shows the spectrum obtained from the reaction mixture (NAP + NCV +
H+) which shows a peak after 4.9 minutes while spectrum (ii) is from standard SNAP
and spectrum (iii) is from a combination o f SNAP, NAP and acid. On superimposing
all three spectra in (iv), one can confirm that our reaction mixture only produces
SNAP. The slight deviation obtained in the appearance o f the peaks o f standard SNAP
and the peak obtained from the reaction mixture is attributable to the excess acid in the
reaction mixture. This explains why peaks for spectra (i) and (iii) coincide exactly.
The concentrations utilized in all three spectra were deliberately made unequal so that
each peak could be clearly resolved on the superimposed spectra in (iv). The time-offlight mass spectrometry spectra from reaction product and synthesized standard
SNAP are shown in Figures 4.2B,C. These two compounds give nearly identical
spectra. The m/z =191.06 peak is from the thiol molecule, NAP. In the reaction
product this peak appears on m/z 192.06 due to protonation o f the nitrogen or thiol
group which occur in the excess acid conditions that were employed in producing this
product solution:

NAP + H+ ^

[NAP-H]+

R4 3

The first protonation would occur at the secondary amine center, which is slightly
more basic that the thiol center. The SNAP, in both spectra in Figure 4.2B, appear at
m/z 221.06.
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(B)
TOFMSES+

1

191.0625

221.0611

171.1487 174.0603 177.0582

11

192.0669

22 .0574

Figure 4.2B: (a) Comparison o f the standard nitrosothiol and the reaction product
(i) 0.454 p M o f SNAP standard in ACN/H 2O and (ii) 0.454p M o f reaction product
in ACN/H 2 O
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Figure 4.2C: The standard nitrosothiol and the reaction product gave the same
fragmentation pattern when MSMS fragmentation was done on the parent peak m/z
221.0570. (i) SNAP standard (ii) reaction product.

The MSMS fragmentation patterns o f the m/z 221.06 peak, in both cases are
also nearly identical (Figure 4.2C (i) and (ii)). The most important deduction from the
QTOF spectra is the absence o f any product from the possible nitrosation o f the
secondary amine in NAP. This is a well known reaction in which nitrous acid reacts
with a secondary amine to yield an N-nitrosoamine:
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R 1R2 NH + HN02 ■-> RiR2N-N=0 + H20

R4.4

It appears that under the conditions in which the kinetics o f formation o f SNAP were
studied, formation o f the nitrosoamine is negligible.

4.1.2 Oxygen Effects: Molecular oxygen is known to be an important reagent in many
reactions involving sulfur compounds. It is also known to interfere in many reactions
involving oxides o f nitrogen. Nitric oxide autooxidizes in aerobic environments to
yield predominantly nitrogen dioxide and other nitrogen oxides.

2NO + 0 2 -> 2 N 0 2

R4.5a

NO + N 0 2 -+ N 20 3

R4.5b

N20 3 + H20

R4.5c

2 N 0 2' + 2H+

Aerobic environments also encourage the formation o f peroxynitrite anions from the
reaction o f superoxide radical anion with nitric oxide.269

NO + 0 2 ‘ -»■ O N O O '

R4.6

Thiols represent preferential targets o f the peroxynitrite anion in biological systems.
Peroxynitrites oxidize thiols to the dimeric disulfides. Reaction R4.6, however, is
more viable in basic environments. Most o f the kinetics data presented in these studies
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were obtained in low pH environment, thus rendering reaction R4.6 less effective
under our reaction conditions. At room temperature and pressure aqueous solutions are
0.2 mM in oxygen in neutral pH conditions, and at such low concentrations, reaction
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Figure 4.3. Effect o f oxygen on the nitrosation o f NAP. 2.5 m M NAP + 2.5 m M
NO£ +1 0 0 mM t f {(a) Bubbled with Ar and (b) O2 present}. Neither initial rates
nor the final amount o f SNAP formed are altered by the absence or presence o f
oxygen.

R4.5a would be too slow to be competitive. Figure 4.3 shows two reaction traces at
identical initial conditions in which one solution was ultrasonicated and degassed with
argon. The final absorbances expected in both experiments were identical, and initial
rates were also identical. The two traces only deviated in the middle part o f the
reaction which was not utilized for kinetics measurements and stoichiometric
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determinations. Thus, in most o f our experiments, ambient oxygen concentrations
were not controlled.
4.1.3 Reaction Kinetics: The reaction involved the nitrosation o f NAP by nitrous acid.
The nitrous acid was prepared in situ by the acidification o f sodium nitrite. The
stopped-flow configuration involved the mixing o f NAP, acid and sodium perchlorate
in one feed stream, with the other feed stream containing solely sodium nitrite. The
injection o f acid and nitrite into separate feed streams precluded the possibility o f the
nitrous acid decomposing before nitrosation commenced. Most reactions were run
with NAP as the limiting reagent.
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Figure 4.4A. Absorbance traces showing the effect o f varying N A P concentrations.
The reaction shows first-order kinetics in NAP. [N O i]o - 5 mM; [FtJo = 20 mM;
[NAPJo = (a) 0.125, (b) 0.188, (c) 0.25, (d) 0.3125, (e) 0.375, and (f) 0.5 mM.
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Figure 4.4A shows the effect o f varying NAP concentrations at constant acid and
nitrite concentrations. Initial rate plots with respect to NAP concentrations show a
linear plot with an intercept kinetically indistinguishable from zero. The reaction
showed a strong first order dependence in NAP for a wide range o f NAP
concentrations for as long as [NCVJo, [H+]0 > [NAP]0. Figure 4.4C shows the same
traces as in Figure 4.4A at higher acid concentrations. At these acid concentrations the
reaction went to completion (producing the expected maximum SNAP as per
stoichiometry R4.1) within 20 s. All NAP introduced into the reaction mixture was
quantitatively converted to SNAP. If observation o f the traces in Figure 4.4C was
continued further, a slow decrease in concentration o f SNAP was next observed.
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Figure 4.4B: Initial rate plot o f the data in part A. The intercept is small enough to
be kinetically indistinguishable from zero. The plot shows the strong first-order
dependence o f the rate offormation o f SNAP on NAP.
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This is expected since nitrosothiols are known to be nitric acid donors. At the
concentrations utilized for Figures 4.4A-C, the rate o f formation o f SNAP is much
faster than its decomposition rate.
The effect o f varying nitrite is shown in Figure 4.5 A. The amount o f SNAP
formed increases until the nitrite concentrations exceed NAP concentrations and
saturation is attained. The final absorbances observed, however, continue to increase
after nitrite concentrations exceed NAP concentrations because o f the contribution to
the absorbance observed at 339 nm from nitrite and HNO 2 .
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Figure 4.4C: The same NAP dependence traces performed at higher acid
concentrations to those shown in part A. The quantitative production o f SNAP
occurs much earlier in high acid conditions. [NO2'Jo = 5 mM; [FtJo = 40 mM;
[NAPJo = (a) 0.125, (b) 0.188, (c) 0.25, (d) 0.3125, (e) 0.375, (f) 0.5, and (g) 0.60
mM.
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Absorbance from SNAP is obtained by subtracting the contributions from
these two species. Figure 4.5B also shows that the rate o f formation o f SNAP is first
order in nitrite concentrations. Kinetics o f formation o f SNAP has a more complex
dependence on acid. Figure 4.6A shows acid variations which show that at high
enough acid concentrations the decomposition o f SNAP occurs before its quantitative
formation is complete. The decomposition o f SNAP can be delayed by the use o f
lower acid concentrations and by having excess nitrite and acid over NAP.
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Figure 4.5A: The effect o f varying nitrite concentrations. Traces a-c have less than
stoichiometric amounts o f nitrite. Trace d has the 1:1 stoichiometric ratio o f N AP to
nitrite. [NAPJo = 0.5 mM; [ l t ] 0 = 40 mM; /NOfJo = (a) 0.125, (b) 0.25, (c) 0.375, (d)
0.5, (e) 0.625, and (f) 0.75 mM.
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Figure 4.6B shows the absorbance traces obtained in low acid conditions in
which acid is less than nitrite concentrations and its concentration is progressively
increased to when it is now slightly higher than nitrite. The acid dependence plot
shown in Figure 4.6C appears discontinuous. With acid concentrations less than nitrite
concentrations, the rate o f formation o f SNAP is first order with respect to nitrite.
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Figure 4.5B: Initial rate plot o f the data shown in part A. The formation o f SNAP
shows first-order kinetics in nitrite concentrations.

This plot also gives the expected intercept o f a vanishing rate o f reaction with zero
nitrite concentrations. The plot, however, changes slope and loses linearity as
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soon as acid concentrations exceed nitrite. This would suggest a simple one-term rate
law at low acid and a more complex multi-term rate law with respect to acid at higher
concentrations.
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Figure 4.6A: Effect o f medium to high acid concentrations on the formation o f
SNAP. High acid concentrations give an early onset o f the decomposition o f SNAP
while also catalyzingformation o f SNAP. [NAPJo = 0.25 mM; [NOiJo ~ 0.25 mM;
[ tfjo = (a) 0.01, (b) 0.02, (c) 0.03, (d) 0.04, and(e) 0.05M.
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Figure 4.6B: Effect o f acid at low acid concentrations. There is a linear dependence
on the rate offormation o f SN AP at low acid concentrations. fNAPJo = 0.25 mM;
[NOiJo = 5 mM; [Ft]0 = (a) 1.25, (b) 2.5, (c) 5, (d) 6.25, (e) 7.5, (f) 8.75, and (g) 10

mM.
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Figure 4.6C: Initial rate plots showing linear dependence o f rate o f reaction on acid
at low acid concentrations. This plot is derivedfrom data in part B.

4.1.4 Effect o f Cu (I) and Cu (II) ions: Cu(I) and Cu(II) ions are known to affect
many reactions involving sulfur compounds. Figure 4.7A shows a series of
experiments with varying amounts o f Cu(I) ions. It shows a decrease in rate as well as
a decrease in amount o f SNAP obtained with increase in Cu(I) ions. It would appear
that Cu(I) ions sequester some o f the NAP and makes them unavailable for further
reaction due to the linear response o f the amount o f SNAP formed to the amount o f
Cu(I) ions added. A plot o f [Cu(I)]o vs absorbance due to SNAP was linear with
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a negative slope. The absorbance due to SNAP had to be calculated by subtracting the
absorbance due to HNO 2 (see Figure 4 .IB), and hence this linearity would not be
evident just by looking at Figure 4.7A.
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Figure 4.7A: Effect o f Cu(I) on SNAPformation. There is a monotonic decrease in
SNAPformation with increase in Cu(I) concentration. [NAPJo = 0.5 mM; [NOi]o 5.0 mM; [Ff]0 = 0.04 M. [Cu(I)J0 = (a) 0, (b) 0.05, (c) 0.075, (d) 0.1, and (e) 0.15
mM.

Figure 4.7B is a control experiment carried out to isolate the effect o f Cu(I) ions.
Trace a in Figure 4.7B represents a normal experimental run without copper ions.
Trace b has the same initial conditions as trace a, but with a metal ion chelator,
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EDTA. There is a very small difference between the two traces, showing that the
water supply used for the preparation o f reagent solutions did not contain enough
metal ions that could affect the reaction dynamics and kinetics.
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Figure 4.7B: Evaluating effect o f Cu(I) by the use o f metal ion chelators, EDTA. All
experimental traces have [NAPJo = 0.5 mM, /NOiJo = 5.0 mM, and [ t t ] o - 0.04 M.
Trace a is the control. Trace b has 0.1 mM EDTA. No difference is discernible
between traces a and b, indicating that the water usedfo r preparing reagent
solutions did not contain enough trace metal ions to affect the kinetics. Trace c has
0.1 mM EDTA and 0.15 m M Cu(I) ions. Trace d is the same as trace c without the
EDTA.
Ill

Trace c has Cu(I) ions with EDTA. The concentrations o f Cu(I) ions used in this trace
were higher than the EDTA concentrations, thus ensuring that some Cu(I) would be
free and not sequestered. This shows depletion o f SNAP formed that is proportional
to the concentrations o f the Cu(I) ions that were not sequestered. The EDTA is
completely, removed in trace d and the result is a lower formation o f SNAP.
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Figure 4.7C: Effect o f Cu(II) ions on the rate offormation o f SNAP. All traces
contained [NAPJo = 0.50 mM, [NOfJo = 5.0 mM, and [itJo = 0.04 M. The other
traces have the following Cu(II) ion concentrations: (a) 0.175 mM, (b) 0.15 mM, (c)
0.125 m M and (d) 0.1 mM.

- 1-

Figure 4.7C shows another series o f experiments with Cu(II) ions. They give the
reverse o f the effects o f Cu(I) ions. Their inclusion gives a complex that contributes to
the absorbance at 339 nm. The initial rates o f formation o f SNAP, however, are not
altered by addition o f Cu(II).

4.2 M ECH A N ISM
The reaction dynamics suggest only four reactions as being relevant in the
production o f SNAP. They involve the protonation o f nitrite to produce nitrous acid
followed by the production of the nitrosyl ion271 and the reaction o f both nitrous acid
and nitrosyl cation with NAP. Since the only chemical reactivity during nitrosation is
occurring at the thiol center of NAP, for the purposes o f this mechanism, NAP is
denoted as the generic thiol RSH.

H+ + N 0 2-

hno2

k „ k . , ; K a-'

(R4.7)

H N 02 + H+

+N=0 + H20

k2, k_2

(R4.8)

RSH + H N 0 2 —► RSNO + H20

k3

(R4.9)

RSH + ^ = 0

k4, k.4

(R4.10)

RSNO + H+

The rate o f reaction, based on the formation o f RSNO is given by:

d[SNAP]/dt = k3[RSH][HN02] + k4[RSH][+N = 0] - k.4[SNAP][H+]

4.1
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At the beginning o f the reaction, before accumulation o f SNAP, the last term in
equation (4.1) can be ignored. All the Nitrogen(III) species in the reaction solution are
bound by the following mass balance equation:

[N(III)]t = [N 02‘] + [H N 02] + [RSNO] + [+N = 0]

4.2

The total N(III) species, in this case would be the nitrite added to the reaction mixture.
Since we expect the nitrosyl ion to be a transient reactive intermediate, its
concentration can be assumed to be negligible. For initial rate measurements,
concentration o f product RSNO can also be ignored. We can apply a steady-state
approximation on the nitrosyl ion to simplify equation (4.1) into measurable
concentrations.

[m+]

k 2[ H N Q 2] [ H +]

4.3

k_2 + k 4[ R S H ]

By using the dissociation constant o f nitrous acid and the mass balance equation (4.2),
the initial rate law can now be re-written as the flowing complex function o f acid
concentrations:
R ate

= djRSNO]
dt

[ RS H) [ N( I I I ) ] T[ H +]
K a + [ H +]

|

k 2k 4[ H +]

4.4

3 k_2 + k 4[ RSH]
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Equation (4.4) is supported by the kinetics data shown in Figures 4.4 - 4.6.
Specifically, it predicts first order kinetics with respect to NAP and nitrite w ithout any
saturation. It also predicts first order kinetics in acid at low concentrations. W hen
[H+]o is low (approximately 0.1 mM or less) the second term in (4.4) becomes
negligible and the reaction retains first-order kinetics on the basis o f the first term
only. The prevailing ‘free’ acid concentrations have to be carefully calculated. They
do not correspond to the acid added to the reaction mixture, but to the acid released by
the dissociation o f the weak nitrous acid added to the acid left after the strong
conjugate base has sequestered as much acid as is needed to form nitrous acid. So,
initial rate acid concentrations have to be calculated for each set o f initial reagent
concentrations. For example, an initial acid concentration o f 1 mM added to 2.5 mM
o f nitrite gives only 0.31 mM o f free acid. When initial acid concentrations are higher
than nitrite, the free acid can be approximated to the excess acid over nitrite.

4.2.1 Evaluation o f kinetics constants: Equation (4.4) has four kinetics constants that
need to be evaluated. These can be reduced to three if the equilibrium constant for
reaction R4.8 (K 2 ) is known with certainty for these experimental conditions. Since
reactions R4.9 and R4.10 are the rate-determining steps, an initial approximation
would be that k .2 »

kzj. This would simplify equation (4.4) to read:
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d[RSNO]
dt

[RSH] [N(III)]t [H+]
K a +[H+]

(k3+K2k 4[H+])

4.5

A series o f three NAP-dependence experiments were performed at different acid
concentrations. To simplify the calculation for acid concentrations, [H+]o = [NCVJo so
that acid concentrations could be calculated from the dissociation o f HNO 2 without
any contribution from the protons derived from excess acid over nitrite. Plots o f the
product [RSH]o vs initial rates gave linear plots which were utilized to evaluate
bimolecular rate constant. k 3 .
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[H N 02] = 9 mM

2.0e-5

a>

2

1.5e-5
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Figure 4.8: Combined NAP dependence plots at three different nitrous acid
concentrations. The traces are labeled with the appropriate nitrous acid
concentrations. The only variable was NAP concentration. These data were utilized
in equation 4.4 fo r the evaluation o fk 3 = 2.69± 0.33 M 1s'- 1
116

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

The slope o f this plot was {[N(III)]T[H+]/(Ka + [H+])}(k3 + K 2k4[H+]).
For these calculations, Ka for nitrous acid was taken to be 0.562 mM. These three
plots are shown in Figure 4.8. Only two NAP dependence series o f initial rate data
were required, but, in this case, a third set was produced to check the validity o f the
other two. The algebraic form o f the slope was intractable with respect to an
independent evaluation o f K 2 and k*, and instead could only deliver the product o f
these two constants. Figure 4.8 was first plotted without weighting the origin, and
when the plots gave an origin kinetically indistinguishable from zero, the plots were
then re-done while utilizing the origin as a data point. The data in Figure 4.8 delivered
a bimolecular rate constant for the direct reaction o f NAP and HNO 2 o f 2.69 ± 0.33 M'
V 1. The product K^lcj was evaluated from the same data as 3.15 x 103 M 'V 1. A
number o f groups have studied reaction R4.9, but none have given a reliable value of
the equilibrium constant, K 2 .

4.2.2 Mechanistic Basis o f the Effect o f Cu(I) ions: Recent studies using density
86 272

functional theory ’

4*

have reported that Cu ions can bind to the S and N centers o f

nitrosothiols but that, for the model compound H SN =0, the binding to the S atom is
39.6 kJ more stable than binding to the N atom. The binding to the S atom also
lengthens and weakens the S-N bond while concomitantly shortening and
strengthening the N = 0 bond. This results in the increase in the decomposition o f
nitrosothiols to release NO. This increase in the lability o f nitrosothiols in the presence
o f copper ions could be the mechanism obtaining in the physiological
117

environment for the biochemical regulation o f NO release from nitrosothiols in the
presence o f some metalloenzymes. The data in Figures 4.7A and B clearly show that
stoichiometric amounts o f SNAP are not obtained in the presence o f Cu+ ions. Some
previous research workers had noted that both Cu(II) and Cu(I) accelerate the
decomposition o f nitrosothiols through a homolytic cleavage o f the C-S bond to yield
disulfides and nitric oxide273 (Reaction R4.2). The effect o f Cu(II) was assumed to
involve its initial reduction to Cu(I) which is the more active ion. This reduction can
be accomplished by the thiolate ions that exist in thiol solutions.274

2RS- + 2C u 2+ — ► RSSR + 2Cu+

R 4 .ll

RSNO + Cu+

R4.12

X+ — ► RSSR + NO + Cu+ (unbalanced)

where X+ is the complex with the copper ion attached to the nucleophilic sulfur center.
The acidic conditions utilized in our experiments preclude the significant formation of
thiolate ions resulting in the inertness o f Cu2+ in this reaction mixture. W ork reported
by Askew275 was performed at the physiological pH 7.4; which can explain the
possibility o f forming thiolate anions. If reaction R 4.11 is not viable, then there is no
possibility o f Cu2+/Cu+ redox cycling as has been suggested by other workers.276 The
data in Figure 4.7C shows that Cu(II) is an inert ion and does not influence the
decomposition o f nitric oxide. The reaction rates are invariant under a change o f
[Cu(II)]o. The observed changes in the absorbances for the different Cu(II)
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concentrations are derived from the contribution the Cu(II) compounds makes to the
absorbance at 339 nm.

4.2.3 Calculations: The formation o f SNAP is a very simple 4-reaction mechanism
with two rate-determining steps and very few unknown kinetics variables. The
simulations were undertaken only to enable us to evaluate the bimolecular rate
constant for reaction R4.9, k*. The value adopted was based on the best fit and the
value reported in the literature for K%. Table 4.1 shows the mechanism utilized in the
calculations as well as the adopted rate constants.

Table 4.1: Reaction Scheme and Kinetics Constants Used in Modeling the NAPHNO 2 Reaction

reaction
na

reaction

forward rate
constant
M 'V 1

reverse rate
constant
M 'V 1

R4.7

H+ + N 0 2"

HN02

1.1 x 109

6.18 x 105

R4.8

HN02 + H+

+N=0 + H20

3.16 x 105

1.00 x 10'

R4.9

RSH + HN02 —► RSNO + H20

2.69

ca. 0

R4.10

RSH + ^ = 0

3.00 x 104

1.00 x 10"

RSNO + H+

Reaction R4.7: This is a rapid protolytic reaction which should be fast in both
directions. The ratio o f the forward and reverse rate constants for this
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equilibrium is constrained to the acid dissociation constant o f nitrous acid, Ka. Once ki
is set, then k_i is also automatically set. The simulations were insensitive to the values
for the kinetics constants adopted for this reaction for as long as they were faster than
any other reaction in the reaction mixture and they adhered to the value o f the acid
dissociation constant, Ka.

Reaction R4.8. Several research groups have studied this reaction, but no-one has been
able to assign a reliable value for the equilibrium constant.271,277 It is normally written
as:

HONO + H30 +

H2ONO+ + H20

(R4.13)

The most recent work reported on this equilibrium established a pKa value o f 1.5 but
quickly added that the pK a value has no real thermodynamic significance apart from
the fact it fit in their numerical modeling studies o f the experimental deviation o f their
calculated pKa for nitrous acid in pH conditions less than 2.7. For our calculations,
then, we used an initial guess o f K2 as 3.162 x 10‘2 M '1. Thus we expect the nitrosyl
ion concentrations to be negligible in pH conditions above 3.0. In this pH range, the
reaction proceeds predominantly through reaction R4.9.

Reaction R4.9. The bimolecular rate constant for this reaction was derived in this
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study and was fixed at that value for all calculations. It was assumed to be irreversible.

Reaction R4.10. There was no experimental technique that could be used to isolate this
reaction for the evaluation o f an upper-limit rate constant value. The value o f IC4 K 2
evaluated from experimental data was only used to estimate an initial guess value. The
final adopted value o f 3.00 x

104

M 'V was derived from the best fit. The reverse rate

constant was important in highly acidic conditions where the decomposition o f RSNO
was much faster.

Reaction R4.2. This is the general decomposition reaction o f RSNO which proceeds at
a much slower pace than the formation o f RSNO. Without Cu(I) ions, this reaction did
not interfere with the kinetics o f formation o f RSNO.

4.2.4 Computational results: The fitting o f the data was simple and the best fit value
was obtained with £4 = 3.00 x 104 M’1s' 1 and

£3

= 2.69 M ' 1 s '1. Figure 4.9 shows a

comparison between experimental and calculated RSNO formation kinetics. The fit is
adequate for such a simple model. Figure 4.9 shows that the model can satisfactorily
reproduce the NAP dependence o f the reaction rate. The value o f £.4 = 0.001 M 'V
was sufficient to simulate the dissociation observed in high acid conditions o f Figure
4.6A. The adopted value for £4 was heavily dependent on the adopted value o f
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K 2 from Koch and Sodeau ,278 and would most likely not be valid in physiological
conditions o f pH 7.4.
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Figure 4.9: Calculations based on mechanism and kinetics constants in Table 4.1
fo r the NAP dependence shown in Figure 4C. Plots fo r (a) (-) experimental and (u)
simulatedfor 0.5 m M N A P + 5 m M N O i + 0.1 M F f and (b) (-) experimental and
(A) simulatedfo r 0.3125 m M N A P + 5 m M N O i + 0.1 M i f .

4.2.5 Conclusion: These studies have shown that the nitrosation o f NAP is
accomplished through the direct reaction o f nitrous acid with NAP, as well as, through
the formation o f the nitrosyl ion which acts as the nitrosation agent. The nitrosyl ion is
abundant only in highly acidic environments, and above pH 3.00 nitrosation is
predominantly through nitrous acid. S-nitrosation occurs solely at the sulfur center on
NAP.
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C H A PTER 5

THE OXIDATION OF MET IN LATEX GLOVES AND ITS POSSIBLE
HAPTENATION PATHWAY

5.1: HYPOTHESIS
The hypothesis is that the thiol is a critical moiety for M BT’s allergenicity.
Alternatively, C YP mediated epoxidation/hydroxylation o f the aromatic ring on MBT
results in protein reactivity. Given the lack o f exploratory data on the skin
sensitization o f MBT and its metabolites, a series o f experiments were carried out to
test the hypothesis via the proposed pathways outlined in Scheme 5.1. These were to;
(A) oxidatively transform MBT within the glove matrix; (B, C) study the fate o f the
oxidation products in the presence o f either endogenous thiols or protein thiols (R/PrSH); (D, E) probe the possibility o f the microsomal phase I metabolism on the
aromatic ring o f the M BT molecule with subsequent adduct formation via nucleophilic
residues (Pr-Nu) on proteins. Possible haptenation between MBT and proteins was
studied by utilizing BSA as a model protein (pathway C).
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Scheme 5.1: Hypothesized pathways through which M BT and its derivatives are
able to covalently modify proteins. Disulfide bridge formation with proteins (Pr-SH)
and adductformation via epoxidation on the ring with nucleophilic residues on
proteins (Pr-Nu) are the proposed mechanisms.

5.2 RESU LTS
5.2.1 Oxidation o f MBT: The stoichiometry o f the HOC1-MBT reaction was
determined to be consistent with reactions R5.1 and R5.2. The oxidation o f MBT
occurs in two stages where CB is produced in the first stage. CI2 is a reactive
intermediate, since it is quickly reduced to the chloride ion, oxidizing more MBT.
Hence the overall oxidation involves the conversion o f 2 moles o f MBT to 2, 2 ’124

dithiobis(benzothiazole) (MBTS), the disulfide (R5.3).

2C 7NS 2 H 5 + 2H0C1

C14N2S4H8 + 2H20 + Cl2

R5.1

2C 7NS 2 H 5 + Cl2

C 14N 2 S4 H 8 + 2HC1

R5.2

2C 7NS 2 H 5 + HOC1

C 14N 2 S4 H 8 + H20 + HC1

R5.3

The stoichiometry was confirmed by a spectrophotometric method (Figure 5.1)
where a 1:1 ratio o f MBT:HOCl (trace /) resulted in complete MBT conversion to
MBTS after 15 minutes. Under these conditions, the only oxidation product o f MBT is
the disulfide and this was confirmed by UV-Vis spectrophotometry, HPLC and mass
spectrometry. The formation o f the disulfide, which has an absorbance at 270 nm, was
a swift reaction that does not appear to involve any acid catalysis. The commercially
available latex glove used contained only MBT (and not MBTS), and oxidation o f the
MBT was readily achieved within the glove matrix. MBT was observed in the
aqueous extract from the unbleached gloves, however, none was observed in the
extract from the bleached glove. Although MBT is slightly soluble in water, MBTS is
not. The ACN extract o f the control glove contained only MBT and that o f the
bleached glove contained mainly MBTS. The HPLC chromatograms in Figure 5.2
clearly demonstrate that the disulfide is retained within the glove matrix. The disulfide
was also detected in the UV-Vis spectrum.
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Figure 5.1: Oxidation o f M BT with CIO'. The reaction solutions were allowed to sit
fo r 15 minutes before scanning. M BT is held constant at (a) 0.071 mMwith
consecutive increments o f the oxidant (b) to (I). When the ratio o f MBT:C10~ was
2:1 (0.071 m M : 0.0355 mM, M B T: CICT) (trace k) almost all the M BT was oxidized
and with a 1:1 ratio all the M BT is oxidized. Absorbance was also monitored at 270
nm.
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Figure 5.2: Oxidation o f M BT in the glove matrix, (a) HPLC chromatogram o f the
acetonitrile extract o f the unbleached glove showing the presence o f MBT. (b)
HPLC chromatogram o f the acetonitrile extract o f the glove after bleach incubation.
The M BT is oxidized to the disulfide.

5.2.2 Reduction o f MBTS: There was a marked loss in reactivity between cysteine
and DTNB when MBTS was incorporated into the reaction solution. The loss in
reactivity between DTNB and cysteine was monitored at 324 nm and 412 nm, as
shown in Figure 5.3. As the amount o f MBTS was increased (traces a - g) there was
less cysteine available to react with DTNB and release the chromophore 2-nitro-5thiobenzene (TNB); hence a decrease in absorbance at 412 nm was observed. There
was no change in the absorbance at 324 nm and 412 nm under the same conditions (as
those for the DTNB + Cysteine + MBTS) for the reaction o f (i) DTNB with MBTS,
(ii) DTNB with MBT and (iii) DTNB with cystine.
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Figure 5.3: Spectrophotometric use o f DTNB to follow the reduction o f M BTS with
cysteine. 0.15 m M cysteine + 0.15 mM DTNB + {(a) 0.025, (b) 0.05, (c) 0.075, (d)
0.1, (e) 0.125, (f) 0.15, (g) 0.175} mMMBTS. As the [MBTS] was increased there
was less cysteine available and consequently less 2-nitro-5-thiobenzene (TNB)
formed. The amount o f free DTNB available also increased.

Therefore, the release o f the chromophore TNB from DTNB could only be
attributed to the reaction o f cysteine with DTNB. When the same reaction conditions
were employed with glutathione, the same reduction o f MBTS was observed.
Chromatographic separation with subsequent mass spectrometry analysis afforded
quantitation and characterization o f the MBTS reduction products. The formation o f
the MBT-Cysteine adduct through a disulfide bridge was confirmed as the major
product o f the thiol-induced reduction o f MBTS.
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Figure 5.4: Mass spectrometry o f the cysteine-MBTS reaction. Spectrum (a)
confirms the presence o f the MBT-cysteine mixed disulfide (2-Amino-3(benzothiazol-2-yl disulfanyl)-propionic acid, m/z = 286.996), M B T (m/z = 167.995)
and cystine (m/z —241.032) as the main products in the reduction o f MBTS with
cysteine. The presence o f M BTS (m/z = 332.962) and absence o f cysteine is due to
the fact that M BTS was in excess. Spectrum (b) is a collision-induced dissociation
(CID) tandem mass spectrum o f the MBT-cysteine disulfide. The cleavage o f the
disulfide bond results in fragment ions indicative o f M BT and cysteine.

MS results (Figure 5.4) demonstrated the formation o f 2-amino-3(benzothiazol-2-yl disulfanyl)-propionic acid (MBT-S-S-Cysteine) with an m/z value
o f 286.9969. Other ions observed in the mass spectrum include MBT (m/z =
167.9958), cystine (m/z = 241.0325) and unreacted MBTS (m/z = 332.9622). The
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presence o f cystine was a result o f the oxidation o f cysteine by MBTS. The presence
o f MBT, MBTS and cystine in Figure 5.4 was due to the fact that no separation and
purification steps were performed to isolate unreacted MBTS. The amount o f
remaining MBTS had to be established to determine the reaction ratios o f MBTS to
cysteine. There was little evidence o f cysteine in the mass spectrum, presumably
because MBTS was in excess. Tandem mass spectrometry o f the ion at m/z 286.9622
(Figure 5.4b) resulted in fragment ions due to both MBT and cysteine, confirming the
ion as the mixed disulfide. The reduction reaction stoichiometry was confirmed by
both HPLC and MS to be 1:3 (MBTS:Cysteine) and Scheme 5.2 outlines the reduction
and subsequent formation o f a mixed disulfide.

nh 2

o.

I

II

III

Scheme 5.2: Reduction o f MBTS with cysteine to give MBT, the MBT-S-S-cysteine
adduct (II) and cystine.
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5.2.3 BSA-MBTS Reactions: The generation o f an easily measurable change in
absorbance when the Cys34 residue on BSA reacts with DTNB is well
documented .279,280 The reaction o f cysteine standards with DTNB gave a good
calibration curve (R 2 = 0.987) which was used to quantify the reaction o f Cys34 with
DTNB. The calibration curve was also used to confirm the production o f 1 mol o f
TNB for 1 mol o f cysteine that reacted with 1 mol o f DTNB. Figure 5.3 shows the
calibration curve (insert) and serial scans o f the BSA-DTNB reaction. The production
o f 0.39 equivalents o f TNB per mol o f BSA ([SH]/[BSA] ratio) was observed when
freshly prepared BSA was reacted with excess DTNB for 2 h. A reductive incubation
with DTT prior to reaction with DTNB led to a 0.96 [SH]/[BSA] ratio which implied a
93 % recovery o f the bound thiols.

(0.96 - 0.39)
Recovery (%)

(1 - 0.39)

x

100

5.1

About 30% o f Cys34 thiol is blocked by disulfide bond formation with cysteine,
homocysteine, or glutathione in plasma and preparations o f albumin usually contain
5-10 % o f dimeric species, with Cys34 being a possible site o f dimerization.
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Figure 5.5: The cysteine-DTNB reaction was used to produce a calibration curve
(insert) fo r the quantification o f the BSA-DTNB reaction. Serial scans were
obtained by reacting 125 juMDTNB and 50 uM BSA in 0.01 M P B S (pH 7.4). Scans
were taken at 2 min intervals fo r 60 min.

MBTS was reduced by BSA, albeit at a slower rate relative to reduction by free
cysteine, under the same reaction conditions that were employed for the cysteineMBTS reaction. Both fresh BSA and DTT-treated BSA (with dialysis) showed a
complete loss o f Cys34 reactivity when they were incubated with MBTS prior to
reaction with DTNB. For the purposes of ascertaining Cys34 as the target residue for
MBTS reactivity, the thiol blocking reagent N-ethylmaleimide (NEM) was also
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incubated with DTT-reduced BSA followed by dialysis prior to the addition o f DTNB.
The same lack o f production of TNB was observed with NEM-treated BSA as shown
in Figure 5.6.
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Figure 5.6: Reaction o f Cys34 on BSA with DTNB. {(a) 50 fiM BSA, (b) 50fiM B SA
+ 0.5 mM MBTS, (c) 50 juM BSA + 0.5 m M NEM } + 227fiM DTNB and (d) 227

fiM DTNB. N E M and M BTS are able to block the free thiol on Cys34.

The appearance o f an absorption shoulder around 320 nm for the MBTStreated BSA even after dialysis, as shown in Figure 5.7 signified the incorporation o f
MBT by the protein. Because MBT also absorbs around 278 nm, the MBTS-treated
BSA shows increased absorbance in that region relative to the control BSA. The loss
o f the reactivity o f the single reduced thiol on BSA coupled with the production o f
MBT is indicative o f a reaction occurring between MBTS and Cys34.
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1.6

Wavelength(nm)

Figure 5.7: Comparison o f the absorptivities o f dialyzedfractions o f BSA. (a) 1.21
mg/ml BSA (control), and (b) 1.21 mg/ml BSA + 48.4 mg/ml M BTS incubatedfo r 24
hrs prior to dialysis against a bicarbonate buffer. The shoulder around 320 nm and
the enhanced absorbance around 278 nm fo r (b) are due to the contributing
absorbance o f the BSA bound M BT (produced by reduction o f MBTS).

To elucidate and confirm if adduct formation with BSA is via the reactive
Cys34 residue, mass spectrometry was used to detect any additive mass shifts on the
BSA molecule under physiological and alkaline pH. Dialysed samples o f DTTreduced BSA incubated with NEM and MBTS in (N H ^C O a buffer at pH 7.4 and 8.2
were subjected to both MALDI and ESI analysis. The MALDI spectra, while
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showing the apparent centroid shift for both the NEM and MBTS-treated BSA at the
two pH’s, were poorly resolved and thus accurate, definitive peak assignments could
not be achieved. Previous attempts to characterize BSA-hapten conjugates by MALDI
have resulted in the same poorly resolved peaks .282 Covalent modification o f the
Cys34 residue o f BSA by NEM and MBT was confirmed by positive ion electrospray
mass spectrometry. The deconvolution o f the multiply-charged mass spectra o f BSA
and MBTS-treated BSA yielded molecular masses o f 66437 and 66601, respectively,
in good agreement with the theoretical average molecular masses. The deconvolved
mass shift is shown in Figure 5.8. The NEM-treated BSA had a mass shift o f 125
corresponding to the addition o f 1 mol o f NEM. A control experiment which involved
preincubation o f reduced BSA with NEM followed by addition o f MBTS after
extensive dialysis had a similar mass shift to the NEM-alkylated BSA showing that
NEM effectively blocks the MBTS reactive residue on BSA. In a similar manner
preincubation o f BSA with MBTS precluded the NEM addition to BSA indicating that
both NEM and MBTS were targeting the same residue on BSA. The formation o f a
mixed disulfide (with MBT) on Cys34 is indicated in Figure 5.8 in the amino acid
sequence GLVLIAFSQYLQQCPFDEHVK, a theoretical trypsin fragment. Despite
the different electronic environments and steric hindrance around Cys34 (compared to
the free cysteine), the sulfhydryl group was still accessible to MBTS and reacted in
m uch the same w ay as the free cysteine. A lthough the reaction rate w as low er relative

to that o f MBTS-Cysteine, both reactions adhered to pseudo-first order kinetics in
excess MBTS. The inference o f the modification at Cys34 was strengthened by the
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fact that MBTS did not react with the amino groups of lysine or arginine, nor with the
carboxylic acid terminus of serine when the free amino acids were incubated with
MBTS under the reaction conditions that were employed for the MBTS-BSA reaction.
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Figure 5.8: Electrospray mass spectrum o f the BSA-MBT adduct. (a) deconvoluted
mass spectra o f untreated BSA and (b) MBTS/BSA incubate. 0.4ml o f 40 mg/ml
BSA and 0.2 ml o f 0.248 m M M B TS were incubated in an ammonium carbonate
buffer (pH 8.2) fo r 1 hr on a shaker at 37 °C with subsequent dialysis. The mass
shift between (a) and (b) corresponds to the mass o f MBT.

It was apparent from the deconvoluted ESI spectra that binding o f both the
NEM and MBTS to BSA was occurring at pH 7.4 and 8.2 even though the reaction
performed at pH 8.2 was more quantitative than that at pH 7.4. Cysteinyl groups are
only alkylated in the deprotonated thiolate anion state as shown by previous studies
where following the alkylation rate as a function o f pH has been used to determine the
pK value of the reactive cysteine .283’284 Given an estimated Cys34 pKa value 285 o f ~ 7
the use o f a carbonate buffer (pH 7.4 and 8.2) was optimum for reduction, as this
ensures the deprotonation o f Cys34 and promotes the reaction o f the cysteine thiolate
with MBTS. Thus the loss o f thiol-DTNB reactivity in the presence o f MBTS was
attributed to the formation o f a strong bond between Cys34 and MBT, and is
supported by the fact that bound MBT could not be removed by dialysis. In fact,
attempts to recover Cys34 reactivity by extensive dialysis were not successful. Even
though reactions o f the control BSA showed a slight decrease in the amount o f total
SH content relative to freshly prepared BSA, after dialysis the [SH]/[BSA] ratio did
not change indicating that the dialysis had caused dilution o f the whole protein, as
expected.
Cys34-containing tryptic and chymotryptic peptides G21-K41
(GLVLIAFSQYLQQCPFDEHVK), Q32-F36 (QQCPF), and L31-F36 (L Q Q C PF)
were observed in the peptide mass map o f wild-type BSA, however, the MBTSconjugated peptides were conspicuously absent from the peptide mass maps o f
derivatized BSA. MBT incorporation in BSA at Cys34 may inhibit digestion o f the
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protein; in fact, this phenomenon is commonly observed in Cys34-modified BSA . 286

5.2.4 Metabolism
Isoniazid and dexamethasone-induced S9 rat liver microsomes were tested on
MBT and MBTS for CYP2E1 and CYP3A4 activities, respectively. The chlorine
substituted oxygen analogue o f MBT, chlorzoxazone (CZ), was used as a positive
control since it has been demonstrated to be a substrate for both CYP2E1 and
CYP3A4. 5-chloro-2-mercaptobenzothiazole (CMBT) was also included as a control
due to its structural resemblance to CZ. Thermally-inactivated microsomes were
employed as a control assay and did not show any activity on the three substrates.
Under the experimental conditions that were used, none o f the three compounds
reacted with NRS, implying that the metabolites were a result o f the protein mediated
hydroxylation.

MBT

CZ

CMBT

Chromatographic separation with diode array detection o f the concentrated organic
extracts is presented in Figure 5.7, demonstrating hydroxylation o f both CZ and
CMBT. The insertion o f the hydroxyl group on the aromatic ring was not observed
with MBT suggesting that (i) MBT might not be a substrate for the CYP2E1 and
CYP3A4 isoforms; (ii) if, however, MBT is a substrate then the induction o f both
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CYP2E1 and CYP3A4 might not be sufficient enough to metabolize MBT to
detectable levels; (iii) the negative inductive effect o f the Cl (as in CZ and CMBT) on
the aromatic ring renders the compounds susceptible to hydroxylation on the carbon
atom adjacent to the Cl.

b
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J
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Figure 5.9: CYP2E1 mediated hydroxylation o f (i) chlorzoxazone (a) to 6hydroxychlorzoxazone (al); (ii) 5-chloro-2-mercaptobenzothiazole (b) to 5-chloro-6hydroxy-2-mercaptobenzothiazole (bl); (iii) the absence o f metabolites with
mercaptobenzothiazole (c).

5.3 Discussion and Conclusion
Efforts to understand the links between protein haptenation and the ability o f a
chemical to cause sensitization have had the limitation of restricting experimental
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studies to congeneric sets o f chemicals, mainly electrophiles, thus overlooking other
functional groups that are also protein reactive. A number o f approaches to
establishing structure activity relationships (SARs) such as the Relative Alkylation
Index (RAI) (mathematical model based on electrophilicity and hydrophobicity
parameters ) 287 and the Deductive Estimation o f Risk from Existing Knowledge
(DEREK ) 288 have been built on existing data bases on structure-toxicity relationships
with a strong emphasis on hapten-protein reaction mechanisms and metabolism. While
the electrophile (hapten)-nucleophile (protein) type interactions are common with
strong skin sensitizers, other forms o f previously ignored protein haptenation
mechanisms, such as disulfide formation, may be important in predicting skin
sensitization. In a study that was carried out on 355 randomly chosen chemicals that
are human sensitizers it was observed that electrophilicity accounted for 30-40% o f
ACD-inducing ability with the remainder being associated with non-electrophilic
structures,

el Dareer reported that MBT and its disulfide 2-mercaptobenzothiazole

disulfide (MBTS) can bind covalently to erythrocyte membranes and soluble proteins,
but the nature o f the binding was not explored. Further experiments have shown the
enzyme-mediated binding o f the MBT derivative benzothiazole-2-sulfonamide to
glutathione .290,291 Numerous latex accelerants, that are skin sensitizers, have sulfhydryl
moieties which react directly with proteins even though they are resistent to enzymatic

or non-enzymatic oxidation to amine (from protein lysines or imidazoles) reactive
sulfones or sulfoxides. BSA was used as a model protein to evaluate direct haptenation
in this study as well as to highlight the importance o f disulfide formation as a protein
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modification pathway. BSA is 80% homologous to human serum albumin (HSA) and
approximately 40% o f extravascular HSA is located in the skin .292 MBT, on the other
hand, is a model compound which seems to exert its potency through a mechanism
deviating from the common mechanism such as 1, 4-Michael type addition and Schiff
base formation, which are electrophile-nucleophile interactions.
The present data supports pathway A (Scheme 5.1) and suggest that exposure
o f MBT-containing gloves to common occupational/hospital oxidants (bleach) results
in quantitative oxidative transformation o f MBT to MBTS as the sole product. Under
normal use conditions, in-situ glove MBT may come into contact with both industrial
(bleach, iodine, peroxide) and biological oxidants (lipid peroxides). It was also
demonstrated that MBTS, once formed, does not leach into bleach/aqueous solutions.
MBTS hydrophobicity suggests a higher chance o f the chemical leaching into the skin
sebum directly from the glove. The rapid reduction o f MBTS with cysteine was
shown, and given the abundance o f this thiol within the epidermis, the interaction o f
MBTS with both protein and non-protein thiols is probable. Under this scenario, MBT
would be allergenic following either exogenous or endogenous oxidation to MBTS,
followed by subsequent formation o f disulfide linkages with protein thiols. Dithiol and
disulfide interconversion is a conspicuous property o f the S-S bond whose reactivity
can be attributed to the presence o f lone pairs and low energy 3d orbitals on S which
make the S-S bond polarizable in the presence o f nucleophiles. Disulfide formation
through an addition-elimination sequence (R5.4) involving a trigonal bipyramidal,
metastable transition state has been proposed where the incoming thiolate anion places
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an appreciable charge on all three sulfurs leading to scission o f the disulfide bond with
formation o f a mixed disulfide .293
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Disulfide interconversion between MBTS and Cys34 on BSA leading to the
incorporation o f MBT onto BSA has been demonstrated, herein, by mass spectrometry
and loss o f BSA thiol-DTNB reactivity. It must be pointed out that the three
surrounding ionisable groups o f Asp38 (carboxylate), His39 (imidazole) and Tyr84
(hydroxyl) tend to make Cys34 inaccessible at acidic pH, however, it has been
demonstrated that a pH greater than 7 results in a structural transition from the N
(neutral) to B (basic) form o f the protein with basic loosening and opening up o f the
shallow crevice enclosing Cys34 .294 The unfolding o f BSA and the deprotonation o f
Cys34 readily occurs at pH ’s 7.4 and 8.2 and an addition-elimination reaction with
MBTS ensues. The modification o f BSA and other sulfhydryl containing proteins by
thiol-based sensitizers is most likely through disulfide bridge formation and adduct
formation on Cys34, which has been shown to exhibit allostericity where distant
conformational changes and reactivities were observed on distant amino acid
residues .295 The data obtained herein demonstrate the importance o f the ‘hapten
hypothesis’ where MBT covalently conjugates to the free cysteine on BSA and data
support the hypothesized pathways B and C in Scheme 5.1 and Scheme 5.3.
The enzymatic bioactivation o f MBT and MBTS to possible reactive
142

epoxide intermediates was not observed following incubation with CYP2E1 and
CYP3 A4 induced microsomes. Hydroxylation would be indicative o f a mechanism
which yields a reactive epoxide as an intermediate as previously reported .296
Microsomal hydroxylation o f the benzene ring is postulated to occur via reactive
epoxide intermediates and epoxides have been shown to form adducts with
nucleophilic residues on proteins .297

h o c // h 2(>

Cys/GSH/BSA
CYP2E1.3A4
CYP2E1 '3A4

C ^Sensitization^)

Scheme 5.3: Modified Scheme 5.1 showing the conclusion derivedfrom
experimental data obtained in these studies.

The metabolic activity o f CYP2E1 on CZ and CMBT, which are structural
analogues o f MBT, was observed. This, along with previous studies in which
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MBT (or MBT glucuronide) was an ultimate metabolite

9Q R OQQ

’

suggest that ring

oxidation is unlikely in the absence o f electron withdrawing groups on the aromatic
ring. Microsomal isoforms expressed in the epidermis are, therefore, not likely to
metabolize MBT. In summary, Scheme 5.1 can be modified into Scheme 5.3 where
the probable predominant mechanism o f haptenation o f proteins by MBT is by first
non-enzymatic oxidation to MBTS, followed by disulfide exchange with a protein
thiol to form the protein-S-MBT adduct. In addition these results assert the potential
importance o f disulfide formation as a general haptenation and protein modification
mechanism.
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CHAPTER 6

INHIBITION OF GLUTATHIONE AND THIOREDOXIN REDUCTASES

6.1 ENZYME INHIBITION
The working hypothesis which was adopted for these studies stated the sulfhydryl
group on MBT as being critical to accelerant-enzyme interactions. Possible
inactivation o f the NADPH dependent glutathione reductase and thioredoxin reductase
with MBT and the analogues in Figure 6.1 was studied to test the hypothesis.

SH
MBTS

MBT

OH

HBT

MTBT

BT

Figure 6.1: Test compounds which were usedfo r glutathione and thioredoxin
reductase inhibition studies. H BT - 5-hydroxybenzothiazole, M TBT - 2(methylthio)benzothiaz.ole, B T - benzothiazole.
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6.1.1 Inhibition o f Glutathione Reductase: There was an observed reduction in
activity o f the flavoprotein glutathione reductase (GR) on GSSG when MBT and
MBTS were incorporated in the reaction. When equivalent molarities o f BT, HBT and
MTBT were tested for inhibitory activity on GR there was no loss in activity. The
progress o f the GR mediated reduction o f GSSG shown in reaction R6.1 was followed
by fluorescence spectrometry. Excitation o f the co-factor NADPH was done at 340 nm
and emission was observed at 450 nm. Fig 6.2 depicts the loss in the fluorescence o f
NADPH as it is oxidized to NADP+ in the GR mediated reduction o f GSSG. The
control experiment utilized GR, NADPH and GSSG in 99.5:0.5 (0.01 M PBS: 0.5%
DMSO (pH 7.4)) in a 37 °C thermostatted quartz cuvette (1 cm path length). Other
control experiments were carried out and dismissed the possibility o f adventitious
reactions occurring between (i) NADPH and MBT and (ii) GSSG and MBT and hence
the oxidation o f NADPH is wholly attributed to the catalyzed reduction o f GSSG.

^

(

NADP+ v

#

2GSH

NADPH X

^

GSSG

The initial rates o f GR activity for the inhibited and uninhibited reactions are shown in
Table 6.1. Comparison o f the initial rates o f the reactions which incoprporated the
thiol lacking MBT analogues (BT, HBT and MTBT) show that the reduction o f GSSG
progressed without any inhibition. MBT (3.3 s '1) and MBTS (3.2 s '1), however,
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lowered the initial rate o f GSSG reduction (7.7 s'1) by more than 50 %.
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Figure 6.2: Comparison o f the inhibitory behaviour o f M BT and its derivatives on
the GR-GSSG system. The reactions consisted o f 10 pM GSSG + 8.33 pM NADPH
+ 0.614 n M (76.17pg/ml) GR + {(a) 0.568pM M BT, (b) 0.568pM M BTS, (c) 0.568

pM H BT, (d) 0.568 pM B T, and (e) 0.568 p M MTBT}. Reaction (f) did not contain
any test compound.

Further experiments were carried out to investigate the nature o f MBT
inhibited GSSG reduction. MBTS-GR interactions could not be investigated further as
MBTS was not sufficiently soluble in 0.01 M PBS at higher concentrations that were
required for inhibition studies. A DMSO concentration above 0.5% (to accommodate
higher concentrations o f MBTS) resulted in non-specific chemical interactions which
could not be followed on the fluorometer.
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Table 6.1: Initial rates o f the GR catalyzed reduction o f GSSG.

Test Compound
(0.568 uM)

Initial Rate
(s'1)

Blank

7.6700

MBT

3.3107

MBTS

3.2437

HBT

7.5780

MMBT

7.0656

BT

7.5382

When the concentration o f MBT was increased a concentration dependent loss
in GR activity was obtained. Assuming Michaelis-Menten kinetics that GR is known
to subscribe to , 300 several sets o f experiments in which GSSG was varied within each
set were performed, where the concentration o f MBT was varied for each set o f
experiments. Table 6.2 outlines the experiment sets, the concentrations o f MBT and
GSSG, and the initial reaction rates which were obtained for each experiment within a
set. When the reciprocals o f the substrate (1/[GSSG]) were plotted against the
reciprocals o f the instantaneous rates (1/v) for a number o f GSSG variations where
MBT was held constant for a set o f experiments (Table 6.2), typical Lineweaver-Burk
plots with a common intercept on the (1/v) axis were obtained. Figure 6.3 clearly
shows plots for the inhibited GR-catalyzed reactions. As the M BT concentration was

changed from 5 pM to 15 pM the inhibition increased by a factor o f 1.7 for a substrate
concentration o f 10 pM. The dose related change in the 1/[GSSG] with a common 1/v
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axis intercept was indicative o f competitive inhibition o f GR activity.

Table 6.2: Dose responsive inhibition o f GR activity was observed with increasing
M BT concentration as shown by the initial reaction rates fo r GR catalyzed
reduction o f GSSG.
Expt
Set

[MBT]
uM

[GSSG]
uM

Initial rate
v/s "1

(a) 1.9
(b) 2.5
(c) 5.0
(d) 1 0 . 0

1.16
1.50
2.59
3.49

(a) 1.9
(b) 2.5
(c) 5.0
(d) 1 0 . 0

0.58
0.84
1.38
2.25

(a) 1.9
(b) 2.5
(c) 5.0
(d) 1 0 . 0

0.44

(a) 1.9
(b) 2.5
(c) 5.0
(d) 1 0 . 0

0 .6 6

1.08
1.84
0.30
0.36
0.75
1.35

The mechanism for GR-MBTS binding was assumed to be the same as that for the
GR-GSSG binding where an enzyme-substrate complex is formed in the initial step
with subsequent dissociation o f the complex to give the free enzyme and products as
shown in equations R6.1, 6.2 and 6.3 where E = GR, S = GSSG, P - GSH, ES =
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GR-GSSG and I = MBT.

E

+

S

Ki

ES

R6.2

k-i
k2

ES

E

E

+

R6.3

P

k-2
+

I

k3

R6.4

El

4.0
3.5
3.0
2.5

— 2.0

0.5

0.0
0

1e+5

2e+5

3e+5

5e+5

4e+5

6e+5

1/[GSSG] (M'1)

Figure 6.3: Lineweaver-Burk plots o f the inhibition o f activity o f GR on GSSG.
Activity o f the enzyme was followed in the presence o f {(a) 0, (b) 5, (c) 7.5 and (d)
15} pM B T .

When the steady state approach (SSA; —

dt

= 0;

at

^ = 0 from R6.2, 3 and 4)
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is adopted for the enzyme substrate complexes (ES and El) with total enzyme
concentration being the combination o f free enzyme (E), enzyme bound to GSSG and
MBT (ES and El),

E t = E + ES + El

6.1

k H” k
equation 6.1 can be used together with the constants K m = — ----hx

k
k3

and Kt = —

derived from equilibrium reactions R6.2, 3 and 4 to give the total amount o f enzyme
(Et) in terms o f Km, K; and S and I. The rate constant k .2 is not included in the
derivations because the product, GSH is not a substrate for the enzyme.

E t = [ES]

Km Km[I]
[5] Kt[S]

6.2

Since the reaction rate (v) which leads to the formation o f the product GSH (P) as
shown in R6.3 is the dissociation o f the ES complex,. v = k2[ES] and

Vmax = k2[Er ] substitution o f these terms for [ES] and [ET] into equation 6.2 and
combining the

K

terms results in the modified Michaelis-Menten equation which

incorporates the effect o f MBT as an inhibitor.

v=

6.3

[S] + K n ' i + m '

v
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As is the case with the original Michaelis-Menten equation the Lineweaver-Burk
modification o f inverting equation 6.3 can be applied, resulting in equation 6.4.

6.4

It is thus apparent from equation 6.4 that a plot o f 1/[S] against 1/v is linear with the
slope equal to the term in parenthesis.
Therefore the slope for each o f the MBT-inhibited GSSG reduction shown in
Figure 6.2 can be written as

from which the enzyme-inhibitor dissociation constant K j can be calculated from
equation

6 .6

for a given MBT (I) concentration.

K m/ V max

is the slope o f the

uninhibited reaction with 1 /V max being the intercept.

Table 6.3 lists the calculated values o f Kj from which a mean value o f 4.19 ± 0.24 pM
was obtained. When equation 6.5 was used to make a secondary plot o f [MBT] as an
independent variable against the corresponding slopes given in Table 6.3 a linear
curve shown in Figure 6.4 was obtained.
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Table 6.3: Calculated enzyme-inhibitor dissociation constants fo r MBT. Slopes and
intercepts are taken from the Lineweaver-Burk plots in Figure 6.2.

Kj
uM

[MBT]
uM

Slope (mMBT)
uMs-1

l/Vmax
S'1

0

1.335

0.1368

9.7 ( K J

5

2.832

0.142

4.46

7.5

3.823

0.1349

4.02

15

6.238

0.1389

4.08

7

6

slope/Ms'

5

4

3

2

1

0

0.0

2.0e-6

4.0e-6

6.0e-6

8.0e-6

1.0e-5

1.2e-5

1.4e-5

1.6e-5

[MBT]/M

Figure 6.4: Secondary plot derivedfrom the slopes obtained in the Lineweaver-Burk
plots in Figure 6.2. The slope was used to compute the value o f Kifor MBT.
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When the intercept was divided by the slope o f Figure 6.4 as given by equation
6.7 the calculated Kj for MBT was 3.93 pM which was in agreement (93.8 %) with the
Kj obtained using the Lineweaver-Burk plots in Figure 6.2.

Intercept
slope

m ax

6.7

The next set o f experiments were carried out to determine whether MBT was binding
irreversibly or reversibly to GR. When 0.5 U/ml o f the enzyme was incubated w ith 5
pM MBT at 37 °C in 0.01 M PBS for 1 h and dialyzed overnight against 4 dm 3 PBS
using a cellulose membrane (MWCO = 1 2 kDa), the reaction kinetics o f the dialyzed
reductase-MBT system were similar to the reaction kinetics o f the dialyzed reductase
(without MBT). Figure 6.5 depicts the similarities in activity between the MBT treated
and untreated GR. Even though the rates were similar as shown in Figure 6.5 the
kinetics showed a reduced rate relative to the kinetics o f the experiments for which
dialysis was not performed. The loss in activity o f the enzyme in the experiments for
which dialysis was performed (traces a and b) was probably due to dilution o f the
enzyme with the dialysis buffer. The inhibitory effect o f MBT is also highlighted in
Figure 6.5 when comparison o f the MBT treated GR (trace c) and MBT free GR (trace
d) for which dialysis was not performed is made. The fact that MBT could be dialysed
away from GR implied the formation o f a labile, reversible bond between MBT and
GR. The reversibility o f the GR-MBT binding is in agreement with competitive
inhibition that the data is showing.
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Figure 6.5: The effect o f dialysis on GR-MBT binding. 0.25 U/ml was incubated
with 2.5 juMMBT and dialysed overnight against 0.01 M P B S before the GSSG
reduction assay could be done. Reactions comprised o f (a) dialysed GR without
MBT, (b) dialysed GR with M BT present, (c) fresh GR with M B T present, and
(d)fresh GR without MBT.

Human platelets that were separated and used as a source for the glutathione
reductase exhibited a similar trend, to reductase from yeast, when MBT was
incorporated in the reaction. Figure

6 .6

shows that the inhibition became enhanced

with increased doses o f MBT. Data from traces a, b and c show that the initial reaction
rate dropped by about 1.5 times when 5 pM MBT was present and by about 3.68 times
when 10 pM MBT was present. The same mechanistic explanation could be inferred
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for the human enzyme as far as the inhibition is concerned.
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Figure 6.6: Inhibition o f GR in human blood platelets. The enzyme assays consisted
o f 0.1 mg/ml protein + 8.33 p M NA DPH +10 p M GSSG + 2 pM MBT.

6.1.2. Inhibition o f Thioredoxin Reductase: When NADPH-reduced TR was
incubated with MBT and MBTS, its DTNB reduction activity were significantly lost
as shown in Figure 6.7. To maintain a total DMSO concentration o f 1% MBT and
MBTS concentrations were 100 times lower than that o f DTNB in the assay. Higher
concentrations o f MBT and MBTS would have meant the use o f more DMSO whose
effect on the enzyme is unpredictable. The MBT-induced inactivation o f TR was timeindependent with no difference in initial rates being observed with longer
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preincubation time.
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Figure 6.7: Activity o f TR on DTNB and the effect o f M BT and its analogues. 0.2
mg/ml (= 3.7 fiM) rat liver TR was incubated with 100 fiM NAD PH and 300 p M
DTNB in a p H 7.4 buffer at 37 °C resulting in the positive assay trace b). Test
assays comprised o f TR, DTNB, NADPH and {(a) 30 pM M TBT, (c) 30 p M B T (d)
30 p M H B T (e) 30 pM M B T S and (f) 30 fiMMBT}.

Figure 6.7 also shows the effect on the MBT derivatives BT, HBT and MTBT
on the TR-DTNB system. There were no significant differences between the activity
o f the positive control (trace b) and that o f TR which was incubated with MTBT (trace
a) and BT (trace c). In fact, the initial rates shown in Table 6.4 attest to the similarity
in activity between these sets o f experiments. HBT-treated TR, however, showed a
slight decrease in activity relative to BT and MTBT. Initial rate o f the positive
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assay was lowered by a factor o f 1.5 when HBT was incorporated. MBT proved to be
a potent inhibitor o f TR with the initial rate o f the MBT-treated TR being comparable
to that o f the TR inhibitor supplied with the TR assay kit.

Table 6.4: Initial rates fo r the TR-DTNB assay. Initial rate ofproduction o f TNB
was used together with equation 3.4 to calculate initial activity o f the enzyme.
T
™
,
Test Chemical
Positive
Control
BT

Initial Rate
.j
0.0003
0.0003

MMBT

0.0003

HBT

0.0002

MBT

0.0001

MBTS

0.00002

When the activity o f MBTS-treated TR was followed at 270 nm in the absence o f
DTNB an initial decrease in the amount o f MBTS was observed. Figure

6 .8

shows the

loss o f MBTS in the reaction. The loss in absorption o f MBTS was attributed to the
activity o f the enzyme since MBTS was shown to be non-reactive to NADPH which is
present in the assay. The observed initial activity o f the enzyme on MBTS with the
subsequent loss in activity could be attributed to the production o f sufficient M BT to
cause inhibition. The results in Figure 6.7 which show MBT as being a more potent
inhibitor correlate with results in Figure

6 .8

which show that MBTS has to be
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reduced to the more potent MBT before any significant loss in TR activity can be
observed. Therefore while MBTS might not necessarily be TR inhibitor the reduction
o f MBTS (chemical or enzymatic) results in formation o f MBT, which inactivates the
enzyme.
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Figure 6.8: Reduction o f M BTS in the TR system. 30 fiM M B TS (a) was stable in
the working buffer and so was 3.7 juM rat liver TR (c) which absorbs at 278 nm.
When 30 /iM M BTS was incubated with TR initial loss o f M BTS was followed by
the inactivation o f TR (b).
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6.2: Discussion

The efficacy o f the MBT sulfhydryl group on protein reactivity was demonstrated by
studying the inactivation o f both GR and TR. Selective deletion, substitution and
blockage o f the -SH group to give BT, HBT and MTBT respectively enabled
comparative studies which tested the critical role o f the sulfyhydryl group in
accelerant-enzyme interactions. MBT and MBTS studies with GR highlight the
importance o f the thiol moiety given the fact that its absence did not result in any
significant loss in activity o f GR. Previous studies have identified MBT as a potent
sulfyhydryl-based inhibitor o f banana polyphenoloxidase (PPO ) , 301 and
potato/mushroom tyrosinase.

While inhibition studies on tyrosinase did not

characterize the nature o f tyrosinase inhibition the effective concentration o f MBT
which resulted in 87 % reduction in original tyrosinase activity was 10 pM which is
within the concentration range for the MBT-GR inhibition

(K j

= 4.19 pM) studied

herein. MBT-PPO studies had mechanistic resemblance to the current MBT-GR
studies in that the inhibition was reversible and seemed to be MBT and not MBTS
mediated. Inclusion o f copper ions which oxidized MBT to MBTS led to the recovery
o f PPO activity and in the case o f the current studies the reducing environment could
have availed MBT from MBTS leading to the inhibition that was observed with both
MBTS and MBT.

Characterization o f MBT as a competitive inhibitor, the lack o f inhibition with
thiol lacking MBT analogues and the fact that MBT could be dialyzed away from GR
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classifies MBT as a sulfhydryl-based inhibitor o f GR. The use o f thiol specific Nalkylmaleimides as inhibitors o f GR 303 lends credence to this current hypothesis which
places the interaction o f the -S H group on MBT with the catalytic sulfyhydryl groups
on GR as being critical to GR inactivation. The inclusion o f TR in the enzyme
interaction studies yielded results which were similar to the GR studies as far as the
importance o f the thiol group is concerned. Human TR and GR are 44% homologous
with a common conserved redox active catalytic site -Cys61-Asn-Val-Gly-Cys66.
Figure 6.9 depicts the similarities between human GR and TR. The role o f both GR
and TR as cellular redox regulators derives from this common active site and the fact
that sulfyhydryl based inhibition using MBT was observed with both GR and TR
might point to the interaction o f this redox active site with MBT. Even though M BT
inactivation o f TR was not amplified to unravel the mechanism the observed loss o f
MBTS might have been due to reduction leading to the more potent MBT. It is
however not clear whether reduction o f MBTS is an enzymatic process or a chemical
interaction between the accessible Cys 61 and Cys

66

on the redox active peptide. The

observed TR inhibition with the -O H bearing HBT, though not o f the same magnitude
as the inhibition observed with MBT and MBTS (Figure

6 .6

and Table 6.4), stands out

as the major difference between the GR and TR studies. The availability o f a second
C-terminal -Cys-SeCys- (where SeCys is selenocysteine) redox active site on TR
which is absent in GR (Figure 6.9) m ight have been responsible for the observed

HBT-TR inactivation. The broad substrate specificity o f mammalian TR relative to
GR has been postulated to be due to this second redox active site .251
161

H um an
TR

H um an
GR

E . coli

I

TR

I
'-------- V-------F A D D o m ain

1

100

f

D o m ain

200

In te r f a c e D o m ain

300

400

500

A m in o A cid N u m b e r

Figure 6.9: Domain structures o f human TR, human GR and E. coli TR. TR and
GR share a common active site indicated by the triangles. Human TR has an
additional active site in the form o f C-terminal penultimate SeCys residue.

The relevance o f the current data to the role o f M BT as a sensitizer can not be
weighted on haptenation betw een the enzym es and MBT. Skin sensitization from
exposure to M BT will hardly occur through this route as the binding o f M BT to the
reductases is not perm anent. H owever, the results support the hypothesis that M BTrelated pathophysiology is m ediated via the sulfyhydryl group. R eduction o f MBTS
avails a free -S H group w hich is reactive to cysteine residues on proteins. D epending
on such factors as the redox environm ent and the steric hindrance around the
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cysteine residue the -S H group on M BT has been shown to attach to the cysteines
either reversibly or irreversibly. W hile the ‘hapten hypothesis’ is w eak in the case o f
the reductases, Schem e 6.1 w hich is based partly on the findings o f the inhibition
studies and the well established TR and G R systems, presents an alternative pathway
through w hich M BT can im pact the physiological system. R eduction o f M BTS avails
M BT w hich is an inhibitor o f both G R and TR disrupting the G R and TR systems.

Trx-(SH)
Pr/R -S
NADPH + H

GSH

NADP

GSSG
Trx-S-

t

Scheme 6.1: Effect o f M BTS and M BT on the antioxidant and redox regulatory
properties o f the GR and TR systems. Reduction o f MBTS by either TR or GSH
produces M BT which is an inhibitor o f both GR and TR.

A lternatively it can be hypothesized that M BTS can be reduced by Trx w hich
has two cysteine residues in the active siteTrp-Cys32-Gly-Pro-Cys3 5. O xidized Trx
has to be reduced by TR (in the same w ay that GSSG is reduced by GR) and since
M BT inhibits TR-m ediated recovery o f reduced Trx the balance betw een
GSH /reduced Trx and G SSG /oxidized Trx is adversely affected. The overall
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impact is the compromised removal o f reactive oxygen species (ROS) and impaired
redox regulation in both intra and extra cellular environments.

164

CHAPTER 7

LOCAL LYMPH NODE ASSAY AND THE GUINEA PIG MAXIMIZATION
TEST
Several tools exist to identify contact allergens. These include bioassays
(murine local lymph node assay (LLNA); guinea pig maximization test (GPMT)) and
predictive computer modeling programs. The chemical studies performed in this
project suggest that the thiol moiety in MBT is critical for its allergenicity. Both
bioassay and in silico assessment o f MBT, its oxidation product, MBTS, and
analogues where the thiol was removed, blocked or substituted were employed to
confirm the role o f the thiol in M BT’s allergenicity. Contact allergic disease has two
phases; induction and elicitation. The LLNA measures the response at the induction
phase. During this phase the animal is becoming sensitized to the test agent, but does
not produce a clinical contact allergenic response. A chemical is considered an
allergen by the LLNA if it induces a proliferative response that is 3-fold higher than
the solvent control. Potency is defined by this threshold (3x background) dose
obtained by extrapolation from dose-response data, and is denoted as the Stimulation
Index (SI) and Effective Concentration (EC3) as calculated in equations 3.5 and 3.6
respectively. The GPMT assesses allergenicity during the elicitation phase by
examining the clinical manifestation o f ACD in sensitized guinea pigs. Potency
determination o f the chemical allergen is more subjectively obtained through scoring
of the dermatological lesion.
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7.1 Prediction o f Skin Sensitization: The in silico assessment o f MBT and its
analogues for skin sensitizing potency was based on computational (quantitative)
structure-activity relationship [(Q)SAR] methods incorporated into TOPKAT. The
predictions were used as a complementary technique prior to animal studies. Table 7.1
lists the structures o f the query chemicals, together with the probabilities and
reasoning (suspect functional groups). O f the two TOPKAT QSAR discriminant
models the first model, which was developed for aliphatic and single benzenes, was
preferably adopted (owing to the single benzene rings on the query chemicals) in place
o f the second model, which was developed for aromatic compounds with two or more
benzene rings. The two dimensional molecular representation, using a set o f over 300
one- and two-atom electrotopological state descriptors was adopted. Shape and
symmetry indices, and molecular transport related descriptors such as molecular
weight and Vlog P (where Vlog P is a coefficient o f the “virtual” model o f the
octanol-water partition coefficient) were used to assess allergenicity o f the
compounds. The query structures were also subjected to a probabilistic analysis to
determine whether they were sensitizers or not. Two cutoff probability values (> 0.7
and < 0.3) were used to classify the compound as a sensitizer and non sensitizer
respectively. If the calculated value was between 0.3 and 0.7, the compound was then
deemed to have fallen into the indeterminate region. On this basis MBT, MBTS, 5chloro-2-mercaptobenzothiazole (Cl-MBT) and 5-hydroxy-2-mercaptobenzothiazole
were assigned probability values greater than 0.7 with the reasoning being the
presence o f the thiol moieties.
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Table 7.1: In-silico predictions o f the skin sensitizing capacity o f M BT and its
analogues.
STRUCTURE

SKIN SENSITIVITY

CO-”
CQ-'-tO
OH

}

REASONING

TOPKAT

PROBABLE (+)

R-SH

0.999 (+)

PLAUSIBLE (+)

R-S-S-R

1.000 (+)

(-)

Unreliable
0.005 (-)

(-)

Unreliable
0.310 (+/-)

SH

PLAUSIBLE (+)

R-SH

0.998 (+)

-SH

PLAUSIBLE (+)

R-SH, R-OH

0.976 (+)

Cl

HOx

S.

x

O'
h

On the other hand BT and HBT were not predicted as sensitizers. The hydroxyl
group on HBT was unable to elicit any favorable predictions from the TOPKAT
model. Although, Cl-MBT was identified as a sensitizer based on the presence o f the
free thiol group metabolism studies demonstrated that Cl-MBT can be metabolized by
the CYP 2E1 isoform to the hydroxylated product and this might be via a reactive
epoxide. This represents an alternative haptenation pathway that does not exist for
MBT.
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7.2 LLNA: The vehicle used to dissolve or suspend the test agent can influence the
results o f the LLNA. W hen acetone olive oil (AOO; 4:1; v/v) was used as the vehicle,
H-thymidine incorporation into proliferating mouse lymph node cells resulted in the
proliferative response shown in Figure 7.1 for both MBT and MBTS.
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Figure 7.1: Acetone Olive Oil LLNA results o f M BT and M BTS administered in
AOO.
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Table 7.2: Stimulation thresholds fo r M BT and M BTS where AOO was used as the
vehicle.
Test Chemical

SI

2.5% MBT

1.98

5% MBT

2.23

7.5% MBT

2.26

0.5% MBTS

1.33

0.75% MBTS

1.19

1% MBTS

1.54

30% HCA

10.55

Even though the 3H-thymidine incorporation for both MBT and MBTS were
greater than that for AOO there was a poor dose-dependent response for the test
chemicals. Concentrations o f MBTS were 5-7.5 times less than those o f MBT due to
the severely limited solubility o f MBTS in acetone relative to MBT and overally lower
concentrations o f both chemicals were used because o f their limited solubility in
AOO. The proliferative responses observed were < 3 fold that o f control. This low
level o f activity cannot distinguish between irritants and allergens. It is also not a
sufficiently vigorous response for SAR studies. Both MBT and MBTS do not dissolve
in olive oil which was incorporated in the LLNA because it is non-volatile thus
producing a long resident time o f test chemicals in solution on the ear surface. MBT
and MBTS, however, dissolve in acetone which is part o f the AOO vehicle. The
immune response for both MBT and MBTS was weak, as shown by the SI values in
Table 7.2 (concentrations as high as 7.5% for MBT and 1% for MBTS were unable to
produce a 3-fold SI). The positive control, 30% HCA/AOO caused 10.5-fold

proliferative response over the vehicle.

14000

t
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-
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-

T-test for Difference in Means between
DMSO and Test Compounds
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10% MBT
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4000 2000

-

0
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Figure 7.2: Effect o f DMSO. DMSO was used as the vehicle fo r both M BT and
MBTS. Acetone was included as a vehicle fo r the delivery o f HCA which was used
as a positive control HCA.

Both MBT and MBTS are more soluble in the solvent DMSO than in
acetone/AOO and allow for testing o f higher concentrations in this assay. However,
there was no remarkable improvement on the elicited proliferative response for either
chemical, as shown in Figure 7.2. DMSO gave high DPM counts relative to AOO
(presumably due to irritant induced proliferation) and even though the test chemicals
provoked higher responses than DMSO (insert in Figure 7.2) the proliferative activity
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was still minimal, with poor dose-responses from both chemicals. Table 7.3 gives the
SI values which were still below the three-fold index. The SI for MBTS were less
when DMSO was used compared to AOO possibly due to the increased denominator
(DMSO irritant proliferative response). The standard deviations for each treatment
group appeared higher where DMSO was the solvent as shown by the results o f 5 and
15 % MBT in Figure 7.2.

Table 7.3: S I fo r M B T and MBTS with DMSO as the vehicle. HCA was used as the
positive control.
Test Chemical

SI

5% MBT

1.65

10% MBT

2.40

15% MBT

2.36

2.5% MBTS

0.95

5% MBTS

0.47

7.5% MBTS

0.67

30% HCA

5

Therefore inconsistent and insignificant proliferative responses were obtained for both
MBT and MBTS despite the higher doses o f the test chemicals. The assay was
modified to include a skin breaching step before topical application o f the test
chemicals. Skin breaching had a profound effect on the proliferative activity o f the
lymph node cells as shown in Figure 7.3. DMSO was maintained as the vehicle and
comparison o f the DMSO mediated DPM values for the intact skin model (Figure 7.2)
with the breached model (Figure 7.3) shows an insignificant difference
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R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

highlighting the fact that DMSO application results in the same effect irregardless o f
the state o f the skin.
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Figure 7.3: Effect o f DMSO on the breached skin model Mice ears were physically
breached prior to application o f the test compounds.

The enhanced proliferative response would be due to increased bioavailability
o f the test chemical. As with the previous AOO and DMSO (intact skin) assays there
was no increased proliferative response with increasing concentration. The increase in

concentration o f MBT seemed to have a suppressive effect on the immune response
resulting in a ‘negative’ dose response as indicated by the decreasing SI values from
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6.25 to 12.5% MBT (Table 7.4). At 6.25% MBT proved to be more potent than the
12.5% HCA which was used as a positive control.

Table 7.4: S I values fo r M B T tested in a breached skin LLNA assay. DMSO was
used as the vehicle. The positive control was HCA.
Test Chemical

SI

6.25 % MBT

4.30

12.5% MBT

3.27

25% MBT__________ 1 6 9 .
12.5% HCA

3.25

7.3. GPMT: Results from the GPMT relied on a subjective evaluation o f 10 guinea
pigs with the adoption o f a dichotomous (sensitizer/nonsensitizer) approach based on
the European Community (EC)-standards304 which states that a substance is
considered a sensitizer if 30% or more o f the test animals show a positive reaction.
The mean scores for erythema and oedema for MBT, MBTS and the analogues are
shown in Tables 7.5-7. The scoring was based on the criteria described in Table 3. 4.
Examples o f the cutaneous reactions observed are shown in Figures 7.4-5. All the six
animals which had been sensitized to MBT with the aid o f Titer Max adjuvant reacted
to dermal challenge to MBT and 83% cross-reacted to MBTS challenge.
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Table 7.5: GPMT Results o f M B T
M BT
N on-S ensitized A nim als

S ensitized A nim als
A nim al

D escription

Score

A nim al

D escrip tio n

Score

I

Bright red and area w ell defined

3

VII

N o edem a

0

II

Bright red and area w ell defined

3

VIII

N o edem a

o

Barely perceptible raising o f the skin

1

IX

N o edem a

0

III

Red in color

2

X

N o edem a

0

IV

Bright red in color, area not well defined

2

V

Bright red skin, skin peeling o ff

4

Slight raising o f the skin

2

Barely perceptible red color

1

VI

Table 7.6: GPMT Results o f MBTS
M BTS
Non-Sensitized A nim als

S ensitized A nim als
Anim al

D escription

Score

A nim al

D escription

Score

I

Pale red

2

VII

No edema

0

II

Pale red

2

VIII

No edema

0

III

Barely perceptible red color

1

DC

N o edema

0

IV

Pale red

2

X

N o edema

0

V

Red color, are well defined

3

VI

N o erythema

0

Table 7.7: Cross reactivity o f BT, H B T and M T B T

BT, HBT and MTBT
Sensitized Animals
Animal

Description

BT

Score
HBT MTBT

I

No edema

0

0

0

II

Slight reddening

0

1

1

III

Pale red

0

0

1

IV

No edema

0

0

0

V

No reaction

0

0

0

VI

No reaction

0

0

0

Non-Sensitized Animals
Animal

Description

BT

Score
HBT MTBT

VII

No edema

0

0

0

VIII

Pale red

1

0

0

IX

No edema

0

0

0

X

Pale red

0

0

1

A score o f at least 1 was observed on all the animals with some animals
exhibiting extensive erythema. An immediate ‘weal and flare’ reaction, diagnostic o f a
Type I (IgE mediated) hypersensitivity, was observed on the dermis o f animal number
2, in addition to an ACD reaction.
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Figure 7.4: Examples o f cutaneous reactions o f the M BT sensitized animals after
challenges with MBT, MBTS, BT, H B T and M TBT

Challenge
Chem ical

C ontrol Animals
24 hrs

48 hrs

M BT

M BTS

Figure 7.5: The lack o f M BT and MBTS induced cutaneous reactions is evident in
the non-sensitized animals. BT, H BT and M TBT did not induce any immune
response in these animals.

Challenge concentrations were prepared as percentage (w/v solvent) and hence
a com parison o f the potencies the M BTS cross-reactivity could not be determ ined. In
fact the scoring, as show n in Table 7.5 and 7.6, shows the variations betw een M BT
and M BTS w ithin each animal. The present protocol does not allow one to com pare
potency. This w ould have required a dose-response study design w ith a greater
num ber o f guinea pigs sensitized to both M BT and M BTS. The necessity o f the -S H
functional group on M BT for allergenicity w as strongly suggested by the lack o f an
ACD reaction in M B T-sensitized guinea pigs challenged w ith BT, H BT and
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MTBT. BT and HBT do not possess the thiol group, whereas the thiol is protected by
a methyl group on MTBT. Table 7.7 shows the scoring for the BT, HBT and MTBT
challenged animals which had been previously sensitized to MBT. A few animals
(both sensitized and non-sensitized) displayed slight irritation reactions from the
chemical or DMSO in the vehicle. Figure 7.4 clearly highlights the differences
between positive skin allergic reactions due to MBT and MBTS and the lack o f cross
reactivity to BH, HBT and MTBT.

7.4 Discussion
Chemical reactivity and metabolism studies suggested that (1) MBT is not
metabolized to a protein reactive form; (2) MBT can be non-enzymatically oxidized to
MBTS; and (3) MBTS can be reduced by both non-protein and protein thiols forming
mixed disulfide. These results suggest that one potential chemical mechanism o f
MBT allergy would be mediated through oxidation to MBTS with subsequent protein
haptenation via disulfide formation on protein thiols. Both MBT and MBTS were
found to be potent inhibitors o f thiol reductases. Inhibition o f reductase activity, in

vivo, would increase the biological stability o f MBT haptenated proteins and thus
increase the potential for dendritic cell mediated antigen presentation.
The murine LLNA and GPMT are commonly used, internationally accepted
methods for identification o f chemical allergens. The LLNA is currently more
commonly employed, as it is less expensive with an objective endpoint. The G PM T’s
endpoints are more subjective, but it has greater sensitivity than the LLNA and allows
for chemical allergen cross-reactivity assessment. The current objective was to
178

evaluate allergenicity of MBT, its oxidation product MBTS, and analogues using an
animal allergenicity model.
Initial studies were conducted using the mouse LLNA, however, consistent and
reliable dose-dependent data for MBT and MBTS could not be obtained. The use o f
different vehicles and disruption o f the skin only slightly altered the lymph node cell
proliferative response to MBT, but the effect was not dose-dependent. Without a
definitive LLNA proliferative response to MBT, chemical allergen mechanism studies
using the analogues BT, HBT and MTBT could not be carried out to test the
hypothesis that the thiol group is critical to M BT’s allergenicity.
LLNA EC3 values reported for MBT in the the literature are inconsistent.
Dearman et al.5 reported that application solvent can greatly influence MBT allergenic
potency in the LLNA. AOO was reported to be the best solvent for MBT application
for MBT giving an EC3 o f <2.5. The EC3 reported in this article for MBT using
DMSO as the application solvent was 6.2. De Jong and et a/.305,306 were only able to
classify MBT as a sensitizer after modification o f the LLNA to include a 10% sodium
dodecyl sulfate (SDS) skin pretreatment step. It must be noted that considerable
intraexperiment variability was evident in this report. The production o f cytokines
IFN-y and IL-4 was also observed with MBT only after pretreatment o f the animals
with 10% SDS.307 On the other hand Van Och308 gave the EC3 value o f MBT to be
9% using AOO as the vehicle. Low EC3 values have been associated with vehicles in
which MBT has considerable solubility and thus probable transport into the epidermal
layer o f the skin. MBT dissolution is also supported by a recently proposed argument
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where the vehicle, in a similar fashion to SDS and skin breaching, is suspected to
provoke the relevant proinflammatory cytokines309 in the presence o f MBT. The use of
vehicles such as DMSO, co-administration with SDS and skin breaching results in
some degree o f dermal trauma which has been associated with the upregulation o f
cytokines IL-1, IL-6 and the tumor necrosis factor a (TNF- a)310 which are all
important in the effective development o f skin sensitization. It should also be noted
that SDS will denature endogeneous and exogeneous proteins (ex. normal bacterial
skin flora proteins) providing potential haptenation sites that would otherwise not
exist. The MBT LLNA results in this study were negative or equivocal regardless of
application solvent or even when the epidermal barrier was physically breached. The
guinea pig model provided a sensitive assay which enabled the testing o f the
hypothesized thiol-mediated pathogenesis. Sensitization to MBT was achieved by
injection o f MBT mixed with the adjuvant, TiterMax, into the guinea pig. This
method of sensitization bypasses the skin barrier. The adjuvant causes influx o f
inflammatory cells, increased cytokine production and oxidative stress at the site. The
increase in oxygen radical production would be expected to promote the oxidation o f
MBT to MBTS. This would be consistent with our proposed mechanism o f MBT
allergenicity proceeding through the initial oxidation product, MBTS. MBTS was
further implicated in the ACD mechanism by its ability to produce an ACD reaction in
MBT sensitized guinea pigs. The importance o f the thiol moiety as being the critical
chemical functional group was further demonstrated by lack o f allergic skin reactions
in MBT sensitized guinea pigs challenged with BT, HBT and MTBT.
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Skin sensitization is a complex immunological phenomenon which depends on
a variety o f biomolecular processes. Protein haptenation with subsequent proteolytic
digestion o f the covalently modified biomolecule leading to immunogenic haptenated
peptides is a prerequisite step in the cascading reactions which culminate in
sensitization. The results herein may explain some o f the shortcomings observed with
the main ‘electrophilic’ hapten hypothesis developed by Dupuis and Benezra.311 This
hypothesis is based on the assumption that the activity o f a chemical is directly related
to its electrophilic properties. While this electrophilic-based mechanism can be used to
explain the activity o f about 42% o f ACD-inducing skin sensitizers312 (aldehydes,
alkyl halides, sulfones, etc.), non-electrophilic protein haptenation mechanisms have
been invoked to explain the allergy related skin disorders that are due to exposure to
other classes o f compounds. MBT and MBTS are typical examples o f compounds
which haptenate proteins by non-electrophilic mechanisms. In this particular case
disulfide formation has been strongly implicated as a viable protein modification
pathway.
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